Name,SMILES,PubChemID,CPE CLASS,IUPAC NAME,CAS,CAS (cactus),logKp,Reference,Total Molweight,cLogP,cLogS,H-Acceptors,H-Donors,Polar Surface Area,Rotatable Bonds,Aromatic Rings,sp3-Atoms,Drug status,DRUGBANK,tag1,tag2,tag3,tag4,tag5,tag6,tag7,tag8 (SCAFFOLD name),Scaffold SMILES
5‐aminolevulinic acid,C(CC(=O)O)C(=O)CN,137,AA,5-amino-4-oxopentanoic acid,106-60-5,106-60-5,-4.15,"Krishnan G, Roberts MS, Grice J, Anissimov YG, Benson HA. Enhanced transdermal delivery of 5‐aminolevulinic acid and a dipeptide by iontophoresis. Biopolymers. 2011;96(2):166‐171.",131.13,-3.0402,-0.49,4,2,80.39,4,0,5,approved,DB00855,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,,
L‐alanyl‐L‐tryptophan,CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)N,85362,AA,2-(2-aminopropanamido)-3-(1H-indol-3-yl)propanoic acid,16305-75-2,16305-75-2,-4.82,"Krishnan G, Roberts MS, Grice J, Anissimov YG, Benson HA. Enhanced transdermal delivery of 5‐aminolevulinic acid and a dipeptide by iontophoresis. Biopolymers. 2011;96(2):166‐171.",275.307,-2.0668,-2.211,6,4,108.21,5,2,6,,,amide,amine,alkyl-amine,,aromatic nitrogen,basic nitrogen,acidic oxygen,,c1ccc2[nH]ccc2c1
Glycine,C(C(=O)O)N,750,AA,2-aminoacetic acid,56-40-6,"32817-15-5,33242-26-1,52955-63-2,57678-19-0,63183-41-5,7490-95-1,87867-94-5,25718-94-9,56-40-6,17829-66-2",-4.9,"Ruland, A., & Kreuter, J. (1991). Transdermal permeability and skin accumulation of amino acids. International Journal of Pharmaceutics, 72(2), 149–155. doi:10.1016/0378-5173(91)90053-q ",75.0667,-3.3504,-0.027999999999999997,3,2,63.32,1,0,3,approved; nutraceutical; vet_approved,DB00145,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,,
Lysine,C(CCN)CC(C(=O)O)N,5962,AA,"2,6-diaminohexanoic acid",56-87-1,"70-54-2,56-87-1",-3.54,"Sznitowska M, Berner B, Maibach HI. In vitro permeation of human skin by multipolar ions. Int J Pharm. 1993;99(1):43‐49",146.189,-4.6792,-0.785,4,3,89.34,5,0,8,approved; nutraceutical,DB00123,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,,
Aspartic acid,C(C(C(=O)O)N)C(=O)O,424,AA,2-aminobutanedioic acid,619-45-4,"617-45-8,56-84-8,1783-96-6",-3.95,"Sznitowska M, Berner B, Maibach HI. In vitro permeation of human skin by multipolar ions. Int J Pharm. 1993;99(1):43‐49",133.10299999999998,-3.813,-0.151,5,3,100.62,3,0,5,approved; nutraceutical,DB00128,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,,
Polyornithine,C(CC(C(=O)O)N)CN,6262,AA,"2,5-diaminopentanoic acid",70-26-8,"70-26-8,7006-33-9,348-66-3,616-07-9",,"Kamiya, Y., Yamaki, T., Omori, S., Uchida, M., Ohtake, K., Kimura, M., ... & Natsume, H. (2018). Improved intranasal retentivity and transnasal absorption enhancement by PEGylated poly-L-ornithine. Pharmaceuticals, 11(1), 9.",132.162,-5.1336,-0.515,4,3,89.34,4,0,7,approved; nutraceutical,DB00129,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,,
Histidine,C1=C(NC=N1)CC(C(=O)O)N,6274,AA,2-amino-3-(1H-imidazol-5-yl)propanoic acid,71-00-1,"184709-11-3,4998-57-6,7006-35-1,71-00-1",-4.25,"Sznitowska M, Berner B, Maibach HI. In vitro permeation of human skin by multipolar ions. Int J Pharm. 1993;99(1):43‐49",155.156,-3.5054,-0.38,5,3,92.0,3,1,4,,,,amine,alkyl-amine,,aromatic nitrogen,basic nitrogen,acidic oxygen,,c1c[nH]cn1
7-Aminoheptanoic (7-AHE) acid,C(CCCN)CCC(=O)O,13580,AA,7-aminoheptanoic acid,929-17-9,929-17-9,,"Hrabálek, A., & Vávrová, K. (2015). Transkarbams: Transdermal Penetration-Enhancing Carbamates. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 309-323). Springer, Berlin, Heidelberg.",145.201,-1.0784,-1.3780000000000001,3,2,63.32,6,0,8,approved; investigational,DB00513,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,,
cis-3-Nonen-1-ol,CCCCCC=CCCO,5364631,ALCOHOL,non-3-en-1-ol,10340-23-5,NA,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",142.241,2.9791,-2.1390000000000002,1,1,20.23,6,0,8,,,,,,,,,,,
Hexanol,CCCCCCO,8103,ALCOHOL,hexan-1-ol,111-27-3,"25917-35-5,111-27-3,220713-27-9",-1.66,"Bond, J.R. and Barry, B.W. (1988): Limitations of hairless mouse skin as a model for in vitro permeation studies through human skin: hydration damage. J. Invest. Dermatol., 90, 486‐489",102.176,1.8681,-1.557,1,1,20.23,4,0,7,approved; investigational,DB00632,,,,,,,,,
n‐octanol,CCCCCCCCO,957,ALCOHOL,octan-1-ol,111-87-5,"220713-26-8,67700-96-3,111-87-5,68603-15-6",-1.09,"Cross, S.E., Magnusson, B.M. Winckle, G., Anissimov, Y. and Roberts, M.S. (2003): Determination of the effect of lipophilicity on the in vitro permeability and tissue reservoir characteristics of topically applied solutes in human skin layers. J. Invest. Dermatol, 120, 759‐764",130.23,2.7769,-2.097,1,1,20.23,6,0,9,approved; investigational,DB00632,,,,,,,,,
Decanol,CCCCCCCCCCO,8174,ALCOHOL,decan-1-ol,112-30-1,"85566-12-7,66455-17-2,112-30-1,70084-71-8,118374-94-0,36729-58-5",-1.0,"Cross, S.E., Magnusson, B.M. Winckle, G., Anissimov, Y. and Roberts, M.S. (2003): Determination of the effect of lipophilicity on the in vitro permeability and tissue reservoir characteristics of topically applied solutes in human skin layers. J. Invest. Dermatol, 120, 759‐764",158.284,3.6857,-2.637,1,1,20.23,8,0,11,approved; investigational,DB00632,,,,,,,,,
1-Undecanol,CCCCCCCCCCCO,8184,ALCOHOL,undecan-1-ol,112-42-5,112-42-5,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",172.31099999999998,4.1401,-2.907,1,1,20.23,9,0,12,approved; investigational,DB00632,,,,,,,,,
Lauryl alcohol,CCCCCCCCCCCCO,8193,ALCOHOL,dodecan-1-ol,112-53-8,"8032-08-4,8032-09-5,8032-10-8,112-53-8,68551-07-5,1322-35-6,68855-55-0,8014-32-2",,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",186.33700000000002,4.5945,-3.177,1,1,20.23,10,0,13,approved; investigational,DB00632,,,,,,,,,
Myristyl alcohol,CCCCCCCCCCCCCCO,8209,ALCOHOL,tetradecan-1-ol,112-72-1,"63393-82-8,150138-88-8,8032-14-2,126339-59-1,126339-60-4,67762-41-8,52439-75-5,60650-34-2,68002-95-9,67762-30-5,67762-42-9,75782-87-5,68333-80-2,71750-71-5,112-72-1,179607-28-4,68855-56-1",,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",214.391,5.5033,-3.717,1,1,20.23,12,0,15,approved; investigational,DB00632,,,,,,,,,
1-Octadecanol,CCCCCCCCCCCCCCCCCCO,8221,ALCOHOL,octadecan-1-ol,112-92-5,"68911-61-5,112-92-5,193766-48-2,8014-37-7,8032-19-7,8032-21-1,8034-90-0",,"Babu, R. J., Chen, L., & Kanikkannan, N. (2015). Fatty alcohols, fatty acids, and fatty acid esters as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 133-150). Springer, Berlin, Heidelberg.",270.499,7.3209,-4.797,1,1,20.23,16,0,19,approved; investigational,DB00632,,,,,,,,,
2-Octanol,CCCCCCC(C)O,20083,ALCOHOL,octan-2-ol,123-96-6,"123-96-6,25339-16-6,4128-31-8,113301-48-7,6169-06-8,113244-40-9",,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",130.23,2.6818,-2.205,1,1,20.23,5,0,9,,,,,,,,,,,
n‐nonanol,CCCCCCCCCO,8914,ALCOHOL,nonan-1-ol,143-08-8,"143-08-8,28473-21-4",-0.98,"R. J. Scheuplein and I. H. Blank, ""Permeability of Skin,"" Physiol. Rev. 51, 702‐747 (1971)",144.257,3.2313,-2.367,1,1,20.23,7,0,10,approved; investigational,DB00632,,,,,,,,,
Oleyl alcohol,CCCCCCCCC=CCCCCCCCCO,5284499,ALCOHOL,octadec-9-en-1-ol,143-28-2,NA,,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",268.483,7.0687,-4.569,1,1,20.23,15,0,17,,,,,,,,,,,
cis-3-Octen-1-ol,CCCCC=CCCO,5364519,ALCOHOL,oct-3-en-1-ol,20125-84-2,NA,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",128.214,2.5247,-1.869,1,1,20.23,5,0,7,,,,,,,,,,,
14-Methyl-1-pentadecanol,CC(C)CCCCCCCCCCCCCO,5283265,ALCOHOL,14-methylpentadecan-1-ol,20194-48-3,NA,,"Babu, R. J., Chen, L., & Kanikkannan, N. (2015). Fatty alcohols, fatty acids, and fatty acid esters as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 133-150). Springer, Berlin, Heidelberg.",242.445,6.176,-4.147,1,1,20.23,13,0,17,,,,,,,,,,,
Isostearyl alcohol,CC(C)CCCCCCCCCCCCCCCO,62825,ALCOHOL,16-methylheptadecan-1-ol,27458-93-1,"120528-41-8,179607-17-1,27458-93-1,59231-38-8,41744-75-6",,"Babu, R. J., Chen, L., & Kanikkannan, N. (2015). Fatty alcohols, fatty acids, and fatty acid esters as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 133-150). Springer, Berlin, Heidelberg.",270.499,7.0848,-4.687,1,1,20.23,15,0,19,,,,,,,,,,,
Cetyl alcohol,CCCCCCCCCCCCCCCCO,2682,ALCOHOL,hexadecan-1-ol,36311-34-9,"36311-34-9,124-29-8,55069-45-9,8014-51-5,8023-37-8,8032-16-4,8032-17-5,8032-89-1,36653-82-4",,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",242.445,6.4121,-4.257,1,1,20.23,14,0,17,approved; investigational,DB00632,,,,,,,,,
Linoleyl alcohol,CCCCCC=CCC=CCCCCCCCCO,5365682,ALCOHOL,"octadeca-9,12-dien-1-ol",506-43-4,NA,,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",266.467,6.8165,-4.341,1,1,20.23,14,0,15,,,,,,,,,,,
Linolenyl alcohol,CCC=CCC=CCC=CCCCCCCCCO,6436081,ALCOHOL,"octadeca-9,12,15-trien-1-ol",506-44-5,NA,,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",264.45099999999996,6.5643,-4.113,1,1,20.23,13,0,13,,,,,,,,,,,
Heptanol,CCCCCCCO,8129,ALCOHOL,heptan-1-ol,53535-33-4,"53535-33-4,111-70-6",-1.49,"Chen, C. P., Chen, C. C., Huang, C. W., & Chang, Y. C. (2018). Evaluating molecular properties involved in transport of small molecules in stratum corneum: a quantitative structure-activity relationship for skin permeability. Molecules, 23(4), 911.",116.20299999999999,2.3225,-1.827,1,1,20.23,5,0,8,approved; investigational,DB00632,,,,,,,,,
2-Heptanol,CCCCCC(C)O,10976,ALCOHOL,heptan-2-ol,543-49-7,"6033-24-5,6033-23-4,52390-72-4,543-49-7",,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",116.20299999999999,2.2274,-1.935,1,1,20.23,4,0,8,,,,,,,,,,,
trans-3-Hexen-1-ol,CCC=CCCO,5284503,ALCOHOL,hex-3-en-1-ol,544-12-7,NA,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",100.16,1.6159,-1.329,1,1,20.23,3,0,5,,,,,,,,,,,
4-Heptanol,CCCC(CCC)O,11513,ALCOHOL,heptan-4-ol,589-55-9,589-55-9,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",116.20299999999999,2.2274,-1.935,1,1,20.23,4,0,8,,,,,,,,,,,
4-Octanol,CCCCC(CCC)O,11515,ALCOHOL,octan-4-ol,589-62-8,589-62-8,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",130.23,2.6818,-2.205,1,1,20.23,5,0,9,,,,,,,,,,,
3-Heptanol,CCCCC(CC)O,11520,ALCOHOL,heptan-3-ol,589-82-2,"40617-58-1,589-82-2",,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",116.20299999999999,2.2274,-1.935,1,1,20.23,4,0,8,,,,,,,,,,,
3-Octanol,CCCCCC(CC)O,11527,ALCOHOL,octan-3-ol,589-98-0,"29063-28-3,20296-29-1,589-98-0",,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",130.23,2.6818,-2.205,1,1,20.23,5,0,9,,,,,,,,,,,
4-Nonanol,CCCCCC(CCC)O,22217,ALCOHOL,nonan-4-ol,5932-79-6,"52708-03-9,5932-79-6,74742-09-9",,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",144.257,3.1362,-2.475,1,1,20.23,6,0,10,,,,,,,,,,,
3-Hexanol,CCCC(CC)O,12178,ALCOHOL,hexan-3-ol,623-37-0,"623-37-0,17015-11-1",,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",102.176,1.7730000000000001,-1.665,1,1,20.23,3,0,7,,,,,,,,,,,
5-Nonanol,CCCCC(CCCC)O,12202,ALCOHOL,nonan-5-ol,623-93-8,623-93-8,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",144.257,3.1362,-2.475,1,1,20.23,6,0,10,,,,,,,,,,,
3-Nonanol,CCCCCCC(CC)O,12216,ALCOHOL,nonan-3-ol,624-51-1,"74742-08-8,624-51-1",,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",144.257,3.1362,-2.475,1,1,20.23,6,0,10,,,,,,,,,,,
2-Hexanol,CCCCC(C)O,12297,ALCOHOL,hexan-2-ol,626-93-7,"626-93-7,20281-86-1,37769-60-1,69203-06-1,26549-24-6,54972-97-3,52019-78-0",,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",102.176,1.7730000000000001,-1.665,1,1,20.23,3,0,7,,,,,,,,,,,
2-Nonanol,CCCCCCCC(C)O,12367,ALCOHOL,nonan-2-ol,628-99-9,"74683-66-2,628-99-9",,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",144.257,3.1362,-2.475,1,1,20.23,6,0,10,,,,,,,,,,,
Ethanol,CCO,702,ALCOHOL,ethanol,64-17-5,"121182-78-3,64-17-5,8024-45-1,8000-16-6,68475-56-9,71076-86-3,71329-38-9",-3.08,"Cross, S.E., Magnusson, B.M. Winckle, G., Anissimov, Y. and Roberts, M.S. (2003): Determination of the effect of lipophilicity on the in vitro permeability and tissue reservoir characteristics of topically applied solutes in human skin layers. J. Invest. Dermatol, 120, 759‐764",46.0686,0.0505,-0.47700000000000004,1,1,20.23,0,0,3,approved,DB00898,,,,,,,,,
Methanol,CO,887,ALCOHOL,methanol,67-56-1,"54841-71-3,67-56-1",-3.0,"McAuliffe, D.J. and Blank, H.I. (1991): Effects of UVA (320‐400 nm) on the barrier characteristics of the skin. J. Invest. Dermatol., 96, 758‐762",32.0418,-0.3558,-0.177,1,1,20.23,0,0,2,,,,,,,,,,,
Isopropyl alcohol,CC(C)O,3776,ALCOHOL,propan-2-ol,67-63-0,"8013-70-5,67-63-0,5131-95-3",,"Ibrahim, S. A., & Li, S. K. (2010). Efficiency of fatty acids as chemical penetration enhancers: mechanisms and structure enhancement relationship. Pharmaceutical research, 27(1), 115.",60.0955,0.4098,-0.855,1,1,20.23,0,0,4,approved; investigational,DB02325,,,,,,,,,
Propanol,CCCO,1031,ALCOHOL,propan-1-ol,71-23-8,"71-23-8,62309-51-7",-2.79,"I.H. Blank, Penetration of low molecular weight alcohols into skin. 1. The effect of concentration of alcohol and type of vehicle, J. Invest. Dermatol. 43 (1964) 415‐420",60.0955,0.5049,-0.747,1,1,20.23,1,0,4,approved; experimental,DB03175,,,,,,,,,
n‐butanol,CCCCO,263,ALCOHOL,butan-1-ol,71-36-3,"107569-51-7,14254-05-8,42031-19-6,220713-25-7,35296-72-1,71-36-3",-2.47,"I. H. Blank, R. J. Scheuplein, and D. J. MacFarlane, ""Mechanism of Percutaneous Absorption. 111. The Effect of Temperature on the Transport of Non‐Electrolytes Across the Skin,"" J. Invest. Dermatol. 49,582‐589 (1967)",74.1224,0.9593,-1.0170000000000001,1,1,20.23,2,0,5,experimental,DB02145,,,,,,,,,
Pentanol,CCCCCO,6276,ALCOHOL,pentan-1-ol,71-41-0,71-41-0,-1.98,"Scheuplein, R.J. (1965): Mechanism of   percutaneous adsorption. I. Routes of penetration and the influence of solubility. J. Invest. Dermatol., 45, 334‐346.",88.1493,1.4137,-1.287,1,1,20.23,3,0,6,,,,,,,,,,,
cis-3-Penten-1-ol,CC=CCCO,5364628,ALCOHOL,pent-3-en-1-ol,764-38-5,NA,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",86.1334,1.1615,-1.0590000000000002,1,1,20.23,2,0,4,,,,,,,,,,,
"2-Heptyl-2-methyl-1,3-dioxolane (Azone_analog-298)",CCCCCCCC1(C)OCCO1,10943191,ALIPH. MISC.,"2-heptyl-2-methyl-1,3-dioxolane",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",186.294,3.199,-2.56,2,0,18.46,6,0,13,,,,,,,,,,Dioxolane,C1COCO1
"2,4-Dimethyl-2-nonyl-1,3-dioxolane (Azone_analog-302)",CCCCCCCCCC1(C)OCC(C)O1,91522586,ALIPH. MISC.,"2,4-dimethyl-2-nonyl-1,3-dioxolane",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",228.37400000000002,4.4325,-3.478,2,0,18.46,8,0,16,,,,,,,,,,Dioxolane,C1COCO1
"2-Methyl-2-undecyl-1,3-dioxolane (Azone_analog-300)",CCCCCCCCCCCC1(C)OCCO1,86181843,ALIPH. MISC.,"2-methyl-2-undecyl-1,3-dioxolane",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",242.40099999999998,5.0166,-3.64,2,0,18.46,10,0,17,,,,,,,,,,Dioxolane,C1COCO1
alpha-cyclodextrin,C(C1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(O2)C(C7O)O)CO)CO)CO)CO)CO)O)O)O,444913,ALIPH. MISC.,"5,10,15,20,25,30-hexakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29-dodecaoxaheptacyclo[26.2.2.2³,⁶.2⁸,¹¹.2¹³,¹⁶.2¹⁸,²¹.2²³,²⁶]dotetracontane-31,32,33,34,35,36,37,38,39,40,41,42-dodecol",10016-20-3,10016-20-3,,"Ghafourian, T., Nokhodchi, A., & Kaialy, W. (2015). Surfactants as penetration enhancers for dermal and transdermal drug delivery. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 207-230). Springer, Berlin, Heidelberg.",972.842,-11.023,1.27,30,18,474.9,6,0,66,experimental,DB01909,,,,,,,,,C1CC2OCC1OC1CCC(CO1)OC1CCC(CO1)OC1CCC(CO1)OC1CCC(CO1)OC1CCC(CO1)O2
Chloroacetonitrile,C(C#N)Cl,7856,ALIPH. MISC.,2-chloroacetonitrile,107-14-2,"107-14-2,1867-10-3",-1.0,"Trabaris M, Laskin JD, Weisel CP. Percutaneous absorption of haloacetonitriles and chloral hydrate and simulated human exposures. J Appl Toxicol. 2012;32(6):387‐394.",75.4979,0.4521,-1.5330000000000001,1,0,23.79,0,0,1,,,,,,,,,,,
Glyphosate,C(C(=O)O)NCP(=O)(O)O,3496,ALIPH. MISC.,2-[(phosphonomethyl)amino]acetic acid,1071-83-6,"40465-66-5,1071-83-6",-3.33,"R.C. Wester, D. Quan, H.I. Maibach, In vitro percutaneous absorption of model compounds glyphosate and malathion from cotton fabric into and through human skin, Food Chem. Toxicol. 34 (1996) 731‐735",169.07299999999998,-6.2784,0.34299999999999997,6,4,116.67,4,0,7,,,,,,,,basic nitrogen,acidic oxygen,,
Alaptide,CC1C(=O)NC2(CCCC2)C(=O)N1,119329,ALIPH. MISC.,"8-methyl-6,9-diazaspiro[4.5]decane-7,10-dione",107447-22-3,NA,,"Jampílek, J., & Dohnal, J. (2015). Alaptide as transdermal permeation modifier. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 115-132). Springer, Berlin, Heidelberg.",182.222,-0.3572,-1.555,4,2,58.2,0,0,7,,,amide,,,,,,,Cyclo(glycine-(1-amino-1-cyclopentane)carbonyl),O=C1CNC(=O)C2(CCCC2)N1
N‐ Nitrosodiethanolamine,C(CO)N(CCO)N=O,14223,ALIPH. MISC.,2-[(2-hydroxyethyl)(nitroso)amino]ethan-1-ol,1116-54-7,1116-54-7,-5.26,"R.L. Bronaugh, E.R. Congdon, R.J. Scheuplein, The effect of cosmetic vehicles on the penetration of N‐nitrosodiethanolamine through excised human skin, J. Invest. Dermatol. 76 (1981) 94‐96",134.134,-1.1784,0.612,5,2,73.13,4,0,6,,,,,,,,,,,
Ethyl acetate,CCOC(=O)C,8857,ALIPH. MISC.,ethyl acetate,141-78-6,141-78-6,,"Dragicevic, N., Atkinson, J. P., & Maibach, H. I. (2015). Chemical penetration enhancers: classification and mode of action. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 11-27). Springer, Berlin, Heidelberg.",88.1055,0.5351,-0.887,2,0,26.3,2,0,4,,,,,,,,,,,
"2-(1-Butyl)-2-methyl-1,3 dioxolane",CCCCC1(OCCO1)C,560042,ALIPH. MISC.,"2-butyl-2-methyl-1,3-dioxolane",14447-27-9,NA,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",144.213,1.8358,-1.75,2,0,18.46,3,0,10,,,,,,,,,,Dioxolane,C1COCO1
"2-Heptyl-2,4-dimethyl-1,3-dioxolane (Azone_analog-301)",CCCCCCCC1(C)OCC(C)O1,246089,ALIPH. MISC.,"2-heptyl-2,4-dimethyl-1,3-dioxolane",165191-91-3,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",200.321,3.5237,-2.938,2,0,18.46,6,0,14,,,,,,,,,,Dioxolane,C1COCO1
Cyclohexene oxide,C1CCC2C(C1)O2,9246,ALIPH. MISC.,7-oxabicyclo[4.1.0]heptane,286-20-4,"26637-95-6,286-20-4,28165-18-6,137422-07-2",,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",98.1444,0.9022,-1.8330000000000002,1,0,12.53,0,0,7,,,,,,,,,,,C1CCC2OC2C1
Dichloroacetonitrile,C(#N)C(Cl)Cl,18177,ALIPH. MISC.,"2,2-dichloroacetonitrile",3018-12-0,3018-12-0,-0.82,"Trabaris M, Laskin JD, Weisel CP. Percutaneous absorption of haloacetonitriles and chloral hydrate and simulated human exposures. J Appl Toxicol. 2012;32(6):387‐394.",109.943,0.8543,-1.83,1,0,23.79,0,0,1,,,,,,,,,,,
dibromoacetonitrile,C(#N)C(Br)Br,18617,ALIPH. MISC.,"2,2-dibromoacetonitrile",3252-43-5,3252-43-5,-0.77,"Trabaris M, Laskin JD, Weisel CP. Percutaneous absorption of haloacetonitriles and chloral hydrate and simulated human exposures. J Appl Toxicol. 2012;32(6):387‐394.",198.845,1.1163,-2.114,1,0,23.79,0,0,1,,,,,,,,,,,
"2-Methyl-2-nonyl-1,3-dioxolane (Azone_analog-299)",CCCCCCCCCC1(C)OCCO1,10013506,ALIPH. MISC.,"2-methyl-2-nonyl-1,3-dioxolane",38986-44-6,38986-44-6,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",214.347,4.1078,-3.1,2,0,18.46,8,0,15,,,,,,,,,,Dioxolane,C1COCO1
"2-Nonyl-1,3-dioxolane (Azone_analog-293)",CCCCCCCCCC1OCCO1,78056,ALIPH. MISC.,"2-nonyl-1,3-dioxolane",4353-06-4,04.06.4353,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",200.321,3.8435,-2.853,2,0,18.46,8,0,14,,,,,,,,,,Dioxolane,C1COCO1
"2-Heptyl-1,3-dioxolane (Azone_analog-292)",CCCCCCCC1OCCO1,78067,ALIPH. MISC.,"2-heptyl-1,3-dioxolane",4359-57-3,4359-57-3,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",172.267,2.9347,-2.313,2,0,18.46,6,0,12,,,,,,,,,,Dioxolane,C1COCO1
"1,1‐dichloropropanone",CC(=O)C(Cl)Cl,10567,ALIPH. MISC.,"1,1-dichloropropan-2-one",513-88-2,"513-88-2,30605-38-0",-1.36,"Xu X, Mariano TM, Laskin JD, Weisel CP. Percutaneous absorption of trihalomethanes, haloacetic acids, and haloketones. Toxicol Appl Pharmacol. 2002;184:19‐26",126.97,1.0101,-1.604,1,0,17.07,1,0,2,,,,,,,,,,,
"4-Methyl-2-nonyl-1,3-dioxolane (Azone_analog-296)",CCCCCCCCCC1OCC(C)O1,95397,ALIPH. MISC.,"4-methyl-2-nonyl-1,3-dioxolane",5421-12-5,05.12.5421,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",214.347,4.1682,-3.2310000000000003,2,0,18.46,8,0,15,,,,,,,,,,Dioxolane,C1COCO1
Nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],4510,ALIPH. MISC.,"1,3-bis(nitrooxy)propan-2-yl nitrate",55-63-0,"105469-31-6,80066-48-4,8013-23-8,9010-02-0,55-63-0",-1.96,"Michaels, A.S., Chandrasekaran, S.K. and Shaw, J.E. (1975): Drug permeation through human skin: Theory and in vitro experimental measurement. AIChE J., 21, 985‐996",227.085,-2.3418,-2.6460000000000004,12,0,165.15,8,0,9,approved; investigational,DB00727,,,,,,,acidic oxygen,,
bromochloroacetic acid,C(C(=O)O)(Cl)Br,542762,ALIPH. MISC.,2-bromo-2-chloroacetic acid,5589-96-8,5589-96-8,-2.79,"Xu X, Mariano TM, Laskin JD, Weisel CP. Percutaneous absorption of trihalomethanes, haloacetic acids, and haloketones. Toxicol Appl Pharmacol. 2002;184:19‐26",173.393,0.4634,-1.2990000000000002,2,1,37.3,1,0,2,,,,,,,,,acidic oxygen,,
Urea,C(=O)(N)N,1176,ALIPH. MISC.,Urea,57-13-6,"4744-36-9,57-13-6,173144-80-4,173994-65-5,174693-33-5,175276-38-7,30535-50-3,37955-36-5",-3.78,"Barber, E.D., Teetsel, N.M., Kolberg, K.F. and Guest, D. (1992): A comparative study of the rates of in vitro percutaneous absorption of eight chemicals using rat and human skin. Fundam. Appl. Toxicol., 19, 493‐497",60.0558,-1.3194,-0.7979999999999999,3,2,69.11,0,0,0,approved; investigational,DB03904,amide,,,,,,,,
"2-Undecyl-1,3-dioxolane (Azone_analog-294)",CCCCCCCCCCCC1OCCO1,241293,ALIPH. MISC.,"2-undecyl-1,3-dioxolane",5735-88-6,5735-88-6,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",228.37400000000002,4.7523,-3.3930000000000002,2,0,18.46,10,0,16,,,,,,,,,,Dioxolane,C1COCO1
dimethylethylamine,CCN(C)C,11723,ALIPH. MISC.,ethyldimethylamine,598-56-1,"70955-13-4,598-56-1",-2.39,"Lundh T, Boman A, Akesson B. Skin absorption of the industrial catalyst dimethylethylamine in vitro in guinea pig and human skin, and of gaseous dimethylethylamine in human volunteers. Int Arch Occup Environ Health. 1997;70(5):309‐313.",73.1383,0.2707,-0.107,1,0,3.24,1,0,5,,,,amine,alkyl-amine,,,basic nitrogen,,,
dibromoacetic acid,C(C(=O)O)(Br)Br,12433,ALIPH. MISC.,"2,2-dibromoacetic acid",631-64-1,631-64-1,-2.58,"Xu X, Mariano TM, Laskin JD, Weisel CP. Percutaneous absorption of trihalomethanes, haloacetic acids, and haloketones. Toxicol Appl Pharmacol. 2002;184:19‐26",217.84400000000002,0.5944,-1.4409999999999998,2,1,37.3,1,0,2,,,,,,,,,acidic oxygen,,
Acetic acid,CC(=O)O,176,ALIPH. MISC.,acetic acid,64-19-7,"157090-22-7,207004-55-5,9035-69-2,64-19-7,68475-71-8,77671-22-8",-2.52,"Buist HE, van Burgsteden JA, Freidig AP, Maas WJ, van de Sandt JJ. New in vitro dermal absorption database and the prediction of dermal absorption under finite conditions for risk assessment purposes. Regul Toxicol Pharmacol. 2010;57(2‐3):200‐209.",60.0518,-0.2991,-0.45899999999999996,2,1,37.3,0,0,2,approved,DB03166,,,,,,,acidic oxygen,,
Dimethyl sulphoxide,CS(=O)C,679,ALIPH. MISC.,methanesulfinylmethane,67-68-5,"164071-41-4,8070-53-9,67-68-5",-3.1,"Dragicevic, N., Atkinson, J. P., & Maibach, H. I. (2015). Chemical penetration enhancers: classification and mode of action. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 11-27). Springer, Berlin, Heidelberg.
Lundborg, M., Wennberg, C. L., Narangifard, A., Lindahl, E., & Norlén, L. (2018). Predicting drug permeability through skin using molecular dynamics simulation. Journal of Controlled Release, 283, 269–279. doi:10.1016/j.jconrel.2018.05.026 ",78.1346,-1.2837,-0.044000000000000004,1,0,36.28,0,0,3,approved; vet_approved,DB01093,,,,,,,,,
"1,1,1‐trichloroethane",CC(Cl)(Cl)Cl,6278,ALIPH. MISC.,"1,1,1-trichloroethane",71-55-6,"74552-83-3,71-55-6",-2.35,"I. H. Blank, R. J. Scheuplein, and D. J. MacFarlane, ""Mechanism of Percutaneous Absorption. 111. The Effect of Temperature on the Transport of Non‐Electrolytes Across the Skin,"" J. Invest. Dermatol. 49,582‐589 (1967)",133.405,2.4217,-2.185,0,0,0.0,0,0,2,,,,,,,,,,,
"2-Heptyl-4-methyl-1,3-dioxolane (Azone_analog-295)",CCCCCCCC1OCC(C)O1,560109,ALIPH. MISC.,"2-heptyl-4-methyl-1,3-dioxolane",74094-61-4,74094-61-4,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",186.294,3.2594,-2.6910000000000003,2,0,18.46,6,0,13,,,,,,,,,,Dioxolane,C1COCO1
bromodichloromethane,C(Cl)(Cl)Br,6359,ALIPH. MISC.,bromodichloromethane,75-27-4,75-27-4,-0.74,"Xu X, Mariano TM, Laskin JD, Weisel CP. Percutaneous absorption of trihalomethanes, haloacetic acids, and haloketones. Toxicol Appl Pharmacol. 2002;184:19‐26",163.829,1.7658,-3.6510000000000002,0,0,0.0,0,0,1,,,,,,,,,,,
Trimethylamine,CN(C)C,1146,ALIPH. MISC.,trimethylamine,75-50-3,"75-50-3,4558-12-7",-3.73,"S.H. Kenyon, P.L. Carmichael, S. Khalaque, S. Panchal, R. Waring, R. Harris, The passage of trimethylamine across rat and human skin, Food Chem. Toxicol. 42 (2004) 1619‐1628",59.1115,-0.1356,0.193,1,0,3.24,0,0,4,,,,amine,alkyl-amine,,,basic nitrogen,,,
trichloroacetic acid,C(=O)(C(Cl)(Cl)Cl)O,6421,ALIPH. MISC.,trichloroacetic acid,76-03-9,76-03-9,-2.72,"Xu X, Mariano TM, Laskin JD, Weisel CP. Percutaneous absorption of trihalomethanes, haloacetic acids, and haloketones. Toxicol Appl Pharmacol. 2002;184:19‐26",163.387,1.1454,-1.66,2,1,37.3,1,0,2,,,,,,,,,acidic oxygen,,
2‐butanone,CCC(=O)C,6569,ALIPH. MISC.,butan-2-one,78-93-3,"78-93-3,135311-02-3",-2.35,"I. H. Blank, R. J. Scheuplein, and D. J. MacFarlane, ""Mechanism of Percutaneous Absorption. 111. The Effect of Temperature on the Transport of Non‐Electrolytes Across the Skin,"" J. Invest. Dermatol. 49,582‐589 (1967)",72.1065,0.833,-1.176,1,0,17.07,1,0,3,,,,,,,,,,,
bromoacetic acid,C(C(=O)O)Br,6227,ALIPH. MISC.,2-bromoacetic acid,79-08-3,"79-08-3,418768-49-7",-2.85,"Xu X, Mariano TM, Laskin JD, Weisel CP. Percutaneous absorption of trihalomethanes, haloacetic acids, and haloketones. Toxicol Appl Pharmacol. 2002;184:19‐26",138.94799999999998,0.0612,-1.002,2,1,37.3,1,0,2,experimental,DB02198,,,,,,,acidic oxygen,,
Chloroacetic acid,C(C(=O)O)Cl,300,ALIPH. MISC.,2-chloroacetic acid,79-11-8,79-11-8,-2.95,"Xu X, Mariano TM, Laskin JD, Weisel CP. Percutaneous absorption of trihalomethanes, haloacetic acids, and haloketones. Toxicol Appl Pharmacol. 2002;184:19‐26",94.4968,-0.0698,-0.86,2,1,37.3,1,0,2,,,,,,,,,acidic oxygen,,
Methyl acetate,CC(=O)OC,6584,ALIPH. MISC.,methyl acetate,79-20-9,79-20-9,,"Dragicevic, N., Atkinson, J. P., & Maibach, H. I. (2015). Chemical penetration enhancers: classification and mode of action. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 11-27). Springer, Berlin, Heidelberg.",74.0786,0.1288,-0.5870000000000001,2,0,26.3,1,0,3,,,,,,,,,,,
dichloroacetic acid,C(C(=O)O)(Cl)Cl,6597,ALIPH. MISC.,"2,2-dichloroacetic acid",79-43-6,"79-43-6,42428-47-7",-2.72,"Xu X, Mariano TM, Laskin JD, Weisel CP. Percutaneous absorption of trihalomethanes, haloacetic acids, and haloketones. Toxicol Appl Pharmacol. 2002;184:19‐26",128.942,0.3324,-1.157,2,1,37.3,1,0,2,approved; investigational,DB08809,,,,,,,acidic oxygen,,
"4-Methyl-2-undecyl-1,3-dioxolane (Azone_analog-297)",CCCCCCCCCCCC1OCC(C)O1,241285,ALIPH. MISC.,"4-methyl-2-undecyl-1,3-dioxolane",82925-11-9,82925-11-9,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",242.40099999999998,5.077,-3.7710000000000004,2,0,18.46,10,0,17,,,,,,,,,,Dioxolane,C1COCO1
bromochloroacetonitrile,C(#N)C(Cl)Br,55004,ALIPH. MISC.,2-bromo-2-chloroacetonitrile,83463-62-1,83463-62-1,-0.79,"Trabaris M, Laskin JD, Weisel CP. Percutaneous absorption of haloacetonitriles and chloral hydrate and simulated human exposures. J Appl Toxicol. 2012;32(6):387‐394.",154.394,0.9853,-1.972,1,0,23.79,0,0,1,,,,,,,,,,,
"1,1,1‐ trichloropropanone",CC(=O)C(Cl)(Cl)Cl,13514,ALIPH. MISC.,"1,1,1-trichloropropan-2-one",918-00-3,"918-00-3,72497-18-8",-1.62,"Xu X, Mariano TM, Laskin JD, Weisel CP. Percutaneous absorption of trihalomethanes, haloacetic acids, and haloketones. Toxicol Appl Pharmacol. 2002;184:19‐26",161.415,1.8231,-2.1069999999999998,1,0,17.07,1,0,2,,,,,,,,,,,
"2-(1-Hexyl)-2-methyl-1,3 dioxolane",CCCCCCC1(C)OCCO1,70307,ALIPH. MISC.,"2-hexyl-2-methyl-1,3-dioxolane",937-94-0,937-94-0,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",172.267,2.7446,-2.29,2,0,18.46,5,0,12,,,,,,,,,,Dioxolane,C1COCO1
4‐nitrophenol,C1=CC(=CC=C1[N+](=O)[O-])O,980,AROM. MISC.,4-nitrophenol,100-02-7,100-02-7,-2.01,"Roberts MS, Anderson RA, Swarbrick J. Permeability of human epidermis to phenofic compounds. J.Pharm.Pharmac. 1977; 29: 677‐683",139.11,0.3923,-1.78,4,1,66.05,1,1,2,experimental,DB04417,,,,,,,acidic oxygen,Benzene,c1ccccc1
Ethyl benzene,CCC1=CC=CC=C1,7500,AROM. MISC.,ethylbenzene,100-41-4,"70955-17-8,68908-88-3,100-41-4,28213-80-1",0.08,"T. Dutkiewicz and H. Tyras, ""A Study of Skin Absorption of Ethylbenzene in Man,"" Br. J. Ind. Med. 24, 330‐332 (1967)",106.167,2.4191,-2.119,0,0,0.0,1,1,2,,,,,,,,,,Benzene,c1ccccc1
Styrene,C=CC1=CC=CC=C1,7501,AROM. MISC.,ethenylbenzene,100-42-5,"79637-11-9,68441-35-0,68987-41-7,9003-53-6,100-42-5,12770-88-6",-0.18,"T. Dutkiewicz and H. Tyras, ""Skin Absorption of Toluene, Styrene, and Xylene by Man,"" Br. J. Ind. Med. 25, 243‐246 (1968)",104.152,2.3625,-2.421,0,0,0.0,1,1,0,,,,,,,,,,Benzene,c1ccccc1
Benzyl alcohol,C1=CC=C(C=C1)CO,244,AROM. MISC.,phenylmethanol,100-51-6,"1336-27-2,185532-71-2,100-51-6",-2.0,"Barry, B.W., Harrison, S.M. and Dugard, P.H. (1985): Vapour and liquid diffusion of model penetrants through human skin: correlation with thermodynamic activity. J. Pharm. Pharmacol., 37, 226‐236",108.14,1.0623,-1.5,1,1,20.23,1,1,2,approved,DB06770,,,,,,,,Benzene,c1ccccc1
Benzaldehyde,C1=CC=C(C=C1)C=O,240,AROM. MISC.,benzaldehyde,100-52-7,100-52-7,-0.74,"Barry, B.W., Harrison, S.M. and Dugard, P.H. (1985): Vapour and liquid diffusion of model penetrants through human skin: correlation with thermodynamic activity. J. Pharm. Pharmacol., 37, 226‐236",106.124,1.5929,-1.94,1,0,17.07,1,1,0,,,,,,,,,,Benzene,c1ccccc1
Anisole,COC1=CC=CC=C1,7519,AROM. MISC.,anisole,100-66-3,100-66-3,-1.24,"Barry, B.W., Harrison, S.M. and Dugard, P.H. (1985): Vapour and liquid diffusion of model penetrants through human skin: correlation with thermodynamic activity. J. Pharm. Pharmacol., 37, 226‐236",108.14,1.5896,-1.6340000000000001,1,0,9.23,1,1,2,,,,,,,,,,Benzene,c1ccccc1
"1,3-diphenylurea",C1=CC=C(C=C1)NC(=O)NC2=CC=CC=C2,7595,AROM. MISC.,"1,3-diphenylurea",102-07-8,102-07-8,,"Williams, A. C. (2015). Urea and derivatives as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 301-308). Springer, Berlin, Heidelberg.",212.25099999999998,2.801,-3.6439999999999997,3,2,41.13,2,2,0,experimental,DB07496,amide,,,,,,,,O=C(Nc1ccccc1)Nc1ccccc1
"1,3-diphenylthiourea",C1=CC=C(C=C1)NC(=S)NC2=CC=CC=C2,700999,AROM. MISC.,"1,3-diphenylthiourea",102-08-9,102-08-9,,"Williams, A. C. (2015). Urea and derivatives as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 301-308). Springer, Berlin, Heidelberg.",228.31799999999998,3.1977,-3.728,2,2,56.15,2,2,1,,,,,,,,,,Sulfocarbanilide,S=C(Nc1ccccc1)Nc1ccccc1
4‐bromophenol,C1=CC(=CC=C1O)Br,7808,AROM. MISC.,4-bromophenol,106-41-2,106-41-2,-1.2,"Roberts MS, Anderson RA, Swarbrick J. Permeability of human epidermis to phenofic compounds. J.Pharm.Pharmac. 1977; 29: 677‐683",173.00900000000001,2.0391,-2.154,1,1,20.23,0,1,1,,,,,,,,,,Benzene,c1ccccc1
p‐cresol,CC1=CC=C(C=C1)O,2879,AROM. MISC.,4-methylphenol,106-44-5,"72269-62-6,106-44-5,1319-77-3,2876-02-0",-1.59,"Roberts MS, Anderson RA, Swarbrick J. Permeability of human epidermis to phenofic compounds. J.Pharm.Pharmac. 1977; 29: 677‐683",108.14,1.6578,-1.6640000000000001,1,1,20.23,0,1,2,experimental,DB01688,,,,,,,,Benzene,c1ccccc1
p‐chlorophenol,C1=CC(=CC=C1O)Cl,4684,AROM. MISC.,4-chlorophenol,106-48-9,106-48-9,-1.2,"Roberts MS, Anderson RA, Swarbrick J. Permeability of human epidermis to phenofic compounds. J.Pharm.Pharmac. 1977; 29: 677‐683",128.558,1.9199,-2.056,1,1,20.23,0,1,1,approved,DB13154,,,,,,,,Benzene,c1ccccc1
p‐phenylenediamine,C1=CC(=CC=C1N)N,7814,AROM. MISC.,"benzene-1,4-diamine",106-50-3,"106-50-3,56481-76-6",-3.52,"Bronaugh, R.L. and Congdon, E.R. (1984): Percutaneous absorption of hair dyes: correlation with partition coefficients. J. Invest. Dermatol., 83, 124‐127",108.14399999999999,0.305,-1.768,2,2,52.04,0,1,0,approved; experimental,DB14141,,amine,,aromatic amine,,,,Benzene,c1ccccc1
m‐cresol,CC1=CC(=CC=C1)O,342,AROM. MISC.,3-methylphenol,108-39-4,"108-39-4,15831-10-4",-1.58,"Roberts MS, Anderson RA, Swarbrick J. Permeability of human epidermis to phenofic compounds. J.Pharm.Pharmac. 1977; 29: 677‐683",108.14,1.6578,-1.6640000000000001,1,1,20.23,0,1,2,experimental,DB01776,,,,,,,,Benzene,c1ccccc1
resorcinol,C1=CC(=CC(=C1)O)O,5054,AROM. MISC.,"benzene-1,3-diol",108-46-3,"108-46-3,26982-54-7",-3.28,"Abraham MH, Martins F, Mitchell RC. 1997. Algorithms for skin permeability using hydrogen bond descriptors: The problem of steroids. J Pharm Pharmacol 49:858‐865",110.11200000000001,0.9682,-1.024,2,2,40.46,0,1,2,approved,DB11085,,,,,,,,Benzene,c1ccccc1
phloroglucinol,C1=C(C=C(C=C1O)O)O,359,AROM. MISC.,"benzene-1,3,5-triol",108-73-6,108-73-6,-2.51,"du Plessis J, Pugh WJ, Judefeind A, Hadgraft J. Physico‐chemical determinants of dermal drug delivery: effects of the number and substitution pattern of polar groups. Eur J Pharm Sci. 2002;16:107‐112.",126.111,0.6225,-0.728,3,3,60.69,0,1,3,investigational,DB12944,,,,,,,,Benzene,c1ccccc1
Toluene,CC1=CC=CC=C1,1140,AROM. MISC.,toluene,108-88-3,"3101-08-4,50643-04-4,108-88-3",-0.04,"B.D. Anderson, P.V. Raykar, Solute structure‐permeability relationships in human stratum corneum, J. Invest. Dermatol. 93 (1989) 280‐286",92.1405,2.1935,-1.96,0,0,0.0,0,1,1,vet_approved,DB11558,,,,,,,,Benzene,c1ccccc1
Phenol,C1=CC=C(C=C1)O,996,AROM. MISC.,phenol,108-95-2,"1336-35-2,108-95-2,63496-48-0,73607-76-8,61788-41-8,14534-23-7,50356-25-7,8002-07-1,27073-41-2",-1.94,"Roberts MS, Anderson RA, Swarbrick J. Permeability of human epidermis to phenofic compounds. J.Pharm.Pharmac. 1977; 29: 677‐683",94.1126,1.3139,-1.32,1,1,20.23,0,1,1,approved; experimental,DB03255,,,,,,,,Benzene,c1ccccc1
2‐Phenyl propanol,CC(CO)C1=CC=CC=C1,14295,AROM. MISC.,2-phenylpropan-1-ol,1123-85-9,"98103-87-8,1123-85-9",-1.28,"Diez Sales, O: Lopez Castellano, A., Maiques Lacer, F.J. and Herraez Dominguez, M. (1993): An in vitro percutaneous absorption study of non‐ionic compounds across human skin. 48, 684‐686",136.19299999999998,1.9199,-1.98,1,1,20.23,2,1,4,,,,,,,,,,Benzene,c1ccccc1
4‐amino‐2‐nitrophenol,C1=CC(=C(C=C1N)[N+](=O)[O-])O,3417419,AROM. MISC.,4-amino-2-nitrophenol,119-34-6,119-34-6,-2.45,"Bronaugh, R.L. and Congdon, E.R. (1984): Percutaneous absorption of hair dyes: correlation with partition coefficients. J. Invest. Dermatol., 83, 124‐127",154.125,-0.285,-1.8559999999999999,5,2,92.07,1,1,2,,,,amine,,aromatic amine,,,acidic oxygen,Benzene,c1ccccc1
isoquinoline,C1=CC=C2C=NC=CC2=C1,8405,AROM. MISC.,isoquinoline,119-65-3,119-65-3,-1.78,"Hadgraft J, Ridout G. Development of model membranes for percutaneous absorption measurements. I Isopropyl Myristate. lnt.J.Pharmaceutics 1987; 39: 149‐156",129.162,1.8531,-2.427,1,0,12.89,0,2,0,experimental,DB04329,,,,,aromatic nitrogen,,,,c1ccc2cnccc2c1
catechol,C1=CC=C(C(=C1)O)O,289,AROM. MISC.,"benzene-1,2-diol",120-80-9,"37349-32-9,16474-90-1,16474-89-8,12385-08-9,120-80-9",-2.51,"du Plessis J, Pugh WJ, Judefeind A, Hadgraft J. Physico‐chemical determinants of dermal drug delivery: effects of the number and substitution pattern of polar groups. Eur J Pharm Sci. 2002;16:107‐112.",110.11200000000001,0.9682,-1.024,2,2,40.46,0,1,2,experimental,DB02232,,,,,,,,Benzene,c1ccccc1
"2,4‐dichlorophenol",C1=CC(=C(C=C1Cl)Cl)O,8449,AROM. MISC.,"2,4-dichlorophenol",120-83-2,120-83-2,-0.98,"Roberts MS, Anderson RA, Swarbrick J. Permeability of human epidermis to phenofic compounds. J.Pharm.Pharmac. 1977; 29: 677‐683",163.003,2.5259,-2.792,1,1,20.23,0,1,1,,,,,,,,,,Benzene,c1ccccc1
Butylated hydroxyanisole,CC(C)(C)C1=C(C=CC(=C1)OC)O,8456,AROM. MISC.,2-tert-butyl-4-methoxyphenol,121-00-6,"1341-82-8,25013-16-5,921-00-6,121-00-6",,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",180.24599999999998,2.8258,-2.498,2,1,29.46,2,1,7,,,,,,,,,,Benzene,c1ccccc1
p‐ethylphenol,CCC1=CC=C(C=C1)O,31242,AROM. MISC.,4-ethylphenol,123-07-9,"29471-88-3,123-07-9,24979-70-2,101052-19-1",-1.21,"Roberts MS, Anderson RA, Swarbrick J. Permeability of human epidermis to phenofic compounds. J.Pharm.Pharmac. 1977; 29: 677‐683",122.166,2.0734,-1.8230000000000002,1,1,20.23,1,1,3,,,,,,,,,,Benzene,c1ccccc1
hydroquinone,C1=CC(=CC=C1O)O,785,AROM. MISC.,"benzene-1,4-diol",123-31-9,"57534-13-1,8027-02-9,123-31-9",-2.95,"du Plessis J, Pugh WJ, Judefeind A, Hadgraft J. Physico‐chemical determinants of dermal drug delivery: effects of the number and substitution pattern of polar groups. Eur J Pharm Sci. 2002;16:107‐112.",110.11200000000001,0.9682,-1.024,2,2,40.46,0,1,2,approved; investigational,DB09526,,,,,,,,Benzene,c1ccccc1
4‐Hydroxy‐ methylphenylacetate,COC(=O)CC1=CC=C(C=C1)O,518900,AROM. MISC.,methyl 2-(4-hydroxyphenyl)acetate,14199-15-6,14199-15-6,-1.7,"B.D. Anderson, P.V. Raykar, Solute structure‐permeability relationships in human stratum corneum, J. Invest. Dermatol. 93 (1989) 280‐286",166.175,1.225,-1.426,3,1,46.53,3,1,4,,,,,,,,,,Benzene,c1ccccc1
4‐Hydroxy‐phenylacetic acid,C1=CC(=CC=C1CC(=O)O)O,127,AROM. MISC.,2-(4-hydroxyphenyl)acetic acid,156-38-7,156-38-7,-2.55,"B.D. Anderson, P.V. Raykar, Solute structure‐permeability relationships in human stratum corneum, J. Invest. Dermatol. 93 (1989) 280‐286",152.149,0.7971,-1.298,3,2,57.53,2,1,3,,,,,,,,,acidic oxygen,Benzene,c1ccccc1
p‐n‐butylphenol,CCCCC1=CC=C(C=C1)O,15420,AROM. MISC.,4-butylphenol,1638-22-8,1638-22-8,-1.11,"Zhang Q, Grice JE, Li P, Jepps OG, Wang GJ, Roberts MS. Skin solubility determines maximum transepidermal flux for similar size molecules. Pharm Res. 2009;26(8):1974‐1985.",150.22,2.9822,-2.363,1,1,20.23,3,1,5,,,,,,,,,,Benzene,c1ccccc1
4‐ hydroxyphenylacetamide,C1=CC(=CC=C1CC(=O)N)O,86986,AROM. MISC.,2-(4-hydroxyphenyl)acetamide,17194-82-0,17194-82-0,-3.33,"B.D. Anderson, P.V. Raykar, Solute structure‐permeability relationships in human stratum corneum, J. Invest. Dermatol. 93 (1989) 280‐286",151.164,0.3993,-1.374,3,2,63.32,2,1,2,,,amide,,,,,,,Benzene,c1ccccc1
2-Phenyl-1-butanol,CCC(CO)C1=CC=CC=C1,95542,AROM. MISC.,2-phenylbutan-1-ol,2035-94-1,2035-94-1,-1.19,"Diez Sales, O: Lopez Castellano, A., Maiques Lacer, F.J. and Herraez Dominguez, M. (1993): An in vitro percutaneous absorption study of non‐ionic compounds across human skin. 48, 684‐686",150.22,2.3743,-2.25,1,1,20.23,3,1,5,,,,,,,,,,Benzene,c1ccccc1
Octoxynol 9,CC(C)(C)CC(C)(C)C1=CC=C(C=C1)OCCO,5590,AROM. MISC.,"2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethan-1-ol",2315-67-5,"81398-86-9,9010-42-8,9010-43-9,9077-65-0,9002-93-1,2315-67-5,63869-93-2,111287-03-7,125692-92-4,13463-07-5,39409-11-5,66057-68-9,66057-69-0,66057-82-7",,"Mélot, M., Pudney, P. D., Williamson, A. M., Caspers, P. J., Van Der Pol, A., & Puppels, G. J. (2009). Studying the effectiveness of penetration enhancers to deliver retinol through the stratum cornum by in vivo confocal Raman spectroscopy. Journal of controlled release, 138(1), 32-39.",250.38,4.343999999999999,-3.464,2,1,29.46,6,1,12,,,,,,,,,,Benzene,c1ccccc1
iso‐thymol,CC1=CC(=C(C=C1)O)C(C)C,78153,AROM. MISC.,4-methyl-2-(propan-2-yl)phenol,4427-56-9,4427-56-9,-1.28,"Chantasart D, Li SK. Relationship between the enhancement effects of chemical permeation enhancers on the lipoidal transport pathway across human skin under the symmetric and asymmetric conditions in vitro. Pharm Res. 2010;27(9):1825‐1836.",150.22,2.8448,-2.535,1,1,20.23,1,1,5,,,,,,,,,,Benzene,c1ccccc1
2‐nitro-p‐phenylenediamine,C1=CC(=C(C=C1N)[N+](=O)[O-])N,4338370,AROM. MISC.,"2-nitrobenzene-1,4-diamine",5307-14-2,"29467-01-4,5307-14-2",-3.2,"Bronaugh, R.L. and Congdon, E.R. (1984): Percutaneous absorption of hair dyes: correlation with partition coefficients. J. Invest. Dermatol., 83, 124‐127",153.141,-0.6166,-2.228,5,2,97.86,1,1,1,,,,amine,,aromatic amine,,,acidic oxygen,Benzene,c1ccccc1
"1,2,4‐benzenetriol",C1=CC(=C(C=C1O)O)O,10787,AROM. MISC.,"benzene-1,2,4-triol",533-73-3,533-73-3,-3.9,"du Plessis J, Pugh WJ, Judefeind A, Hadgraft J. Physico‐chemical determinants of dermal drug delivery: effects of the number and substitution pattern of polar groups. Eur J Pharm Sci. 2002;16:107‐112.",126.111,0.6225,-0.728,3,3,60.69,0,1,3,,,,,,,,,,Benzene,c1ccccc1
3‐nitrophenol,C1=CC(=CC(=C1)O)[N+](=O)[O-],11137,AROM. MISC.,3-nitrophenol,554-84-7,554-84-7,-2.01,"Roberts MS, Anderson RA, Swarbrick J. Permeability of human epidermis to phenofic compounds. J.Pharm.Pharmac. 1977; 29: 677‐683",139.11,0.3923,-1.78,4,1,66.05,1,1,2,,,,,,,,,acidic oxygen,Benzene,c1ccccc1
chlorocresol,CC1=C(C=CC(=C1)O)Cl,1732,AROM. MISC.,4-chloro-3-methylphenol,59-50-7,59-50-7,-1.26,"Roberts MS, Anderson RA, Swarbrick J. Permeability of human epidermis to phenofic compounds. J.Pharm.Pharmac. 1977; 29: 677‐683",142.585,2.2638,-2.4,1,1,20.23,0,1,2,,,,,,,,,,Benzene,c1ccccc1
2‐phenylethanol,C1=CC=C(C=C1)CCO,6054,AROM. MISC.,2-phenylethan-1-ol,60-12-8,"60-12-8,1321-27-3",-1.64,"Barry, B.W., Harrison, S.M. and Dugard, P.H. (1985): Vapour and liquid diffusion of model penetrants through human skin: correlation with thermodynamic activity. J. Pharm. Pharmacol., 37, 226‐236",122.166,1.4924,-1.6119999999999999,1,1,20.23,2,1,3,experimental,DB02192,,,,,,,,Benzene,c1ccccc1
aniline,C1=CC=C(C=C1)N,6115,AROM. MISC.,aniline,62-53-3,"62-53-3,146997-94-6,17843-02-6,53894-37-4,37342-16-8",-1.42,"B. Baranowska‐Dutkiewicz, ""Skin Absorption of Aniline from Aqueous Solutions in Man,"" Toxicol. Lett. 10, 367‐372 (1982)",93.1286,0.9823,-1.692,1,1,26.02,0,1,0,experimental,DB06728,,amine,,aromatic amine,,,,Benzene,c1ccccc1
4‐hydroxybenzyl alcohol,C1=CC(=CC=C1CO)O,125,AROM. MISC.,4-(hydroxymethyl)phenol,623-05-2,623-05-2,-2.7,"B.D. Anderson, P.V. Raykar, Solute structure‐permeability relationships in human stratum corneum, J. Invest. Dermatol. 93 (1989) 280‐286",124.139,0.7166,-1.204,2,2,40.46,1,1,3,,,,,,,,,,Benzene,c1ccccc1
Phenylethylamine,C1=CC=C(C=C1)CCN,1001,AROM. MISC.,2-phenylethan-1-amine,64-04-0,64-04-0,-3.77,"Singh, P., Anliker, M., Smith, G.A., Zavortink, D. and Maibach, H.I. (1995): Transdermal iontophoresis and solute penetration across excised human skin. J. Pharm.  Sci., 84, 1342‐1346",121.182,1.0946,-1.6880000000000002,1,1,26.02,2,1,3,experimental,DB04325,,amine,alkyl-amine,,,basic nitrogen,,Benzene,c1ccccc1
benzoic acid,C1=CC=C(C=C1)C(=O)O,243,AROM. MISC.,benzoic acid,65-85-0,"65-85-0,8013-63-6",-1.85,"Buist HE, van Burgsteden JA, Freidig AP, Maas WJ, van de Sandt JJ. New in vitro dermal absorption database and the prediction of dermal absorption under finite conditions for risk assessment purposes. Regul Toxicol Pharmacol. 2010;57(2‐3):200‐209.",122.12299999999999,1.1447,-1.629,2,1,37.3,1,1,1,approved; investigational,DB03793,,,,,,,acidic oxygen,Benzene,c1ccccc1
Benzene,C1=CC=CC=C1,241,AROM. MISC.,benzene,71-43-2,"27271-55-2,68956-52-5,26181-88-4,174973-66-1,54682-86-9,71-43-2",-0.88,"I. H. Blank and D. J. McAuliffe, ""Penetration of Benzene through Human Skin,"" J. Invest. Dennatol. 85, 522‐526 (1985)",78.1136,1.6596,-1.6159999999999999,0,0,0.0,0,1,0,,,,,,,,,,Benzene,c1ccccc1
4‐cyanophenol,C1=CC(=CC=C1C#N)O,13019,AROM. MISC.,4-hydroxybenzonitrile,767-00-0,767-00-0,-2.17,Romonchuk WJ. Mechanism of enhanced dermal permeation of 4‐cyanophenol and methyl paraben from saturated aqueous solutions containing both solutes. Skin Pharmacol Physiol. 2010;23(3):152‐163.,119.12299999999999,1.1495,-2.093,2,1,44.02,0,1,1,,,,,,,,,,Benzene,c1ccccc1
pyrogallol,C1=CC(=C(C(=C1)O)O)O,1057,AROM. MISC.,"benzene-1,2,3-triol",87-66-1,87-66-1,-2.81,"du Plessis J, Pugh WJ, Judefeind A, Hadgraft J. Physico‐chemical determinants of dermal drug delivery: effects of the number and substitution pattern of polar groups. Eur J Pharm Sci. 2002;16:107‐112.",126.111,0.6225,-0.728,3,3,60.69,0,1,3,,,,,,,,,,Benzene,c1ccccc1
chloroxylenol,CC1=CC(=CC(=C1Cl)C)O,2723,AROM. MISC.,"4-chloro-3,5-dimethylphenol",88-04-0,88-04-0,-1.17,"Roberts MS, Anderson RA, Swarbrick J. Permeability of human epidermis to phenofic compounds. J.Pharm.Pharmac. 1977; 29: 677‐683",156.611,2.6077,-2.7439999999999998,1,1,20.23,0,1,3,approved,DB11121,,,,,,,,Benzene,c1ccccc1
"2,4,6‐trichlorophenol",C1=C(C=C(C(=C1Cl)O)Cl)Cl,6914,AROM. MISC.,"2,4,6-trichlorophenol",88-06-2,88-06-2,-1.06,"Roberts MS, Anderson RA, Swarbrick J. Permeability of human epidermis to phenofic compounds. J.Pharm.Pharmac. 1977; 29: 677‐683",197.44799999999998,3.1319,-3.528,1,1,20.23,0,1,1,,,,,,,,,,Benzene,c1ccccc1
o‐t‐butylphenol,CC(C)(C)C1=CC=CC=C1O,6923,AROM. MISC.,2-tert-butylphenol,88-18-6,"88-18-6,27178-34-3",-1.12,"Zhang Q, Grice JE, Li P, Jepps OG, Wang GJ, Roberts MS. Skin solubility determines maximum transepidermal flux for similar size molecules. Pharm Res. 2009;26(8):1974‐1985.",150.22,2.8958,-2.48,1,1,20.23,1,1,5,,,,,,,,,,Benzene,c1ccccc1
Salicylaldehyde,C1=CC=C(C(=C1)C=O)O,6998,AROM. MISC.,2-hydroxybenzaldehyde,90-02-8,"90-02-8,27761-48-4",,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",122.12299999999999,1.2472,-1.6440000000000001,2,1,37.3,1,1,1,,,,,,,,,,Benzene,c1ccccc1
o‐cresol,CC1=CC=CC=C1O,335,AROM. MISC.,2-methylphenol,95-48-7,95-48-7,-1.56,"Roberts MS, Anderson RA, Swarbrick J. Permeability of human epidermis to phenofic compounds. J.Pharm.Pharmac. 1977; 29: 677‐683",108.14,1.6578,-1.6640000000000001,1,1,20.23,0,1,2,,,,,,,,,,Benzene,c1ccccc1
o‐phenylenediamine,C1=CC=C(C(=C1)N)N,7243,AROM. MISC.,"benzene-1,2-diamine",95-54-5,95-54-5,-3.25,"Bronaugh, R.L. and Congdon, E.R. (1984): Percutaneous absorption of hair dyes: correlation with partition coefficients. J. Invest. Dermatol., 83, 124‐127",108.14399999999999,0.305,-1.768,2,2,52.04,0,1,0,,,,amine,,aromatic amine,,,,Benzene,c1ccccc1
2‐chlorophenol,C1=CC=C(C(=C1)O)Cl,7245,AROM. MISC.,2-chlorophenol,95-57-8,"25167-80-0,95-57-8",-1.24,"Roberts MS, Anderson RA, Swarbrick J. Permeability of human epidermis to phenofic compounds. J.Pharm.Pharmac. 1977; 29: 677‐683",128.558,1.9199,-2.056,1,1,20.23,0,1,1,experimental,DB03110,,,,,,,,Benzene,c1ccccc1
"3,4‐xylenol",CC1=C(C=C(C=C1)O)C,7249,AROM. MISC.,"3,4-dimethylphenol",95-65-8,95-65-8,-1.2,"Roberts MS, Anderson RA, Swarbrick J. Permeability of human epidermis to phenofic compounds. J.Pharm.Pharmac. 1977; 29: 677‐683",122.166,2.2017,-2.008,1,1,20.23,0,1,3,experimental,DB04052,,,,,,,,Benzene,c1ccccc1
4‐chloro‐m‐ phenylenediamine,C1=CC(=C(C=C1Cl)N)N,7263,AROM. MISC.,"4-chlorobenzene-1,2-diamine",95-83-0,95-83-0,-2.83,"Bronaugh, R.L. and Congdon, E.R. (1984): Percutaneous absorption of hair dyes: correlation with partition coefficients. J. Invest. Dermatol., 83, 124‐127",142.589,0.9109999999999999,-2.504,2,2,52.04,0,1,0,,,,amine,,aromatic amine,,,,Benzene,c1ccccc1
2‐amino‐4‐nitrophenol,C1=CC(=C(C=C1[N+](=O)[O-])N)O,3613389,AROM. MISC.,2-amino-4-nitrophenol,99-57-0,99-57-0,-3.08,"Bronaugh, R.L. and Congdon, E.R. (1984): Percutaneous absorption of hair dyes: correlation with partition coefficients. J. Invest. Dermatol., 83, 124‐127",154.125,-0.285,-1.8559999999999999,5,2,92.07,1,1,2,,,,amine,,aromatic amine,,,acidic oxygen,Benzene,c1ccccc1
1-(Azepan-1-yl)non-8-en-1-one (Azone_analog-69),C=CCCCCCCC(=O)N1CCCCCC1,19855841,AZEPANE,1-(azepan-1-yl)non-8-en-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",237.385,4.3914,-3.1439999999999997,2,0,20.31,7,0,12,,,amide,,,,,,,Azepane,C1CCCNCC1
1-(Azepan-1-yl)dec-9-en-1-one (Azone_analog-70),C=CCCCCCCCC(=O)N1CCCCCC1,19855875,AZEPANE,1-(azepan-1-yl)dec-9-en-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",251.412,4.8458,-3.4139999999999997,2,0,20.31,8,0,13,,,amide,,,,,,,Azepane,C1CCCNCC1
1-(Azepan-1-yl)undec-10-en-1-one (Azone_analog-71),C=CCCCCCCCCC(=O)N1CCCCCC1,14772396,AZEPANE,1-(azepan-1-yl)undec-10-en-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",265.439,5.3002,-3.6839999999999997,2,0,20.31,9,0,14,,,amide,,,,,,,Azepane,C1CCCNCC1
"1-(2,6-Dimethylazepan-1-yl)dodec-10-en-1-one (Azone_analog-77)",CC=CCCCCCCCCC(=O)N1CC(C)CCCC1C,53958437,AZEPANE,"1-(2,6-dimethylazepan-1-yl)dodec-10-en-1-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",307.52,6.2819,-4.325,2,0,20.31,9,0,17,,,amide,,,,,,,Azepane,C1CCCNCC1
1-(Azepan-1-yl)tetradec-13-en-1-one (Azone_analog-72),C=CCCCCCCCCCCCC(=O)N1CCCCCC1,19855877,AZEPANE,1-(azepan-1-yl)tetradec-13-en-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",307.52,6.6634,-4.494,2,0,20.31,12,0,17,,,amide,,,,,,,Azepane,C1CCCNCC1
"1-(2,6-Dimethylazepan-1-yl)tridec-11-en-1-one (Azone_analog-78)",CC=CCCCCCCCCCC(=O)N1CC(C)CCCC1C,53993548,AZEPANE,"1-(2,6-dimethylazepan-1-yl)tridec-11-en-1-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",321.547,6.7363,-4.595,2,0,20.31,10,0,18,,,amide,,,,,,,Azepane,C1CCCNCC1
1-(Azepan-1-yl)pentadec-14-en-1-one (Azone_analog-73),C=CCCCCCCCCCCCCC(=O)N1CCCCCC1,19855842,AZEPANE,1-(azepan-1-yl)pentadec-14-en-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",321.547,7.1178,-4.763999999999999,2,0,20.31,13,0,18,,,amide,,,,,,,Azepane,C1CCCNCC1
"1-(2,6-Dimethylazepan-1-yl)tetradec-12-en-1-one (Azone_analog-79)",CC=CCCCCCCCCCCC(=O)N1CC(C)CCCC1C,54086713,AZEPANE,"1-(2,6-dimethylazepan-1-yl)tetradec-12-en-1-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",335.574,7.1907,-4.865,2,0,20.31,11,0,19,,,amide,,,,,,,Azepane,C1CCCNCC1
1-(Azepan-1-yl)hexadec-15-en-1-one (Azone_analog-74),C=CCCCCCCCCCCCCCC(=O)N1CCCCCC1,19855829,AZEPANE,1-(azepan-1-yl)hexadec-15-en-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",335.574,7.5722,-5.034,2,0,20.31,14,0,19,,,amide,,,,,,,Azepane,C1CCCNCC1
"1-(2,6-Dimethylazepan-1-yl)hexadec-10-en-1-one (Azone_analog-80)",CCCCCC=CCCCCCCCCC(=O)N1CC(C)CCCC1C,54030725,AZEPANE,"1-(2,6-dimethylazepan-1-yl)hexadec-10-en-1-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",363.62699999999995,8.0995,-5.405,2,0,20.31,13,0,21,,,amide,,,,,,,Azepane,C1CCCNCC1
1-(Azepan-1-yl)octadec-17-en-1-one (Azone_analog-75),C=CCCCCCCCCCCCCCCCC(=O)N1CCCCCC1,19855826,AZEPANE,1-(azepan-1-yl)octadec-17-en-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",363.62699999999995,8.481,-5.574,2,0,20.31,16,0,21,,,amide,,,,,,,Azepane,C1CCCNCC1
"1-(2,6-Dimethylazepan-1-yl)octadec-10-en-1-one (Azone_analog-81)",CCCCCCCC=CCCCCCCCCC(=O)N1CC(C)CCCC1C,54409994,AZEPANE,"1-(2,6-dimethylazepan-1-yl)octadec-10-en-1-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",391.681,9.1983,-5.945,2,0,20.31,15,0,23,,,amide,,,,,,,Azepane,C1CCCNCC1
1-Decylhexahydro-1H-azepine (Azone_analog-59),CCCCCCCCCCN1CCCCCC1,10331834,AZEPANE,1-decylazepane,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",239.445,5.3809,-3.4930000000000003,1,0,3.24,9,0,17,,,,amine,alkyl-amine,,,basic nitrogen,,Azepane,C1CCCNCC1
1-Octadecylazepane (Azone_analog-64),CCCCCCCCCCCCCCCCCCN1CCCCCC1,19736098,AZEPANE,1-octadecylazepane,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",351.66,9.0161,-5.653,1,0,3.24,17,0,25,,,,amine,alkyl-amine,,,basic nitrogen,,Azepane,C1CCCNCC1
"1H-Azepine, 1-hexadecylhexahydro- (Azone_analog-63)",CCCCCCCCCCCCCCCCN1CCCCCC1,10403939,AZEPANE,1-hexadecylazepane,113458-98-3,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",323.606,8.1073,-5.113,1,0,3.24,15,0,23,,,,amine,alkyl-amine,,,basic nitrogen,,Azepane,C1CCCNCC1
1-(Azepan-1-yl)octan-1-one (Azone_analog-65),CCCCCCCC(=O)N1CCCCCC1,246824,AZEPANE,1-(azepan-1-yl)octan-1-one,18494-58-1,18494-58-1,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",225.37400000000002,4.1225,-2.935,2,0,20.31,6,0,13,,,amide,,,,,,,Azepane,C1CCCNCC1
Hexamethylenelauramide (Azone_analog-66),CCCCCCCCCCCC(=O)N1CCCCCC1,96224,AZEPANE,1-(azepan-1-yl)dodecan-1-one,18494-60-5,18494-60-5,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",281.482,5.9401,-4.015,2,0,20.31,10,0,17,,,amide,,,,,,,Azepane,C1CCCNCC1
1-Dodecylazepane (Azone_analog-61),CCCCCCCCCCCCN1CCCCCC1,3366129,AZEPANE,1-dodecylazepane,20422-09-7,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",267.499,6.2897,-4.033,1,0,3.24,11,0,19,,,,amine,alkyl-amine,,,basic nitrogen,,Azepane,C1CCCNCC1
1-(Azepan-1-yl)hexadecan-1-one (Azone_analog-67),CCCCCCCCCCCCCCCC(=O)N1CCCCCC1,246834,AZEPANE,1-(azepan-1-yl)hexadecan-1-one,70974-50-4,70974-50-4,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",337.589,7.7577,-5.095,2,0,20.31,14,0,21,,,amide,,,,,,,Azepane,C1CCCNCC1
1-Undecylazepane (Azone_analog-60),CCCCCCCCCCCN1CCCCCC1,12760937,AZEPANE,1-undecylazepane,79089-51-3,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",253.472,5.8353,-3.763,1,0,3.24,10,0,18,,,,amine,alkyl-amine,,,basic nitrogen,,Azepane,C1CCCNCC1
"1H-Azepine, hexahydro-1-tetradecyl- (Azone_analog-62)",CCCCCCCCCCCCCCN1CCCCCC1,3276058,AZEPANE,1-tetradecylazepane,89632-36-0,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",295.553,7.1985,-4.573,1,0,3.24,13,0,21,,,,amine,alkyl-amine,,,basic nitrogen,,Azepane,C1CCCNCC1
1-Dodecylazepane-2-thione (Azone_analog-50),N1(C(=S)CCCCC1)CCCCCCCCCCCC,10108679,AZONE OTHER,1-dodecylazepane-2-thione,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",297.54900000000004,5.9429,-4.952,1,0,35.33,11,0,18,,,,,,,,,,Thiocaprolactam,S=C1CCCCCN1
1-Butylpyrrolidine-2-thione (Azone_analog-230),CCCCN1CCCC1=S,19736097,AZONE OTHER,1-butylpyrrolidine-2-thione,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",157.28,1.6237,-2.252,1,0,35.33,3,0,8,,,,,,,,,,ThioPyrrolidonee,S=C1CCCN1
1-Octylpyrrolidine-2-thione (Azone_analog-231),CCCCCCCCN1CCCC1=S,19736095,AZONE OTHER,1-octylpyrrolidine-2-thione,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",213.388,3.4413,-3.332,1,0,35.33,7,0,12,,,,,,,,,,ThioPyrrolidonee,S=C1CCCN1
1-Dodecylpyrrolidine-2-thione (Azone_analog-232),CCCCCCCCCCCCN1CCCC1=S,19786390,AZONE OTHER,1-dodecylpyrrolidine-2-thione,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",269.495,5.2589,-4.412,1,0,35.33,11,0,16,,,,,,,,,,ThioPyrrolidonee,S=C1CCCN1
1-Dodecylpiperidine-2-thione (Azone_analog-100),CCCCCCCCCCCCN1CCCCC1=S,19736096,AZONE OTHER,1-dodecylpiperidine-2-thione,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",283.522,5.6009,-4.6819999999999995,1,0,35.33,11,0,17,,,,,,,,,,ThioPyrrolidonee,S=C1CCCCN1
1-[7-(2-Oxopyrrolidin-1-yl)heptyl]pyrrolidin-2-one (Azone_analog-315),O=C1CCCN1CCCCCCCN1CCCC1=O,4398813,AZONE OTHER,1-[7-(2-oxopyrrolidin-1-yl)heptyl]pyrrolidin-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",266.383,2.2858,-1.916,4,0,40.62,8,0,13,,,amide,,,,,,,"1,1'-heptane-1,7-diyldipyrrolidin-2-one",O=C1CCCN1CCCCCCCN1CCCC1=O
"1-Dodecylpyrrolidine-2,4-dione (Azone_analog-271)",CCCCCCCCCCCCN1CC(=O)CC1=O,24876780,AZONE OTHER,"1-dodecylpyrrolidine-2,4-dione",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",267.411,4.3311,-3.127,3,0,37.38,11,0,14,,,amide,,,,,,,"2,4-Pyrrolidinedione",O=C1CNC(=O)C1
"4-Dodecylmorpholine-3,5-dione (Azone_analog-136)",CCCCCCCCCCCCN1C(=O)COCC1=O,85853009,AZONE OTHER,"4-dodecylmorpholine-3,5-dione",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",283.41,3.6513,-2.838,4,0,46.61,11,0,15,,,amide,,,,,,,Diglycolimide,O=C1COCC(=O)N1
"4-Tetradecylmorpholine-3,5-dione (Azone_analog-137)",CCCCCCCCCCCCCCN1C(=O)COCC1=O,85693241,AZONE OTHER,"4-tetradecylmorpholine-3,5-dione",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",311.464,4.5601,-3.378,4,0,46.61,13,0,17,,,amide,,,,,,,Diglycolimide,O=C1COCC(=O)N1
4-Methoxy-1-methyl-3H-azepin-2-one (Azone_analog-87),COC1=CC=CN(C)C(=O)C1,19881566,AZONE OTHER,"4-methoxy-1-methyl-2,3-dihydro-1H-azepin-2-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",153.18,0.1584,-1.07,3,0,29.54,1,0,4,,,amide,,,,,,,Dihydroazepinone,O=C1CC=CC=CN1
4-Acetyl-1-methyl-3H-azepin-2-one (Azone_analog-88),CN1C=CC=C(CC1=O)C(C)=O,19881561,AZONE OTHER,"4-acetyl-1-methyl-2,3-dihydro-1H-azepin-2-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",165.19099999999997,0.0719,-1.057,3,0,37.38,1,0,3,,,amide,,,,,,,Dihydroazepinone,O=C1CC=CC=CN1
"N,N-Diethyl-1-methyl-2-oxo-3H-azepine-4-carboxamide (Azone_analog-89)",CCN(CC)C(=O)C1=CC=CN(C)C(=O)C1,19881558,AZONE OTHER,"N,N-diethyl-1-methyl-2-oxo-2,3-dihydro-1H-azepine-4-carboxamide",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",222.287,0.42700000000000005,-0.84,4,0,40.62,3,0,6,,,amide,,,,,,,Dihydroazepinone,O=C1CC=CC=CN1
1-Methyl-4-phenyl-3H-azepin-2-one (Azone_analog-86),CN1C=CC=C(CC1=O)C1=CC=CC=C1,19881572,AZONE OTHER,"1-methyl-4-phenyl-2,3-dihydro-1H-azepin-2-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",199.252,1.4855,-1.9680000000000002,2,0,20.31,1,1,2,,,amide,,,,,,,,O=C1CC(c2ccccc2)=CC=CN1
"4-decyl-1,4-oxazepan-5,7-dione (Azone_analog-57)",O1CCN(C(=O)CC1=O)CCCCCCCCCC,85693237,AZONE OTHER,"4-decyl-1,4-oxazepane-5,7-dione",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",269.383,3.0845,-2.568,4,0,46.61,9,0,14,,,amide,,,,,,,,O=C1CC(=O)OCCN1
1-Dodecyl-2H-azepin-7-one (Azone_analog-55),N1(C(=O)C=CC=CC1)CCCCCCCCCCCC,19881564,AZONE OTHER,"1-dodecyl-2,7-dihydro-1H-azepin-2-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",277.45,5.1727,-3.5589999999999997,2,0,20.31,11,0,13,,,amide,,,,,,,,O=C1C=CC=CCN1
1-Dodecylazacyclohept-3-ene-2-one (Azone_analog-51),N1(C(=O)C=CCCC1)CCCCCCCCCCCC,14182696,AZONE OTHER,"1-dodecyl-2,5,6,7-tetrahydro-1H-azepin-2-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",279.466,5.4481,-3.787,2,0,20.31,11,0,15,,,amide,,,,,,,,O=C1C=CCCCN1
1-Dodecylazacyclohept-4-ene-2-one (Azone_analog-53),N1(C(=O)CC=CCC1)CCCCCCCCCCCC,14182697,AZONE OTHER,"1-dodecyl-2,3,6,7-tetrahydro-1H-azepin-2-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",279.466,5.4481,-3.787,2,0,20.31,11,0,15,,,amide,,,,,,,,O=C1CC=CCCN1
1-[3-(2-Oxoazepan-1-yl)butyl]azepan-2-one (Azone_analog-326),CC(CCN1CCCCCC1=O)N1CCCCCC1=O,15389348,AZONE OTHER,1-[3-(2-oxoazepan-1-yl)butyl]azepan-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",280.41,2.1955,-2.294,4,0,40.62,4,0,14,,,amide,,,,,,,,O=C1CCCCCN1CCCN1CCCCCC1=O
1-[8-(2-Oxopyrrolidin-1-yl)octyl]pyrrolidin-2-one (Azone_analog-316),O=C1CCCN1CCCCCCCCN1CCCC1=O,85608703,AZONE OTHER,1-[8-(2-oxopyrrolidin-1-yl)octyl]pyrrolidin-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",280.41,2.7402,-2.186,4,0,40.62,9,0,14,,,amide,,,,,,,,O=C1CCCN1CCCCCCCCN1CCCC1=O
1-Thiomorpholino-1-dodecanone (Azone_analog-135),CCCCCCCCCCCC(=O)N1CCSCC1,11778705,AZONE OTHER,1-(thiomorpholin-4-yl)dodecan-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",285.494,4.841,-3.542,2,0,45.61,10,0,16,,,amide,,,,,,,,C1CSCCN1
"1-Dodecanoyl-3,4-dihydro-2H-azepin-7-one (Azone_analog-82)",CCCCCCCCCCCC(=O)N1CCCC=CC1=O,19881559,AZONE OTHER,"1-dodecanoyl-2,5,6,7-tetrahydro-1H-azepin-2-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",293.449,5.0985,-3.7689999999999997,3,0,37.38,10,0,14,,,amide,,,,,,,,O=C1C=CCCCN1
"1-Dodecanoyl-3,6-dihydro-2H-azepin-7-one (Azone_analog-83)",CCCCCCCCCCCC(=O)N1CCC=CCC1=O,21881379,AZONE OTHER,"1-dodecanoyl-2,3,6,7-tetrahydro-1H-azepin-2-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",293.449,5.0985,-3.7689999999999997,3,0,37.38,10,0,14,,,amide,,,,,,,,O=C1CC=CCCN1
"2,3-Dihydro-4-dodecyl-1,4-oxazepine-5,7(4H,6H)-dione (Azone_analog-58)",N1(C(=O)CC(=O)OCC1)CCCCCCCCCCCC,85693238,AZONE OTHER,"4-dodecyl-1,4-oxazepane-5,7-dione",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",297.437,3.9933,-3.108,4,0,46.61,11,0,16,,,amide,,,,,,,,O=C1CC(=O)OCCN1
"1H-Azepine-2,7-dione, 1-dodecyltetrahydro- (Azone_analog-56)",N1(C(=O)CCCCC1=O)CCCCCCCCCCCC,9904244,AZONE OTHER,"1-dodecylazepane-2,7-dione",114609-80-2,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",295.465,5.1573,-3.997,3,0,37.38,11,0,16,,,amide,,,,,,,Hexanimide,O=C1CCCCC(=O)N1
"1,1'-Hexamethylenebis(pyrrolidin-2-one) (Azone_analog-314)",O=C1CCCN1CCCCCCN1CCCC1=O,118729,AZONE OTHER,1-[6-(2-oxopyrrolidin-1-yl)hexyl]pyrrolidin-2-one,34751-43-4,34751-43-4,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",252.357,1.8314,-1.646,4,0,40.62,7,0,12,,,amide,,,,,,,"1,1'-hexane-1,6-diyldipyrrolidin-2-one",O=C1CCCN1CCCCCCN1CCCC1=O
1-Phenylpyrrolidin-2-one (Azone_analog-219),O=C1CCCN1C1=CC=CC=C1,78375,AZONE OTHER,1-phenylpyrrolidin-2-one,4641-57-0,4641-57-0,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",161.203,1.5844,-2.32,2,0,20.31,1,1,3,,,amide,,,,,,,N-Phenyl-2-Pyrrolidonee,O=C1CCCN1c1ccccc1
1-Benzyl-2-pyrrolidinone (Azone_analog-220),O=C1CCCN1CC1=CC=CC=C1,79176,AZONE OTHER,1-benzylpyrrolidin-2-one,5291-77-0,5291-77-0,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",175.23,1.5073,-1.798,2,0,20.31,2,1,4,,,amide,,,,,,,N-benzylpyrrolidinone,O=C1CCCN1Cc1ccccc1
2-Decylcyclopentanone (Azone_analog-234),CCCCCCCCCCC1CCCC1=O,12823821,AZONE OTHER,2-decylcyclopentan-1-one,53724-67-7,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",224.386,5.3605,-4.122,1,0,17.07,9,0,14,,,,,,,,,,cyclopentanon,O=C1CCCC1
"1,6-Di(morpholin-4-yl)hexane-1,6-dione (Azone_analog-319)",O=C(CCCCC(=O)N1CCOCC1)N1CCOCC1,223658,AZONE OTHER,"1,6-bis(morpholin-4-yl)hexane-1,6-dione",5421-70-5,5421-70-5,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",284.355,0.6206,-0.408,6,0,59.08,5,0,14,,,amide,,,,,,,,O=C(CCCCC(=O)N1CCOCC1)N1CCOCC1
2-Decylcyclohexanone (Azone_analog-101),CCCCCCCCCCC1CCCCC1=O,10263617,AZONE OTHER,2-decylcyclohexan-1-one,59386-47-9,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",238.41299999999998,5.7025,-4.3919999999999995,1,0,17.07,9,0,15,,,,,,,,,,Cyclohexanon,O=C1CCCCC1
1-Butylazepane-2-thione (Azone_analog-47),N1(C(=S)CCCCC1)CCCC,12348066,AZONE OTHER,1-butylazepane-2-thione,62353-45-1,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",185.334,2.3077,-2.792,1,0,35.33,3,0,10,,,,,,,,,,Thiocaprolactam,S=C1CCCCCN1
1-Octylazepane-2-thione (Azone_analog-48),N1(C(=S)CCCCC1)CCCCCCCC,12348068,AZONE OTHER,1-octylazepane-2-thione,62353-47-3,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",241.44099999999997,4.1253,-3.872,1,0,35.33,7,0,14,,,,,,,,,,Thiocaprolactam,S=C1CCCCCN1
N-Cyclohexyl-2-pyrrolidone (Azone_analog-218),O=C1CCCN1C1CCCCC1,81278,AZONE OTHER,1-cyclohexylpyrrolidin-2-one,6837-24-7,6837-24-7,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",167.25099999999998,1.6449,-2.049,2,0,20.31,1,0,9,,,amide,,,,,,,N-CyclohexylPyrrolidonee,O=C1CCCN1C1CCCCC1
"1,6-Dithiomorpholin-4-ylhexane-1,6-dione (Azone_analog-320)",O=C(CCCCC(=O)N1CCSCC1)N1CCSCC1,12517845,AZONE OTHER,"1,6-bis(thiomorpholin-4-yl)hexane-1,6-dione",,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",316.48900000000003,1.4344,-1.78,4,0,91.22,5,0,14,,,amide,,,,,,,,O=C(CCCCC(=O)N1CCSCC1)N1CCSCC1
1-Methyl-3-(2-oxopyrrolidin-1-yl)azepan-2-one (Azone_analog-328),CN1CCCCC(N2CCCC2=O)C1=O,101123345,CAPROLACTAM,1-methyl-3-(2-oxopyrrolidin-1-yl)azepan-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",210.27599999999998,0.3661,-0.914,4,0,40.62,1,0,9,,,amide,,,,,,,3-(2-oxopyrrolidin-1-yl)azepan-2-one,O=C1NCCCCC1N1CCCC1=O
Methyl 2-[2-oxo-3-(2-oxopyrrolidin-1-yl)azepan-1-yl]acetate (Azone_analog-334),COC(=O)CN1CCCCC(N2CCCC2=O)C1=O,101123346,CAPROLACTAM,methyl 2-[2-oxo-3-(2-oxopyrrolidin-1-yl)azepan-1-yl]acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",268.312,-0.076,-0.8170000000000001,6,0,66.92,4,0,11,,,amide,,,,,,,3-(2-oxopyrrolidin-1-yl)azepan-2-one,O=C1NCCCCC1N1CCCC1=O
1-Hexyl-3-(2-oxopyrrolidin-1-yl)azepan-2-one (Azone_analog-329),CCCCCCN1CCCCC(N2CCCC2=O)C1=O,101123343,CAPROLACTAM,1-hexyl-3-(2-oxopyrrolidin-1-yl)azepan-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",280.41,2.59,-2.294,4,0,40.62,6,0,14,,,amide,,,,,,,3-(2-oxopyrrolidin-1-yl)azepan-2-one,O=C1NCCCCC1N1CCCC1=O
1-Decyl-3-(2-oxopyrrolidin-1-yl)azepan-2-one (Azone_analog-330),CCCCCCCCCCN1CCCCC(N2CCCC2=O)C1=O,10449700,CAPROLACTAM,1-decyl-3-(2-oxopyrrolidin-1-yl)azepan-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",336.51800000000003,4.4076,-3.3739999999999997,4,0,40.62,10,0,18,,,amide,,,,,,,3-(2-oxopyrrolidin-1-yl)azepan-2-one,O=C1NCCCCC1N1CCCC1=O
Hexyl 2-[2-oxo-3-(2-oxopyrrolidin-1-yl)azepan-1-yl]acetate (Azone_analog-335),CCCCCCOC(=O)CN1CCCCC(N2CCCC2=O)C1=O,101123348,CAPROLACTAM,hexyl 2-[2-oxo-3-(2-oxopyrrolidin-1-yl)azepan-1-yl]acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",338.44599999999997,2.1479,-2.197,6,0,66.92,9,0,16,,,amide,,,,,,,3-(2-oxopyrrolidin-1-yl)azepan-2-one,O=C1NCCCCC1N1CCCC1=O
1-Dodecyl-3-(2-oxopyrrolidin-1-yl)azepan-2-one (Azone_analog-331),CCCCCCCCCCCCN1CCCCC(N2CCCC2=O)C1=O,9976047,CAPROLACTAM,1-dodecyl-3-(2-oxopyrrolidin-1-yl)azepan-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",364.57199999999995,5.3164,-3.9139999999999997,4,0,40.62,12,0,20,,,amide,,,,,,,3-(2-oxopyrrolidin-1-yl)azepan-2-one,O=C1NCCCCC1N1CCCC1=O
3-(2-Oxopyrrolidin-1-yl)-1-tetradecylazepan-2-one (Azone_analog-332),CCCCCCCCCCCCCCN1CCCCC(N2CCCC2=O)C1=O,10023452,CAPROLACTAM,3-(2-oxopyrrolidin-1-yl)-1-tetradecylazepan-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",392.625,6.2252,-4.454,4,0,40.62,14,0,22,,,amide,,,,,,,3-(2-oxopyrrolidin-1-yl)azepan-2-one,O=C1NCCCCC1N1CCCC1=O
Decyl 2-[2-oxo-3-(2-oxopyrrolidin-1-yl)azepan-1-yl]acetate (Azone_analog-337),CCCCCCCCCCOC(=O)CN1CCCCC(N2CCCC2=O)C1=O,101123349,CAPROLACTAM,decyl 2-[2-oxo-3-(2-oxopyrrolidin-1-yl)azepan-1-yl]acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",394.55400000000003,3.9655,-3.2769999999999997,6,0,66.92,13,0,20,,,amide,,,,,,,3-(2-oxopyrrolidin-1-yl)azepan-2-one,O=C1NCCCCC1N1CCCC1=O
1-Hexadecyl-3-(2-oxopyrrolidin-1-yl)azepan-2-one (Azone_analog-333),CCCCCCCCCCCCCCCCN1CCCCC(N2CCCC2=O)C1=O,101123344,CAPROLACTAM,1-hexadecyl-3-(2-oxopyrrolidin-1-yl)azepan-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",420.67900000000003,7.1339999999999995,-4.994,4,0,40.62,16,0,24,,,amide,,,,,,,3-(2-oxopyrrolidin-1-yl)azepan-2-one,O=C1NCCCCC1N1CCCC1=O
Dodecyl 2-[2-oxo-3-(2-oxopyrrolidin-1-yl)azepan-1-yl]acetate (Azone_analog-338),CCCCCCCCCCCCOC(=O)CN1CCCCC(N2CCCC2=O)C1=O,101123350,CAPROLACTAM,dodecyl 2-[2-oxo-3-(2-oxopyrrolidin-1-yl)azepan-1-yl]acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",422.60699999999997,4.8743,-3.8169999999999997,6,0,66.92,15,0,22,,,amide,,,,,,,3-(2-oxopyrrolidin-1-yl)azepan-2-one,O=C1NCCCCC1N1CCCC1=O
Tetradecyl 2-[2-oxo-3-(2-oxopyrrolidin-1-yl)azepan-1-yl]acetate (Azone_analog-339),CCCCCCCCCCCCCCOC(=O)CN1CCCCC(N2CCCC2=O)C1=O,101123351,CAPROLACTAM,tetradecyl 2-[2-oxo-3-(2-oxopyrrolidin-1-yl)azepan-1-yl]acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",450.661,5.7831,-4.357,6,0,66.92,17,0,24,,,amide,,,,,,,3-(2-oxopyrrolidin-1-yl)azepan-2-one,O=C1NCCCCC1N1CCCC1=O
1-(3-Hydroxypropyl)hexahydro-2H-azepin-2-one (Azone_analog-18),O=C1CCCCCN1CCCO,15263935,CAPROLACTAM,1-(3-hydroxypropyl)azepan-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",171.239,0.7072,-1.078,3,1,40.54,3,0,9,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
"1-(2,3-Dihydroxypropyl)azepan-2-one (Azone_analog-19)",O=C1CCCCCN1CC(O)CO,115773358,CAPROLACTAM,"1-(2,3-dihydroxypropyl)azepan-2-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",187.238,-0.3146,-0.679,4,2,60.77,3,0,10,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
1-Pent-4-enoylazepan-2-one (Azone_analog-24),C=CCCC(=O)N1CCCCCC1=O,19855819,CAPROLACTAM,1-(pent-4-enoyl)azepan-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",195.261,2.1976,-2.046,3,0,37.38,3,0,7,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
1-Hex-5-enoylazepan-2-one (Azone_analog-25),C=CCCCC(=O)N1CCCCCC1=O,19855827,CAPROLACTAM,1-(hex-5-enoyl)azepan-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",209.28799999999998,2.4619999999999997,-2.316,3,0,37.38,4,0,8,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
1-Heptylazepan-2-one (Azone_analog-7),CCCCCCCN1CCCCCC1=O,12833262,CAPROLACTAM,1-heptylazepan-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",211.34799999999998,3.4515,-2.665,2,0,20.31,6,0,12,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
1-Hept-6-enoylazepan-2-one (Azone_analog-26),C=CCCCCC(=O)N1CCCCCC1=O,19855878,CAPROLACTAM,1-(hept-6-enoyl)azepan-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",223.315,2.9164,-2.5860000000000003,3,0,37.38,5,0,9,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
2-(2-Oxoazepan-1-yl)hexanoic acid (Azone_analog-35),CCCCC(C(=O)O)N1CCCCCC1=O,57191554,CAPROLACTAM,2-(2-oxoazepan-1-yl)hexanoic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",227.303,1.6257,-1.9780000000000002,4,1,57.61,5,0,11,,,amide,,,,,,acidic oxygen,Caprolactam,O=C1CCCCCN1
1-Oct-7-enoylazepan-2-one (Azone_analog-27),C=CCCCCCC(=O)N1CCCCCC1=O,19855867,CAPROLACTAM,1-(oct-7-enoyl)azepan-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",237.342,3.3708,-2.8560000000000003,3,0,37.38,6,0,10,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
2-(2-Oxoazepan-1-yl)heptanoic acid (Azone_analog-36),CCCCCC(C(=O)O)N1CCCCCC1=O,57102964,CAPROLACTAM,2-(2-oxoazepan-1-yl)heptanoic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",241.33,2.0801,-2.248,4,1,57.61,6,0,12,,,amide,,,,,,acidic oxygen,Caprolactam,O=C1CCCCCN1
1-Non-8-enoylazepan-2-one (Azone_analog-28),C=CCCCCCCC(=O)N1CCCCCC1=O,19855835,CAPROLACTAM,1-(non-8-enoyl)azepan-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",251.36900000000003,3.8252,-3.1260000000000003,3,0,37.38,7,0,11,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
2-(2-Oxoazepan-1-yl)octanoic acid (Azone_analog-37),CCCCCCC(C(=O)O)N1CCCCCC1=O,57246227,CAPROLACTAM,2-(2-oxoazepan-1-yl)octanoic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",255.356,2.5345,-2.5180000000000002,4,1,57.61,7,0,13,,,amide,,,,,,acidic oxygen,Caprolactam,O=C1CCCCCN1
1-Dec-9-enoylazepan-2-one (Azone_analog-29),C=CCCCCCCCC(=O)N1CCCCCC1=O,19855838,CAPROLACTAM,1-(dec-9-enoyl)azepan-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",265.395,4.2796,-3.3960000000000004,3,0,37.38,8,0,12,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
1-Decanoylazepan-2-one (Azone_analog-21),CCCCCCCCCC(=O)N1CCCCCC1=O,15240681,CAPROLACTAM,1-decanoylazepan-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",267.411,4.4651,-3.457,3,0,37.38,8,0,14,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
2-(2-Oxoazepan-1-yl)nonanoic acid (Azone_analog-38),CCCCCCCC(C(=O)O)N1CCCCCC1=O,57310438,CAPROLACTAM,2-(2-oxoazepan-1-yl)nonanoic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",269.383,2.9889,-2.7880000000000003,4,1,57.61,8,0,14,,,amide,,,,,,acidic oxygen,Caprolactam,O=C1CCCCCN1
2-(2-Oxoazepan-1-yl)decanoic acid (Azone_analog-39),CCCCCCCCC(C(=O)O)N1CCCCCC1=O,57274316,CAPROLACTAM,2-(2-oxoazepan-1-yl)decanoic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",283.41,3.4433,-3.0580000000000003,4,1,57.61,9,0,15,,,amide,,,,,,acidic oxygen,Caprolactam,O=C1CCCCCN1
2-(2-Oxoazepan-1-yl)undecanoic acid (Azone_analog-40),CCCCCCCCCC(C(=O)O)N1CCCCCC1=O,57258142,CAPROLACTAM,2-(2-oxoazepan-1-yl)undecanoic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",297.437,3.8977,-3.3280000000000003,4,1,57.61,10,0,16,,,amide,,,,,,acidic oxygen,Caprolactam,O=C1CCCCCN1
2-(2-Oxoazepan-1-yl)dodecanoic acid (Azone_analog-41),CCCCCCCCCCC(C(=O)O)N1CCCCCC1=O,57264343,CAPROLACTAM,2-(2-oxoazepan-1-yl)dodecanoic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",311.464,4.3521,-3.5980000000000003,4,1,57.61,11,0,17,,,amide,,,,,,acidic oxygen,Caprolactam,O=C1CCCCCN1
1-Tetradec-13-enoylazepan-2-one (Azone_analog-32),C=CCCCCCCCCCCCC(=O)N1CCCCCC1=O,19855853,CAPROLACTAM,1-(tetradec-13-enoyl)azepan-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",321.503,6.0972,-4.476,3,0,37.38,12,0,16,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
1-Tetradecanoylazepan-2-one (Azone_analog-23),CCCCCCCCCCCCCC(=O)N1CCCCCC1=O,10448891,CAPROLACTAM,1-tetradecanoylazepan-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",323.519,6.2827,-4.537,3,0,37.38,12,0,18,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
"1-(3,7,11-Trimethyldodecyl)azepan-2-one (Azone_analog-13)",CC(C)CCCC(C)CCCC(C)CCN1CCCCCC1=O,21881342,CAPROLACTAM,"1-(3,7,11-trimethyldodecyl)azepan-2-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",323.563,6.3784,-4.495,2,0,20.31,11,0,20,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
2-(2-Oxoazepan-1-yl)tetradecanoic acid (Azone_analog-42),CCCCCCCCCCCCC(C(=O)O)N1CCCCCC1=O,56987081,CAPROLACTAM,2-(2-oxoazepan-1-yl)tetradecanoic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",339.51800000000003,5.2609,-4.138,4,1,57.61,13,0,19,,,amide,,,,,,acidic oxygen,Caprolactam,O=C1CCCCCN1
Dodecyl 2-(2-oxoazepan-1-yl)acetate (Azone_analog-45),CCCCCCCCCCCCOC(=O)CN1CCCCCC1=O,85693229,CAPROLACTAM,dodecyl 2-(2-oxoazepan-1-yl)acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",339.51800000000003,5.2814,-3.918,4,0,46.61,14,0,19,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
1-Hexadec-15-enoylazepan-2-one (Azone_analog-33),C=CCCCCCCCCCCCCCC(=O)N1CCCCCC1=O,19855848,CAPROLACTAM,1-(hexadec-15-enoyl)azepan-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",349.55699999999996,7.006,-5.016,3,0,37.38,14,0,18,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
2-(2-Oxoazepan-1-yl)hexadecanoic acid (Azone_analog-43),CCCCCCCCCCCCCCC(C(=O)O)N1CCCCCC1=O,57179469,CAPROLACTAM,2-(2-oxoazepan-1-yl)hexadecanoic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",367.57199999999995,6.1697,-4.678,4,1,57.61,15,0,21,,,amide,,,,,,acidic oxygen,Caprolactam,O=C1CCCCCN1
Tetradecyl 2-(2-oxoazepan-1-yl)acetate (Azone_analog-46),CCCCCCCCCCCCCCOC(=O)CN1CCCCCC1=O,85693230,CAPROLACTAM,tetradecyl 2-(2-oxoazepan-1-yl)acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",367.57199999999995,6.1902,-4.458,4,0,46.61,16,0,21,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
1-Octadec-17-enoylazepan-2-one (Azone_analog-34),C=CCCCCCCCCCCCCCCCC(=O)N1CCCCCC1=O,19855824,CAPROLACTAM,1-(octadec-17-enoyl)azepan-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",377.61,7.9148,-5.556,3,0,37.38,16,0,20,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
2-(2-Oxoazepan-1-yl)octadecanoic acid (Azone_analog-44),CCCCCCCCCCCCCCCCC(C(=O)O)N1CCCCCC1=O,57233669,CAPROLACTAM,2-(2-oxoazepan-1-yl)octadecanoic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",395.625,7.0785,-5.218,4,1,57.61,17,0,23,,,amide,,,,,,acidic oxygen,Caprolactam,O=C1CCCCCN1
"2H-Azepin-2-one, 1-(3,7-dimethyloctyl)hexahydro- (Azone_analog-12)",CC(C)CCCC(C)CCN1CCCCCC1=O,21881377,CAPROLACTAM,"1-(3,7-dimethyloctyl)azepan-2-one",112899-70-4,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",253.428,4.3425,-3.255,2,0,20.31,7,0,15,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
"2H-Azepin-2-one, hexahydro-1-tetradecyl- (Azone_analog-11)",CCCCCCCCCCCCCCN1CCCCCC1=O,9972634,CAPROLACTAM,1-tetradecylazepan-2-one,116430-52-5,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",309.536,6.6323,-4.555,2,0,20.31,13,0,19,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
1-Hexadecylazepan-2-one (Azone_analog-95),CCCCCCCCCCCCCCCCN1CCCCCC1=O,189405,CAPROLACTAM,1-hexadecylazepan-2-one,116489-97-5,116489-97-5,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",337.589,7.5411,-5.095,2,0,20.31,15,0,21,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
"1-(3,7-Dimethylocta-2,6-dienyl)azepan-2-one (Azone_analog-14)",CC(C)=CCCC(C)=CCN1CCCCCC1=O,164048,CAPROLACTAM,"1-(3,7-dimethylocta-2,6-dien-1-yl)azepan-2-one",117694-76-5,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",249.396,4.6143,-2.727,2,0,20.31,5,0,11,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
1-Farnesylazacycloheptan-2-one (Azone_analog-15),CC(C)=CCCC(C)=CCCC(C)=CCN1CCCCCC1=O,184182,CAPROLACTAM,"1-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)azepan-2-one",117694-77-6,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",317.515,6.7861,-3.7030000000000003,2,0,20.31,8,0,14,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
"1-(3,7,11,15-Tetramethylhexadeca-2,6,10,14-tetraen-1-yl)azepan-2-one (Azone_analog-16)",CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCN1CCCCCC1=O,53440371,CAPROLACTAM,"1-(3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl)azepan-2-one",117694-78-7,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",385.63300000000004,8.9579,-4.678999999999999,2,0,20.31,11,0,17,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
N-Acetylcaprolactam (Azone_analog-20),CC(=O)N1CCCCCC1=O,15904,CAPROLACTAM,1-acetylazepan-2-one,1888-91-1,1888-91-1,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",155.196,0.8299,-1.297,3,0,37.38,0,0,6,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
1-butylazepan-2-one (Azone_analog-4),CCCCN1CCCCCC1=O,9989643,CAPROLACTAM,1-butylazepan-2-one,19090-89-2,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",169.267,2.0883,-1.855,2,0,20.31,3,0,9,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
N-Methylcaprolactam (Azone_analog-2),CN1CCCCCC1=O,17369,CAPROLACTAM,1-methylazepan-2-one,2556-73-2,2556-73-2,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",127.186,0.7732,-1.015,2,0,20.31,0,0,6,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
1-(Undec-10-enoyl)azepan-2-one (Azone_analog-30),C=CCCCCCCCCC(=O)N1CCCCCC1=O,14772397,CAPROLACTAM,1-(undec-10-enoyl)azepan-2-one,36363-27-6,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",279.422,4.734,-3.6660000000000004,3,0,37.38,9,0,13,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
1-Hexyl-2-azacycloheptanone,CCCCCCN1CCCCCC1=O,181537,CAPROLACTAM,1-hexylazepan-2-one,37672-43-8,37672-43-8,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",197.321,2.9971,-2.395,2,0,20.31,5,0,11,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
1-(2-Hydroxyethyl)azepan-2-one (Azone_analog-17),O=C1CCCCCN1CCO,181752,CAPROLACTAM,1-(2-hydroxyethyl)azepan-2-one,45889-43-8,45889-43-8,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",157.21200000000002,0.2528,-0.8079999999999999,3,1,40.54,2,0,8,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
1-Propylazepan-2-one (Azone_analog-3),CCCN1CCCCCC1=O,12833260,CAPROLACTAM,1-propylazepan-2-one,52644-85-6,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",155.24,1.6339,-1.585,2,0,20.31,2,0,8,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
N-Lauroyl caprolactam (Azone_analog-22),CCCCCCCCCCCC(=O)N1CCCCCC1=O,21713,CAPROLACTAM,1-dodecanoylazepan-2-one,5551-77-9,5551-77-9,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",295.465,5.3739,-3.997,3,0,37.38,10,0,16,,,,,,,,,,Caprolactam,O=C1CCCCCN1
1‐octyl‐2‐ azacycloheptanone,CCCCCCCCN1CCCCCC1=O,2754067,CAPROLACTAM,1-octylazepan-2-one,59227-88-2,NA,-1.28,"Chantasart D, Li SK. Relationship between the enhancement effects of chemical permeation enhancers on the lipoidal transport pathway across human skin under the symmetric and asymmetric conditions in vitro. Pharm Res. 2010;27(9):1825‐1836.",225.37400000000002,3.9059,-2.935,2,0,20.31,7,0,13,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
Azone,CCCCCCCCCCCCN1CCCCCC1=O,42981,CAPROLACTAM,1-dodecylazepan-2-one,59227-89-3,59227-89-3,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",281.482,5.7235,-4.015,2,0,20.31,11,0,17,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
1-Pentylazepan-2-one (Azone_analog-5),CCCCCN1CCCCCC1=O,12833261,CAPROLACTAM,1-pentylazepan-2-one,59746-36-0,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",183.294,2.5427,-2.125,2,0,20.31,4,0,10,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
1-Nonylazepan-2-one (Azone_analog-9),CCCCCCCCCN1CCCCCC1=O,12833263,CAPROLACTAM,1-nonylazepan-2-one,59746-38-2,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",239.40099999999998,4.3603,-3.205,2,0,20.31,8,0,14,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
1-Decylazepan-2-one (Azone_analog-10),CCCCCCCCCCN1CCCCCC1=O,12833264,CAPROLACTAM,1-decylazepan-2-one,59746-39-3,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",253.428,4.8147,-3.475,2,0,20.31,9,0,15,,,amide,,,,,,,Caprolactam,O=C1CCCCCN1
Octyl salicylate,CCCCCCCCOC(=O)C1=CC=CC=C1O,62624,ESTER,octyl 2-hydroxybenzoate,-,6969-49-9,,"El Maghraby, G. M., Campbell, M., & Finnin, B. C. (2005). Mechanisms of action of novel skin penetration enhancers: phospholipid versus skin lipid liposomes. International journal of pharmaceutics, 305(1-2), 90-104.",250.33700000000002,4.3596,-3.3810000000000002,3,1,46.53,9,1,10,,,,,,,,,,Benzene,c1ccccc1
"2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydro-2H-1-benzopyran-6-yl 4-chloro-4-oxobutanoate",CC(C)CCCC(C)CCCC(C)CCCC1(C)CCC2=C(C)C(OC(=O)CCC(Cl)=O)=C(C)C(C)=C2O1,11295791,ESTER,"2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydro-2H-1-benzopyran-6-yl 4-chloro-4-oxobutanoate",-,NA,,"Coufalová, L., Mrózek, L., Rárová, L., Plaček, L., Opatřilová, R., Dohnal, J., ... & Jampílek, J. (2013). New propanoyloxy derivatives of 5β-cholan-24-oic acid as drug absorption modifiers. Steroids, 78(5), 435-453.",549.2330000000001,9.9906,-7.882999999999999,4,0,52.6,17,1,27,,,,,,,,,,,c1ccc2c(c1)CCCO2
4-{2-[2-(decanoyloxy)ethoxy]ethoxy}-4-oxobutanoic acid,CCCCCCCCCC(=O)OCCOCCOC(=O)CCC(O)=O,71665688,ESTER,4-{2-[2-(decanoyloxy)ethoxy]ethoxy}-4-oxobutanoic acid,-,NA,,"Coufalová, L., Mrózek, L., Rárová, L., Plaček, L., Opatřilová, R., Dohnal, J., ... & Jampílek, J. (2013). New propanoyloxy derivatives of 5β-cholan-24-oic acid as drug absorption modifiers. Steroids, 78(5), 435-453.",360.445,3.2682,-2.886,7,1,99.13,19,0,19,,,,,,,,,acidic oxygens,,
"4-[2,3-bis(decanoyloxy)propoxy]-4-oxobutanoic acid",CCCCCCCCCC(=O)OCC(COC(=O)CCC(O)=O)OC(=O)CCCCCCCCC,71665689,ESTER,"4-[2,3-bis(decanoyloxy)propoxy]-4-oxobutanoic acid",-,NA,,"Coufalová, L., Mrózek, L., Rárová, L., Plaček, L., Opatřilová, R., Dohnal, J., ... & Jampílek, J. (2013). New propanoyloxy derivatives of 5β-cholan-24-oic acid as drug absorption modifiers. Steroids, 78(5), 435-453.",500.67,01.06,-5.406000000000001,8,1,116.2,27,0,27,,,,,,,,,acidic oxygens,,
Triacetin,CC(=O)OCC(COC(=O)C)OC(=O)C,5541,ESTER,"1,3-bis(acetyloxy)propan-2-yl acetate",102-76-1,102-76-1,,"Quan, D., Deshpanday, N. A., Venkateshwaran, S., & Ebert, C. D. (1997). U.S. Patent No. 5,601,839. Washington, DC: U.S. Patent and Trademark Office.",218.204,0.0102,-1.071,6,0,78.9,8,0,9,,,,,,,,,,,
Isopropyl myristate,CCCCCCCCCCCCCC(=O)OC(C)C,8042,ESTER,propan-2-yl tetradecanoate,110-27-0,"110-27-0,1405-98-7",-5.41,"Ibrahim, S. A., & Li, S. K. (2010). Efficiency of fatty acids as chemical penetration enhancers: mechanisms and structure enhancement relationship. Pharmaceutical research, 27(1), 115.",270.455,6.3472,-4.505,2,0,26.3,14,0,17,approved; experimental,DB13966,,,,,,,,,
Diethyl decanedioate,CCOC(=O)CCCCCCCCC(=O)OCC,8049,ESTER,"1,10-diethyl decanedioate",110-40-7,110-40-7,,"Babu, R. J., Chen, L., & Kanikkannan, N. (2015). Fatty alcohols, fatty acids, and fatty acid esters as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 133-150). Springer, Berlin, Heidelberg.",258.356,3.7282,-2.95,4,0,52.6,13,0,14,,,,,,,,,,,
Ethyl oleate,CCCCCCCCC=CCCCCCCCC(=O)OCC,5363269,ESTER,ethyl octadec-9-enoate,111-62-6,NA,,"Babu, R. J., Chen, L., & Kanikkannan, N. (2015). Fatty alcohols, fatty acids, and fatty acid esters as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 133-150). Springer, Berlin, Heidelberg.",310.52,7.5533,-4.979,2,0,26.3,17,0,18,,,,,,,,,,,
Methyl laurate,CCCCCCCCCCCC(=O)OC,8139,ESTER,methyl dodecanoate,111-82-0,111-82-0,,"Babu, R. J., Chen, L., & Kanikkannan, N. (2015). Fatty alcohols, fatty acids, and fatty acid esters as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 133-150). Springer, Berlin, Heidelberg.",214.347,4.6728,-3.287,2,0,26.3,11,0,13,experimental,DB01631,,,,,,,,,
methyl salicylate,COC(=O)C1=CC=CC=C1O,4133,ESTER,methyl 2-hydroxybenzoate,119-36-8,"119-36-8,8022-86-4,8024-54-2",-1.44,"Zhang Q, Grice JE, Li P, Jepps OG, Wang GJ, Roberts MS. Skin solubility determines maximum transepidermal flux for similar size molecules. Pharm Res. 2009;26(8):1974‐1985.",152.149,1.2269,-1.4609999999999999,3,1,46.53,2,1,3,approved; vet_approved,DB09543,,,,,,,,Benzene,c1ccccc1
Octylparaben,CCCCCCCCOC(=O)C1=CC=C(C=C1)O,14642,ESTER,octyl 4-hydroxybenzoate,1219-38-1,1219-38-1,-2.03,"Buist HE, van Burgsteden JA, Freidig AP, Maas WJ, van de Sandt JJ. New in vitro dermal absorption database and the prediction of dermal absorption under finite conditions for risk assessment purposes. Regul Toxicol Pharmacol. 2010;57(2‐3):200‐209.",250.33700000000002,4.3596,-3.3810000000000002,3,1,46.53,9,1,10,,,,,,,,,,Benzene,c1ccccc1
Butyl acetate,CCCCOC(=O)C,31272,ESTER,butyl acetate,123-86-4,123-86-4,,"Dragicevic, N., Atkinson, J. P., & Maibach, H. I. (2015). Chemical penetration enhancers: classification and mode of action. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 11-27). Springer, Berlin, Heidelberg.",116.15899999999999,1.4439,-1.4269999999999998,2,0,26.3,4,0,6,,,,,,,,,,,
"1,2-Dihydroxypropyl octanoate",CCCCCCCC(=O)OCC(CO)O,3033877,ESTER,"2,3-dihydroxypropyl octanoate",1330-55-8,"1330-55-8,26402-26-6,26894-47-3,119938-58-8",,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",218.292,1.7674,-1.871,4,2,66.76,10,0,13,experimental,DB06801,,,,,,,,,
Sorbitan monolaurate,CCCCCCCCCCCC(=O)OCC(C1C(C(CO1)O)O)O,11046239,ESTER,"2-(3,4-dihydroxyoxolan-2-yl)-2-hydroxyethyl dodecanoate",1338-39-2,16287-68-6,,"Ghafourian, T., Nokhodchi, A., & Kaialy, W. (2015). Surfactants as penetration enhancers for dermal and transdermal drug delivery. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 207-230). Springer, Berlin, Heidelberg.",346.462,2.701,-3.045,6,3,96.22,14,0,22,,,,,,,,,,Tetrahydrofuran,C1CCOC1
Sorbitan monostearate,CCCCCCCCCCCCCCCCCC(=O)OCC(C1C(C(CO1)O)O)O,16218600,ESTER,"2-(3,4-dihydroxyoxolan-2-yl)-2-hydroxyethyl octadecanoate",1338-41-6,NA,,"Ghafourian, T., Nokhodchi, A., & Kaialy, W. (2015). Surfactants as penetration enhancers for dermal and transdermal drug delivery. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 207-230). Springer, Berlin, Heidelberg.",430.62300000000005,5.4274,-4.665,6,3,96.22,20,0,28,,,,,,,,,,Tetrahydrofuran,C1CCOC1
Sorbitan monooleate,CCCCCCCCC=CCCCCCCCC(=O)OCC(C1C(C(CO1)O)O)O,9920342,ESTER,"2-(3,4-dihydroxyoxolan-2-yl)-2-hydroxyethyl octadec-9-enoate",1338-43-8,NA,,"Ghafourian, T., Nokhodchi, A., & Kaialy, W. (2015). Surfactants as penetration enhancers for dermal and transdermal drug delivery. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 207-230). Springer, Berlin, Heidelberg.",428.60699999999997,5.1752,-4.437,6,3,96.22,19,0,26,,,,,,,,,,Tetrahydrofuran,C1CCOC1
Monolaurin,CCCCCCCCCCCC(=O)OCC(CO)O,14871,ESTER,"2,3-dihydroxypropyl dodecanoate",142-18-7,"142-18-7,83382-35-8,1322-88-9,67701-26-2,152872-58-7,40738-26-9,83382-36-9",,"Burkoth, T. L., Taskovich, L. T., Beste, R. D., Gale, R. M., Lee, E. S., Hamlin, R. D., & Yum, S. L. (1998). U.S. Patent No. 5,843,468. Washington, DC: U.S. Patent and Trademark Office.",274.399,3.585,-2.951,4,2,66.76,14,0,17,experimental,DB06801,,,,,,,,,
Isopropyl palmitate,CCCCCCCCCCCCCCCC(=O)OC(C)C,8907,ESTER,propan-2-yl hexadecanoate,142-91-6,142-91-6,,"Ibrahim, S. A., & Li, S. K. (2010). Efficiency of fatty acids as chemical penetration enhancers: mechanisms and structure enhancement relationship. Pharmaceutical research, 27(1), 115.",298.509,7.256,-5.045,2,0,26.3,16,0,19,approved; experimental,DB13966,,,,,,,,,
Padimate O,CCCCC(CC)COC(=O)C1=CC=C(C=C1)N(C)C,30541,ESTER,2-ethylhexyl 4-(dimethylamino)benzoate,21245-02-3,"127361-11-9,21245-02-3",,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",277.406,4.3656,-3.603,3,0,29.54,9,1,11,approved,DB11570,,amine,,aromatic amine,,,,Benzene,c1ccccc1
"1,2-Dihydroxypropyl decanoate",CCCCCCCCCC(=O)OC(C(C)O)O,92926,ESTER,"1,2-dihydroxypropyl decanoate",2277-23-8,NA,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",246.345,2.8952,-2.7319999999999998,4,2,66.76,11,0,15,,,,,,,,,,,
Isopropyl decanoate,CCCCCCCCCC(=O)OC(C)C,16833,ESTER,propan-2-yl decanoate,2311-59-3,2311-59-3,,"Ibrahim, S. A., & Li, S. K. (2010). Efficiency of fatty acids as chemical penetration enhancers: mechanisms and structure enhancement relationship. Pharmaceutical research, 27(1), 115.",214.347,4.5296,-3.425,2,0,26.3,10,0,13,approved; experimental,DB13966,,,,,,,,,
Sorbitan monopalmitate,CCCCCCCCCCCCCCCC(=O)OCC(C1C(C(CO1)O)O)O,70687305,ESTER,"2-(3,4-dihydroxyoxolan-2-yl)-2-hydroxyethyl hexadecanoate",26266-57-9,NA,,"Ghafourian, T., Nokhodchi, A., & Kaialy, W. (2015). Surfactants as penetration enhancers for dermal and transdermal drug delivery. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 207-230). Springer, Berlin, Heidelberg.",402.569,4.5186,-4.125,6,3,96.22,18,0,26,,,,,,,,,,Tetrahydrofuran,C1CCOC1
"2,3-Dihydroxypropyl-Eicosanoic Ester",CCCCCCCCCCCCCCCCCCCC(=O)OCC(CO)O,3246944,ESTER,"2,3-dihydroxypropyl icosanoate",30208-87-8,NA,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",386.61400000000003,7.2202,-5.111000000000001,4,2,66.76,22,0,25,experimental,DB06801,,,,,,,,,
Methyl propionate,CCC(=O)OC,11124,ESTER,methyl propanoate,554-12-1,554-12-1,,"Babu, R. J., Chen, L., & Kanikkannan, N. (2015). Fatty alcohols, fatty acids, and fatty acid esters as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 133-150). Springer, Berlin, Heidelberg.",88.1055,0.5832,-0.857,2,0,26.3,2,0,4,,,,,,,,,,,
methyl p‐aminobenzoate,COC(=O)C1=CC=C(C=C1)N,12082,ESTER,methyl 4-aminobenzoate,619-45-4,"83763-44-4,619-45-4",-1.63,"Roy SD, Fujiki J, Fleitman JS. Permeabilities of alkyl p‐aminobenzoates through living skin equivalent and cadaver skin. J Pharm Sci. 1993;82(12):1266‐1268.",151.164,0.8953,-1.8330000000000002,3,1,52.32,2,1,2,,,,amine,,aromatic amine,,,,Benzene,c1ccccc1
Methyl pentanoate,CCCCC(=O)OC,12206,ESTER,methyl pentanoate,624-24-8,624-24-8,,"Babu, R. J., Chen, L., & Kanikkannan, N. (2015). Fatty alcohols, fatty acids, and fatty acid esters as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 133-150). Springer, Berlin, Heidelberg.",116.15899999999999,1.492,-1.3969999999999998,2,0,26.3,4,0,6,,,,,,,,,,,
diethylene glycol monodecanoate,CCCCCCCCCC(=O)OCCOCCO,12422954,ESTER,2-(2-hydroxyethoxy)ethyl decanoate,7735-31-1,NA,,"Coufalová, L., Mrózek, L., Rárová, L., Plaček, L., Opatřilová, R., Dohnal, J., ... & Jampílek, J. (2013). New propanoyloxy derivatives of 5β-cholan-24-oic acid as drug absorption modifiers. Steroids, 78(5), 435-453.",260.372,3.1511,-2.461,4,1,55.76,14,0,16,,,,,,,,,,,
Diethylene glycol succinate,OCCOCCOC(=O)CCC(O)=O,82282,ESTER,4-[2-(2-hydroxyethoxy)ethoxy]-4-oxobutanoic acid,9050-18-4,9050-18-4,,"Coufalová, L., Mrózek, L., Rárová, L., Plaček, L., Opatřilová, R., Dohnal, J., ... & Jampílek, J. (2013). New propanoyloxy derivatives of 5β-cholan-24-oic acid as drug absorption modifiers. Steroids, 78(5), 435-453.",206.19299999999998,-0.8516,-0.316,6,2,93.06,9,0,10,,,,,,,,,acidic oxygens,,
Propylparaben,CCCOC(=O)C1=CC=C(C=C1)O,7175,ESTER,propyl 4-hydroxybenzoate,94-13-3,"94-13-3,59593-07-6,85403-59-4",-1.85,"Buist HE, van Burgsteden JA, Freidig AP, Maas WJ, van de Sandt JJ. New in vitro dermal absorption database and the prediction of dermal absorption under finite conditions for risk assessment purposes. Regul Toxicol Pharmacol. 2010;57(2‐3):200‐209.",180.202,2.0876,-2.031,3,1,46.53,4,1,5,approved; experimental,DB14177,,,,,,,,Benzene,c1ccccc1
Butyl paraben,CCCCOC(=O)C1=CC=C(C=C1)O,7184,ESTER,butyl 4-hydroxybenzoate,94-26-8,"94-26-8,8068-49-3",-0.98,"Akomeah FK, Martin GP, Brown MB. Variability in human skin permeability in vitro: comparing penetrants with different physicochemical properties. J Pharm Sci. 2007;4:824‐834",194.229,2.542,-2.301,3,1,46.53,5,1,6,approved; experimental,DB14084,,,,,,,,Benzene,c1ccccc1
Methyl‐4‐ hydroxybenzoate,COC(=O)C1=CC=C(C=C1)O,7456,ESTER,methyl 4-hydroxybenzoate,99-76-3,99-76-3,-1.85,"Akomeah FK, Martin GP, Brown MB. Variability in human skin permeability in vitro: comparing penetrants with different physicochemical properties. J Pharm Sci. 2007;4:824‐834",152.149,1.2269,-1.4609999999999999,3,1,46.53,2,1,3,approved,DB14212,,,,,,,,Benzene,c1ccccc1
1‐Methoxypropan‐2‐ol,CC(COC)O,7900,ETHER,1-methoxypropan-2-ol,107-98-2,"107-98-2,58769-19-0",-2.84,"S.C. Wilkinson, F.M. Williams, Effects of experimental conditions on absorption of glycol ethers through human skin in vitro, Int. Arch. Occup. Environ. Health 75 (2002) 519‐527",90.1214,-0.08900000000000001,-0.47600000000000003,2,1,29.46,2,0,6,,,,,,,,,,,
2‐Isopropoxyethanol,CC(C)OCCO,7996,ETHER,2-(propan-2-yloxy)ethan-1-ol,109-59-1,"109-59-1,63992-09-6",-3.35,"M. Venier, G. Adami, F. Larese, G. Maina, N. Renzi, Percutaneous absorption of 5 glycol ethers through human skin in vitro, Toxicol. In Vitro 18 (2004) 665‐671",104.148,0.3173,-0.7759999999999999,2,1,29.46,3,0,7,,,,,,,,,,,
2‐Methoxyethyl acetate,CC(=O)OCCOC,8054,ETHER,2-methoxyethyl acetate,110-49-6,"32718-56-2,110-49-6",-2.74,"M. Venier, G. Adami, F. Larese, G. Maina, N. Renzi, Percutaneous absorption of 5 glycol ethers through human skin in vitro, Toxicol. In Vitro 18 (2004) 665‐671",118.131,0.0363,-0.508,3,0,35.53,4,0,6,,,,,,,,,,,
2‐ethoxyethanol,CCOCCO,8076,ETHER,2-ethoxyethan-1-ol,110-80-5,"110-80-5,96231-36-6",-3.36,"I. H. Blank, R. J. Scheuplein, and D. J. MacFarlane, ""Mechanism of Percutaneous Absorption. 111. The Effect of Temperature on the Transport of Non‐Electrolytes Across the Skin,"" J. Invest. Dermatol. 49,582‐589 (1967)",90.1214,-0.042,-0.39799999999999996,2,1,29.46,3,0,6,experimental,DB02249,,,,,,,,,
Butoxyethanol,CCCCOCCO,8133,ETHER,2-butoxyethan-1-ol,111-76-2,"9004-77-7,111-76-2",-2.44,"Buist HE, van Burgsteden JA, Freidig AP, Maas WJ, van de Sandt JJ. New in vitro dermal absorption database and the prediction of dermal absorption under finite conditions for risk assessment purposes. Regul Toxicol Pharmacol. 2010;57(2‐3):200‐209.",118.175,0.8668,-0.938,2,1,29.46,5,0,8,,,,,,,,,,,
Transcutol,CCOCCOCCO,8146,ETHER,2-(2-ethoxyethoxy)ethan-1-ol,111-90-0,111-90-0,,"Javadzadeh, Y., Adibkia, K., & Hamishekar, H. (2015). Transcutol®(diethylene glycol monoethyl ether): A potential penetration enhancer. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 195-205). Springer, Berlin, Heidelberg.",134.174,-0.1345,-0.319,3,1,38.69,6,0,9,experimental,DB03556,,,,,,,,,
2-Phenoxyethanol,C1=CC=C(C=C1)OCCO,31236,ETHER,2-phenoxyethan-1-ol,122-99-6,"122-99-6,37220-49-8,134367-25-2,18249-17-7,200260-63-5,79586-53-1,9004-78-8,56257-90-0",,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",138.165,1.0692,-1.4269999999999998,2,1,29.46,3,1,4,approved,DB11304,,,,,,,,Benzene,c1ccccc1
diethylene glycol mono n‐butyl ether acetate,CCCCOCCOCCOC(=O)C,31288,ETHER,2-(2-butoxyethoxy)ethyl acetate,124-17-4,"124-17-4,98100-70-0",-3.49,"M. Venier, G. Adami, F. Larese, G. Maina, N. Renzi, Percutaneous absorption of 5 glycol ethers through human skin in vitro, Toxicol. In Vitro 18 (2004) 665‐671",204.265,1.2589,-1.2690000000000001,4,0,44.76,10,0,12,,,,,,,,,,,
4‐propoxyphenol,CCCOC1=CC=C(C=C1)O,29352,ETHER,4-propoxyphenol,18979-50-5,18979-50-5,-1.82,"Zhang Q, Grice JE, Li P, Jepps OG, Wang GJ, Roberts MS. Skin solubility determines maximum transepidermal flux for similar size molecules. Pharm Res. 2009;26(8):1974‐1985.",152.192,2.1046,-1.9080000000000001,2,1,29.46,3,1,5,,,,,,,,,,Benzene,c1ccccc1
Polyoxyethylene (2) stearyl ether (Brij-72),CCCCCCCCCCCCCCCCCCOCCO,75050,ETHER,2-(octadecyloxy)ethan-1-ol,2136-72-3,2136-72-3,,"Ghafourian, T., Nokhodchi, A., & Kaialy, W. (2015). Surfactants as penetration enhancers for dermal and transdermal drug delivery. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 207-230). Springer, Berlin, Heidelberg.",314.551,7.2284,-4.718,2,1,29.46,19,0,22,experimental,DB04233,,,,,,,,,
Nonoxynol 9,CCCCCCCCCC1=CC=C(C=C1)OCCOCCOCCOCCOCCOCCOCCOCCOCCO,72385,ETHER,"26-(4-nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol",26571-11-9,"26571-11-9,41257-07-2",,"Friedman-Kien, A. E., Klein, R. J., Glaser, R. D., & Czelusniak, S. M. (1986). Treatment of recurrent genital herpes with topical alpha interferon gel combined with nonoxynol 9. Journal of the American Academy of Dermatology, 15(5), 989-994.",616.8290000000001,4.2695,-3.188,10,1,103.3,35,1,37,approved; withdrawn,DB06804,,,,,,,,Benzene,c1ccccc1
n‐Propoxyethanol,CCCOCCO,17756,ETHER,2-propoxyethan-1-ol,2807-30-9,"83855-85-0,2807-30-9",-2.98,"M. Venier, G. Adami, F. Larese, G. Maina, N. Renzi, Percutaneous absorption of 5 glycol ethers through human skin in vitro, Toxicol. In Vitro 18 (2004) 665‐671",104.148,0.4124,-0.6679999999999999,2,1,29.46,4,0,7,,,,,,,,,,,
Laureth-3 oxyethylene ether,CCCCCCCCCCCCOCCOCCOCCO,76458,ETHER,2-[2-(2-dodecoxyethoxy)ethoxy]ethanol,3055-94-5,3055-94-5,,"Alzoubi, F. Y., Al-Omari, H. A., & Aljarrh, K. (2014). Evaluating the photosensitivity of the Chinese Chlorella on Red Blood Cells. Journal of Molecular Pharmaceutics & Organic Process Research.",318.496,4.317,-2.94,4,1,47.92,19,0,22,experimental,DB04233,,,,,,,,,
Dodecyloctaethyleneglycol monoether,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCO,123921,ETHER,"3,6,9,12,15,18,21,24-octaoxahexatriacontan-1-ol",3055-98-9,"101226-62-4,3055-98-9,81208-94-8",,"Park, E. S., Chang, S. Y., Hahn, M., & Chi, S. C. (2000). Enhancing effect of polyoxyethylene alkyl ethers on the skin permeation of ibuprofen. International journal of pharmaceutics, 209(1-2), 109-119.",538.76,3.8545,-2.545,9,1,94.07,34,0,37,experimental,DB04233,,,,,,,,,
Dipropylene glycol methyl ether,CCC(O)OCCCOC,22833331,ETHER,1-(3-methoxypropoxy)propan-1-ol,34590-94-8,NA,-4.09,"M. Venier, G. Adami, F. Larese, G. Maina, N. Renzi, Percutaneous absorption of 5 glycol ethers through human skin in vitro, Toxicol. In Vitro 18 (2004) 665‐671",148.201,0.5870000000000001,-0.88,3,1,38.69,6,0,10,,,,,,,,,,,
polyoxyethylene-2-oleyl ether,CCCCCCCCC=CCCCCCCCCOCCO.OP(=O)(O)O,93217,ETHER,2-octadec-9-enoxyethanol,39464-69-2,NA,,"Alzoubi, F. Y., Al-Omari, H. A., & Aljarrh, K. (2014). Evaluating the photosensitivity of the Chinese Chlorella on Red Blood Cells. Journal of Molecular Pharmaceutics & Organic Process Research.",312.536,6.9762,-4.49,2,1,29.46,18,0,20,,,,,,,,,,,
Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,4946,ETHER,1-(naphthalen-1-yloxy)-3-[(propan-2-yl)amino]propan-2-ol,525-66-6,"13013-17-7,525-66-6",-2.49,"Chantasart D, Hao J, Li SK. Evaluation of Skin Permeation of b‐Blockers for Topical Drug Delivery. Pharm Res. 2013;30(3):866‐877.",259.348,2.4155,-3.574,3,2,41.49,6,2,9,approved; investigational,DB00571,,amine,alkyl-amine,,,basic nitrogen,,Naphthalene,c1ccc2ccccc2c1
Polyoxyethylene (2) cetyl ether (Brij-52),CCCCCCCCCCCCCCCCOCCOCCO,4303686,ETHER,2-[2-(hexadecyloxy)ethoxy]ethan-1-ol,5274-61-3,NA,,"Ghafourian, T., Nokhodchi, A., & Kaialy, W. (2015). Surfactants as penetration enhancers for dermal and transdermal drug delivery. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 207-230). Springer, Berlin, Heidelberg.",330.55,6.2271,-4.099,3,1,38.69,20,0,23,experimental,DB04233,,,,,,,,,
Ethylether,CCOCC,3283,ETHER,ethoxyethane,60-29-7,"60-29-7,74446-43-8,7578-39-4,69227-20-9,70131-58-7,68991-48-0,71011-10-4,69013-19-0",-2.3,"I. H. Blank, R. J. Scheuplein, and D. J. MacFarlane, ""Mechanism of Percutaneous Absorption. 111. The Effect of Temperature on the Transport of Non‐Electrolytes Across the Skin,"" J. Invest. Dermatol. 49,582‐589 (1967)",74.1224,0.8847,-0.905,1,0,9.23,2,0,5,experimental,DB13598,,,,,,,,,
Polyoxyethylene (23) lauryl ether (Brij-35),CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,2724258,ETHER,"3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66,69-tricosaoxahenoctacontan-1-ol",68439-50-9,NA,,"Ghafourian, T., Nokhodchi, A., & Kaialy, W. (2015). Surfactants as penetration enhancers for dermal and transdermal drug delivery. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 207-230). Springer, Berlin, Heidelberg.",1199.55,2.467,-1.36,24,1,232.52,79,0,82,experimental,DB04233,,,,,,,,,
Polyoxyethylene (4) lauryl ether (Brij-30),CCCCCCCCCCCCOCCO,24750,ETHER,2-(dodecyloxy)ethan-1-ol,9002-92-0,"4536-30-5,9002-92-0,37343-87-6",,"Ghafourian, T., Nokhodchi, A., & Kaialy, W. (2015). Surfactants as penetration enhancers for dermal and transdermal drug delivery. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 207-230). Springer, Berlin, Heidelberg.",230.39,4.502,-3.0980000000000003,2,1,29.46,13,0,16,experimental,DB04233,,,,,,,,,
Polyoxyethylene (20) oleyl ether (Brij-98),CCCCCCCCC=CCCCCCCCCOCCO,5364713,ETHER,2-(octadec-9-en-1-yloxy)ethan-1-ol,9004-98-2,NA,,"Ghafourian, T., Nokhodchi, A., & Kaialy, W. (2015). Surfactants as penetration enhancers for dermal and transdermal drug delivery. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 207-230). Springer, Berlin, Heidelberg.",312.536,6.9762,-4.49,2,1,29.46,18,0,20,,,,,,,,,,,
Pentadecanoic acid,CCCCCCCCCCCCCCC(=O)O,13849,FATTY ACID,pentadecanoic acid,1002-84-2,1002-84-2,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",242.40099999999998,5.6081,-3.969,2,1,37.3,13,0,15,experimental,DB02448,,,,,,,acidic oxygen,,
Butyric acid,CCCC(=O)O,264,FATTY ACID,butanoic acid,107-92-6,107-92-6,-2.92,"R. J. Scheuplein and I. H. Blank, ""Permeability of Skin,"" Physiol. Rev. 51, 702‐747 (1971)",88.1055,0.6097,-0.9990000000000001,2,1,37.3,2,0,4,experimental; investigational,DB03568,,,,,,,acidic oxygen,,
Pentanoic acid,CCCCC(=O)O,7991,FATTY ACID,pentanoic acid,109-52-4,"109-52-4,12124-87-7",-2.55,"R. J. Scheuplein and I. H. Blank, ""Permeability of Skin,"" Physiol. Rev. 51, 702‐747 (1971)",102.132,1.0641,-1.2690000000000001,2,1,37.3,3,0,5,experimental,DB02406,,,,,,,acidic oxygen,,
Heptanoic acid,CCCCCCC(=O)O,8094,FATTY ACID,heptanoic acid,111-14-8,111-14-8,-1.7,"R. J. Scheuplein and I. H. Blank, ""Permeability of Skin,"" Physiol. Rev. 51, 702‐747 (1971)",130.186,1.9729,-1.8090000000000002,2,1,37.3,5,0,7,experimental,DB02448,,,,,,,acidic oxygen,,
Nonanoic acid,CCCCCCCCC(=O)O,8158,FATTY ACID,nonanoic acid,112-05-0,"112-05-0,58253-02-4,68937-75-7",,"Ibrahim, S. A., & Li, S. K. (2010). Efficiency of fatty acids as chemical penetration enhancers: mechanisms and structure enhancement relationship. Pharmaceutical research, 27(1), 115.",158.24,2.8817,-2.349,2,1,37.3,7,0,9,experimental,DB02448,,,,,,,acidic oxygen,,
Undecanoic acid,CCCCCCCCCCC(=O)O,8180,FATTY ACID,undecanoic acid,112-37-8,112-37-8,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",186.294,3.7905,-2.889,2,1,37.3,9,0,11,experimental,DB02448,,,,,,,acidic oxygen,,
Oleic acid,CCCCCCCCC=CCCCCCCCC(=O)O,445639,FATTY ACID,octadec-9-enoic acid,112-80-1,NA,-2.88,"Buist HE, van Burgsteden JA, Freidig AP, Maas WJ, van de Sandt JJ. New in vitro dermal absorption database and the prediction of dermal absorption under finite conditions for risk assessment purposes. Regul Toxicol Pharmacol. 2010;57(2‐3):200‐209.",282.466,6.7191,-4.551,2,1,37.3,15,0,16,approved; investigational; vet_approved,DB04224,,,,,,,acidic oxygen,,
Docosanoic acid,CCCCCCCCCCCCCCCCCCCCCC(=O)O,8215,FATTY ACID,docosanoic acid,112-85-6,"16529-65-0,112-85-6",,"Ibrahim, S. A., & Li, S. K. (2010). Efficiency of fatty acids as chemical penetration enhancers: mechanisms and structure enhancement relationship. Pharmaceutical research, 27(1), 115.",340.589,8.7889,-5.859,2,1,37.3,20,0,22,experimental,DB02448,,,,,,,acidic oxygen,,
cis-13-Docosenoic acid,CCCCCCCCC=CCCCCCCCCCCCC(=O)O,5281116,FATTY ACID,docos-13-enoic acid,112-86-7,NA,,"Babu, R. J., Chen, L., & Kanikkannan, N. (2015). Fatty alcohols, fatty acids, and fatty acid esters as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 133-150). Springer, Berlin, Heidelberg.",338.57300000000004,8.5367,-5.631,2,1,37.3,19,0,20,approved; investigational; vet_approved,DB04224,,,,,,,acidic oxygen,,
"2,2-Dimethyl pentanoic acid",CCCC(C)(C)C(=O)O,14455,FATTY ACID,"2,2-dimethylpentanoic acid",1185-39-3,1185-39-3,,"Babu, R. J., Chen, L., & Kanikkannan, N. (2015). Fatty alcohols, fatty acids, and fatty acid esters as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 133-150). Springer, Berlin, Heidelberg.",130.186,1.8482,-1.6059999999999999,2,1,37.3,3,0,7,,,,,,,,,acidic oxygen,,
Caprylic acid,CCCCCCCC(=O)O,379,FATTY ACID,octanoic acid,124-07-2,"68937-74-6,18312-04-4,124-07-2",,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",144.213,2.4273,-2.079,2,1,37.3,6,0,8,experimental,DB02448,,,,,,,acidic oxygen,,
Ricinoleic acid,CCCCCCC(CC=CCCCCCCCC(=O)O)O,643684,FATTY ACID,12-hydroxyoctadec-9-enoic acid,141-22-0,NA,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",298.465,5.6973,-4.152,3,2,57.53,15,0,17,experimental,DB02955,,,,,,,acidic oxygen,,
Hexanoic acid,CCCCCC(=O)O,8892,FATTY ACID,hexanoic acid,142-62-1,"142-62-1,51109-46-7,68603-84-9,13476-79-4,16571-42-9,19455-00-6,53896-26-7,67762-36-1,70248-25-8,8040-17-3",-1.92,"R. J. Scheuplein and I. H. Blank, ""Permeability of Skin,"" Physiol. Rev. 51, 702‐747 (1971)",116.15899999999999,1.5185,-1.5390000000000001,2,1,37.3,4,0,6,,,,,,,,,acidic oxygen,,
"2,2-Dimethyl heptanoic acid",CCCCCC(C)(C)C(=O)O,9801869,FATTY ACID,"2,2-dimethylheptanoic acid",14250-73-8,NA,,"Babu, R. J., Chen, L., & Kanikkannan, N. (2015). Fatty alcohols, fatty acids, and fatty acid esters as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 133-150). Springer, Berlin, Heidelberg.",158.24,2.7569999999999997,-2.146,2,1,37.3,5,0,9,,,,,,,,,acidic oxygen,,
Lauric acid,CCCCCCCCCCCC(=O)O,3893,FATTY ACID,dodecanoic acid,143-07-7,"8045-27-0,203714-07-2,7632-48-6,143-07-7,8000-62-2",,"Dragicevic, N., Atkinson, J. P., & Maibach, H. I. (2015). Chemical penetration enhancers: classification and mode of action. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 11-27). Springer, Berlin, Heidelberg.",200.321,4.2449,-3.159,2,1,37.3,10,0,12,experimental,DB02448,,,,,,,acidic oxygen,,
2-Heptyl undecanoic acid,CCCCCCCCCC(CCCCCCC)C(=O)O,14513632,FATTY ACID,2-heptylundecanoic acid,22890-21-7,NA,,"Babu, R. J., Chen, L., & Kanikkannan, N. (2015). Fatty alcohols, fatty acids, and fatty acid esters as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 133-150). Springer, Berlin, Heidelberg.",284.482,6.7352,-4.669,2,1,37.3,15,0,18,,,,,,,,,acidic oxygen,,
"2,2-Dimethyl octanoic acid",CCCCCCC(C)(C)C(=O)O,62847,FATTY ACID,"2,2-dimethyloctanoic acid",29662-90-6,29662-90-6,,"Babu, R. J., Chen, L., & Kanikkannan, N. (2015). Fatty alcohols, fatty acids, and fatty acid esters as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 133-150). Springer, Berlin, Heidelberg.",172.267,3.2114,-2.416,2,1,37.3,6,0,10,,,,,,,,,acidic oxygen,,
Capric acid,CCCCCCCCCC(=O)O,2969,FATTY ACID,decanoic acid,334-48-5,"334-48-5,52627-73-3",,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",172.267,3.3361,-2.6189999999999998,2,1,37.3,8,0,10,experimental,DB02448,,,,,,,acidic oxygen,,
cis-9-Hexadecenoic acid,CCCCCCC=CCCCCCCCC(=O)O,445638,FATTY ACID,hexadec-9-enoic acid,373-49-9,NA,,"Babu, R. J., Chen, L., & Kanikkannan, N. (2015). Fatty alcohols, fatty acids, and fatty acid esters as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 133-150). Springer, Berlin, Heidelberg.",254.412,5.8103,-4.011,2,1,37.3,13,0,14,approved; investigational; vet_approved,DB04224,,,,,,,acidic oxygen,,
Linolenic acid,CCC=CCC=CCC=CCCCCCCCC(=O)O,5280934,FATTY ACID,"octadeca-9,12,15-trienoic acid",463-40-1,NA,-2.43,"Buist HE, van Burgsteden JA, Freidig AP, Maas WJ, van de Sandt JJ. New in vitro dermal absorption database and the prediction of dermal absorption under finite conditions for risk assessment purposes. Regul Toxicol Pharmacol. 2010;57(2‐3):200‐209.",278.434,6.2147,-4.095,2,1,37.3,13,0,12,approved; investigational; nutraceutical,DB00132,,,,,,,acidic oxygen,,
cis-11-Octadecenoic acid,CCCCCCC=CCCCCCCCCCC(=O)O,5282761,FATTY ACID,octadec-11-enoic acid,506-17-2,NA,,"Babu, R. J., Chen, L., & Kanikkannan, N. (2015). Fatty alcohols, fatty acids, and fatty acid esters as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 133-150). Springer, Berlin, Heidelberg.",282.466,6.7191,-4.551,2,1,37.3,15,0,16,approved; investigational; vet_approved,DB04224,,,,,,,acidic oxygen,,
Eicosanoic acid,CCCCCCCCCCCCCCCCCCCC(=O)O,10467,FATTY ACID,icosanoic acid,506-30-9,"506-30-9,22302-43-8",,"Ibrahim, S. A., & Li, S. K. (2010). Efficiency of fatty acids as chemical penetration enhancers: mechanisms and structure enhancement relationship. Pharmaceutical research, 27(1), 115.",312.536,7.8801,-5.319,2,1,37.3,18,0,20,experimental,DB02448,,,,,,,acidic oxygen,,
Myristic acid,CCCCCCCCCCCCCC(=O)O,11005,FATTY ACID,tetradecanoic acid,544-63-8,"45184-05-2,32112-52-0,544-63-8",,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",228.37400000000002,5.1537,-3.699,2,1,37.3,12,0,14,experimental,DB02448,,,,,,,acidic oxygen,,
cis-9-Tetradecenoic acid,CCCCC=CCCCCCCCC(=O)O,5281119,FATTY ACID,tetradec-9-enoic acid,544-64-9,NA,,"Babu, R. J., Chen, L., & Kanikkannan, N. (2015). Fatty alcohols, fatty acids, and fatty acid esters as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 133-150). Springer, Berlin, Heidelberg.",226.358,4.9015,-3.471,2,1,37.3,11,0,12,,,,,,,,,acidic oxygen,,
cis-11-Eicosenoic acid,CCCCCCCCC=CCCCCCCCCCC(=O)O,5282768,FATTY ACID,icos-11-enoic acid,5561-99-9,NA,,"Babu, R. J., Chen, L., & Kanikkannan, N. (2015). Fatty alcohols, fatty acids, and fatty acid esters as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 133-150). Springer, Berlin, Heidelberg.",310.52,7.6279,-5.091,2,1,37.3,17,0,18,approved; investigational; vet_approved,DB04224,,,,,,,acidic oxygen,,
Tetracosanoic acid,CCCCCCCCCCCCCCCCCCCCCCCC(=O)O,11197,FATTY ACID,tetracosanoic acid,557-59-5,557-59-5,,"Ibrahim, S. A., & Li, S. K. (2010). Efficiency of fatty acids as chemical penetration enhancers: mechanisms and structure enhancement relationship. Pharmaceutical research, 27(1), 115.",368.64300000000003,9.6977,-6.399,2,1,37.3,22,0,24,experimental,DB02448,,,,,,,acidic oxygen,,
Palmitic acid,CCCCCCCCCCCCCCCC(=O)O,985,FATTY ACID,hexadecanoic acid,57-10-3,"67701-02-4,116860-99-2,212625-86-0,60605-23-4,66321-94-6,57-10-3",,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",256.428,6.0625,-4.239,2,1,37.3,14,0,16,experimental,DB02448,,,,,,,acidic oxygen,,
Stearic acid,CCCCCCCCCCCCCCCCCC(=O)O,5281,FATTY ACID,octadecanoic acid,57-11-4,"609343-71-7,68937-76-8,134503-33-6,39390-61-9,58392-66-8,8013-28-3,8023-06-1,57-11-4,8037-83-0,8037-40-9,8039-52-9,8039-53-0,8039-54-1,82497-27-6,126539-56-8,30399-84-9,57485-56-0,85404-83-7,8039-51-8",,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",284.482,6.9713,-4.779,2,1,37.3,16,0,18,experimental,DB02448,,,,,,,acidic oxygen,,
cis-6-Octadecenoic acid,CCCCCCCCCCCC=CCCCCC(=O)O,5281125,FATTY ACID,octadec-6-enoic acid,593-39-5,NA,,"Babu, R. J., Chen, L., & Kanikkannan, N. (2015). Fatty alcohols, fatty acids, and fatty acid esters as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 133-150). Springer, Berlin, Heidelberg.",282.466,6.7191,-4.551,2,1,37.3,15,0,16,approved; investigational; vet_approved,DB04224,,,,,,,acidic oxygen,,
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,5280450,FATTY ACID,"octadeca-9,12-dienoic acid",60-33-3,NA,,"Dragicevic, N., Atkinson, J. P., & Maibach, H. I. (2015). Chemical penetration enhancers: classification and mode of action. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 11-27). Springer, Berlin, Heidelberg.",280.45,6.4669,-4.323,2,1,37.3,14,0,14,investigational; nutraceutical,DB00154,,,,,,,acidic oxygen,,
Tridecanoic acid,CCCCCCCCCCCCC(=O)O,12530,FATTY ACID,tridecanoic acid,638-53-9,"638-53-9,68002-90-4",,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",214.347,4.6993,-3.429,2,1,37.3,11,0,13,experimental,DB02448,,,,,,,acidic oxygen,,
Boric acid,B(O)(O)O,7628,INORGANIC MISC.,boric acid,10043-35-3,"11113-50-1,12795-04-9,13460-50-9,10043-35-3,11129-12-7,13813-79-1",-3.58,"R.C. Wester, X. Hui, T. Hartway, H.I. Maibach, K. Bell, M.J. Schell, D.J. Northington, P. Strong, B.D. Culver, In vivo percutaneous absorption of boric acid, borax, and disodium octaborate tetrahydrate in humans compared to in vitro absorption in human skin from infinite and finite doses, Toxicol. Sci. 45 (1998) 42‐51",61.8318,0.0,3.28,3,3,60.69,0,0,3,approved,DB11326,,,,,,,,,
Water,O,962,INORGANIC MISC.,water,7732-18-5,"14314-42-2,558440-22-5,13670-17-2,7732-18-5,17778-80-2",-2.99,"Astley, J. P.; Levine, M. J. Pharm. Sci. 1976, 65, 210‐215",18.0149,0.0,-0.53,1,1,9.23,0,0,1,approved,DB09145,,,,,,,,,
1-Morpholin-4-ylhept-6-en-1-one (Azone_analog-155),C=CCCCCC(=O)N1CCOCC1,19855845,MORPHOLINE,1-(morpholin-4-yl)hept-6-en-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",197.27700000000002,1.9766,-1.445,3,0,29.54,5,0,9,,,amide,,,,,,,Morpholine,C1COCCN1
1-Morpholin-4-yloct-7-en-1-one (Azone_analog-156),C=CCCCCCC(=O)N1CCOCC1,19855843,MORPHOLINE,1-(morpholin-4-yl)oct-7-en-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",211.304,2.431,-1.715,3,0,29.54,6,0,10,,,amide,,,,,,,Morpholine,C1COCCN1
1-Morpholin-4-ylnon-8-en-1-one (Azone_analog-157),C=CCCCCCCC(=O)N1CCOCC1,19855872,MORPHOLINE,1-(morpholin-4-yl)non-8-en-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",225.331,2.8854,-1.985,3,0,29.54,7,0,11,,,amide,,,,,,,Morpholine,C1COCCN1
"1-morpholin-4-yl-deca-2,3-dien-1-one (Azone_analog-172)",CCCCCCC=C=CC(=O)N1CCOCC1,19855860,MORPHOLINE,"1-(morpholin-4-yl)deca-2,3-dien-1-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",237.342,2.8187,-1.818,3,0,29.54,6,0,11,,,amide,,,,,,,Morpholine,C1COCCN1
1-Morpholin-4-yldec-9-en-1-one (Azone_analog-158),C=CCCCCCCCC(=O)N1CCOCC1,19855840,MORPHOLINE,1-(morpholin-4-yl)dec-9-en-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",239.358,3.3398,-2.255,3,0,29.54,8,0,12,,,amide,,,,,,,Morpholine,C1COCCN1
1-Morpholin-4-ylundec-2-en-1-one (Azone_analog-171),CCCCCCCCC=CC(=O)N1CCOCC1,54196588,MORPHOLINE,1-(morpholin-4-yl)undec-2-en-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",253.38400000000001,3.7275,-2.358,3,0,29.54,8,0,13,,,amide,,,,,,,Morpholine,C1COCCN1
"1-(2,6-Dimethylmorpholin-4-yl)decan-1-one (Azone_analog-148)",CCCCCCCCCC(=O)N1CC(C)OC(C)C1,19981245,MORPHOLINE,"1-(2,6-dimethylmorpholin-4-yl)decan-1-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",269.427,4.1747,-3.072,3,0,29.54,8,0,16,,,amide,,,,,,,Morpholine,C1COCCN1
1-Morpholin-4-yltridec-12-en-1-one (Azone_analog-161),C=CCCCCCCCCCCC(=O)N1CCOCC1,19855868,MORPHOLINE,1-(morpholin-4-yl)tridec-12-en-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",281.438,4.703,-3.065,3,0,29.54,11,0,15,,,amide,,,,,,,Morpholine,C1COCCN1
"1-(2,6-Dimethylmorpholin-4-yl)undecan-1-one (Azone_analog-149)",CCCCCCCCCCC(=O)N1CC(C)OC(C)C1,19981255,MORPHOLINE,"1-(2,6-dimethylmorpholin-4-yl)undecan-1-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",283.454,4.6291,-3.342,3,0,29.54,9,0,17,,,amide,,,,,,,Morpholine,C1COCCN1
"1-(2,6-Dimethylmorpholin-4-yl)dodec-10-en-1-one (Azone_analog-166)",CC=CCCCCCCCCC(=O)N1CC(C)OC(C)C1,53639403,MORPHOLINE,"1-(2,6-dimethylmorpholin-4-yl)dodec-10-en-1-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",295.465,4.8313,-3.384,3,0,29.54,9,0,16,,,amide,,,,,,,Morpholine,C1COCCN1
1-Morpholin-4-yltetradec-13-en-1-one (Azone_analog-162),C=CCCCCCCCCCCCC(=O)N1CCOCC1,19855858,MORPHOLINE,1-(morpholin-4-yl)tetradec-13-en-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",295.465,5.1574,-3.335,3,0,29.54,12,0,16,,,amide,,,,,,,Morpholine,C1COCCN1
"1-(2,6-Dimethylmorpholin-4-yl)dodecan-1-one (Azone_analog-150)",CCCCCCCCCCCC(=O)N1CC(C)OC(C)C1,19981247,MORPHOLINE,"1-(2,6-dimethylmorpholin-4-yl)dodecan-1-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",297.481,5.0835,-3.612,3,0,29.54,10,0,18,,,amide,,,,,,,Morpholine,C1COCCN1
1-Morpholin-4-ylpentadec-14-en-1-one (Azone_analog-163),C=CCCCCCCCCCCCCC(=O)N1CCOCC1,19855869,MORPHOLINE,1-(morpholin-4-yl)pentadec-14-en-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",309.492,5.6118,-3.605,3,0,29.54,13,0,17,,,amide,,,,,,,Morpholine,C1COCCN1
"1-(2,6-Dimethylmorpholin-4-yl)tridecan-1-one (Azone_analog-151)",CCCCCCCCCCCCC(=O)N1CC(C)OC(C)C1,19981242,MORPHOLINE,"1-(2,6-dimethylmorpholin-4-yl)tridecan-1-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",311.508,5.5379,-3.8819999999999997,3,0,29.54,11,0,19,,,amide,,,,,,,Morpholine,C1COCCN1
Tetradecylmorpholino ketone (Azone_analog-144),CCCCCCCCCCCCCCC(=O)N1CCOCC1,10335649,MORPHOLINE,1-(morpholin-4-yl)pentadecan-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",311.508,5.7973,-3.6660000000000004,3,0,29.54,13,0,19,,,amide,,,,,,,Morpholine,C1COCCN1
"1-(2,6-Dimethylmorpholin-4-yl)tetradec-12-en-1-one (Azone_analog-168)",CC=CCCCCCCCCCCC(=O)N1CC(C)OC(C)C1,54524553,MORPHOLINE,"1-(2,6-dimethylmorpholin-4-yl)tetradec-12-en-1-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",323.519,5.7401,-3.924,3,0,29.54,11,0,18,,,amide,,,,,,,Morpholine,C1COCCN1
1-Morpholin-4-ylhexadec-15-en-1-one (Azone_analog-164),C=CCCCCCCCCCCCCCC(=O)N1CCOCC1,19855859,MORPHOLINE,1-(morpholin-4-yl)hexadec-15-en-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",323.519,6.0662,-3.875,3,0,29.54,14,0,18,,,amide,,,,,,,Morpholine,C1COCCN1
"1-(2,6-Dimethylmorpholin-4-yl)tetradecan-1-one (Azone_analog-152)",CCCCCCCCCCCCCC(=O)N1CC(C)OC(C)C1,19981250,MORPHOLINE,"1-(2,6-dimethylmorpholin-4-yl)tetradecan-1-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",325.535,5.9923,-4.152,3,0,29.54,12,0,20,,,amide,,,,,,,Morpholine,C1COCCN1
1-Morpholin-4-ylheptadecan-1-one (Azone_analog-146),CCCCCCCCCCCCCCCCC(=O)N1CCOCC1,10925833,MORPHOLINE,1-(morpholin-4-yl)heptadecan-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",339.56199999999995,6.7061,-4.206,3,0,29.54,15,0,21,,,amide,,,,,,,Morpholine,C1COCCN1
"1-(2,6-Dimethylmorpholin-4-yl)hexadec-10-en-1-one (Azone_analog-169)",CCCCCC=CCCCCCCCCC(=O)N1CC(C)OC(C)C1,54283557,MORPHOLINE,"1-(2,6-dimethylmorpholin-4-yl)hexadec-10-en-1-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",351.57300000000004,6.6489,-4.4639999999999995,3,0,29.54,13,0,20,,,amide,,,,,,,Morpholine,C1COCCN1
1-Morpholin-4-yloctadec-17-en-1-one (Azone_analog-165),C=CCCCCCCCCCCCCCCCC(=O)N1CCOCC1,19855833,MORPHOLINE,1-(morpholin-4-yl)octadec-17-en-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",351.57300000000004,6.975,-4.415,3,0,29.54,16,0,20,,,amide,,,,,,,Morpholine,C1COCCN1
"1-(2,6-Dimethylmorpholin-4-yl)hexadecan-1-one (Azone_analog-153)",CCCCCCCCCCCCCCCC(=O)N1CC(C)OC(C)C1,19981248,MORPHOLINE,"1-(2,6-dimethylmorpholin-4-yl)hexadecan-1-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",353.588,6.9011,-4.692,3,0,29.54,14,0,22,,,amide,,,,,,,Morpholine,C1COCCN1
"1-(2,6-Dimethylmorpholin-4-yl)octadec-10-en-1-one (Azone_analog-170)",CCCCCCCC=CCCCCCCCCC(=O)N1CC(C)OC(C)C1,53809464,MORPHOLINE,"1-(2,6-dimethylmorpholin-4-yl)octadec-10-en-1-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",379.626,7.5577,-5.004,3,0,29.54,15,0,22,,,amide,,,,,,,Morpholine,C1COCCN1
"1-(2,6-Dimethylmorpholin-4-yl)octadecan-1-one (Azone_analog-154)",CCCCCCCCCCCCCCCCCC(=O)N1CC(C)OC(C)C1,19981243,MORPHOLINE,"1-(2,6-dimethylmorpholin-4-yl)octadecan-1-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",381.642,7.8099,-5.232,3,0,29.54,16,0,24,,,amide,,,,,,,Morpholine,C1COCCN1
2-Morpholin-4-ylhexanoic acid (Azone_analog-177),CCCCC(N1CCOCC1)C(O)=O,57245578,MORPHOLINE,2-(morpholin-4-yl)hexanoic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",201.265,-0.2406,-0.8370000000000001,4,1,49.77,5,0,12,,,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,Morpholine,C1COCCN1
2-Morpholin-4-yloctanoic acid (Azone_analog-178),CCCCCCC(N1CCOCC1)C(O)=O,43803371,MORPHOLINE,2-(morpholin-4-yl)octanoic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",229.31900000000002,0.6682,-1.3769999999999998,4,1,49.77,7,0,14,,,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,Morpholine,C1COCCN1
2-Morpholin-4-yldecanoic acid (Azone_analog-179),CCCCCCCCC(N1CCOCC1)C(O)=O,57259608,MORPHOLINE,2-(morpholin-4-yl)decanoic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",257.372,1.577,-1.9169999999999998,4,1,49.77,9,0,16,,,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,Morpholine,C1COCCN1
2-[2-(4-Propylheptyl)morpholin-4-yl]ethanol (Azone_analog-174),CCCC(CCC)CCCC1CN(CCO)CCO1,70579181,MORPHOLINE,2-[2-(4-propylheptyl)morpholin-4-yl]ethan-1-ol,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",271.443,3.4912,-2.365,3,1,32.7,10,0,19,,,,amine,alkyl-amine,,,basic nitrogen,,Morpholine,C1COCCN1
2-Morpholin-4-yldodecanoic acid (Azone_analog-180),CCCCCCCCCCC(N1CCOCC1)C(O)=O,56988066,MORPHOLINE,2-(morpholin-4-yl)dodecanoic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",285.426,2.4858,-2.457,4,1,49.77,11,0,18,,,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,Morpholine,C1COCCN1
2-Morpholin-4-yltetradecanoic acid (Azone_analog-181),CCCCCCCCCCCCC(N1CCOCC1)C(O)=O,57012303,MORPHOLINE,2-(morpholin-4-yl)tetradecanoic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",313.48,3.3946,-2.997,4,1,49.77,13,0,20,,,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,Morpholine,C1COCCN1
1-Morpholin-4-yldodecane-1-thione (Azone_analog-134),CCCCCCCCCCCC(=S)N1CCOCC1,10379215,MORPHOLINE,1-(morpholin-4-yl)dodecane-1-thione,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",285.494,4.9071,-3.793,2,0,44.56,10,0,17,,,,,,,,,,Morpholine,C1COCCN1
"4-Dodecylmorpholine-2,3-dione (Azone_analog-138)",CCCCCCCCCCCCN1CCOC(=O)C1=O,85693234,MORPHOLINE,"4-dodecylmorpholine-2,3-dione",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",283.41,3.6513,-2.838,4,0,46.61,11,0,15,,,amide,,,,,,,"Morpholine-2,3-dione",O=C1NCCOC1=O
"4-Tetradecylmorpholine-2,3-dione (Azone_analog-139)",CCCCCCCCCCCCCCN1CCOC(=O)C1=O,85693235,MORPHOLINE,"4-tetradecylmorpholine-2,3-dione",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",311.464,4.5601,-3.378,4,0,46.61,13,0,17,,,amide,,,,,,,"Morpholine-2,3-dione",O=C1NCCOC1=O
4-Tridecanoylmorpholine (Azone_analog-142),CCCCCCCCCCCCC(=O)N1CCOCC1,294274,MORPHOLINE,1-(morpholin-4-yl)tridecan-1-one,101831-42-9,101831-42-9,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",283.454,4.8885,-3.1260000000000003,3,0,29.54,11,0,17,,,amide,,,,,,,Morpholine,C1COCCN1
4-Methylmorpholine (Azone_analog-131),CN1CCOCC1,7972,MORPHOLINE,4-methylmorpholine,109-02-4,"109-02-4,205657-43-8",,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",101.148,-0.1666,0.126,2,0,12.47,0,0,7,,,,amine,alkyl-amine,,,basic nitrogen,,Morpholine,C1COCCN1
4-Dodecylmorpholine (Azone_analog-132),CCCCCCCCCCCCN1CCOCC1,73764,MORPHOLINE,4-dodecylmorpholine,1541-81-7,1541-81-7,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",255.44400000000002,4.7837,-2.8739999999999997,2,0,12.47,11,0,18,,,,amine,alkyl-amine,,,basic nitrogen,,Morpholine,C1COCCN1
4-(1-Oxoundecyl)morpholine (Azone_analog-141),CCCCCCCCCCC(=O)N1CCOCC1,98730,MORPHOLINE,1-(morpholin-4-yl)undecan-1-one,32972-24-0,32972-24-0,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",255.4,3.9797,-2.5860000000000003,3,0,29.54,9,0,15,,,amide,,,,,,,Morpholine,C1COCCN1
10-undecenoylmorpholine (Azone_analog-159),C=CCCCCCCCCC(=O)N1CCOCC1,96360,MORPHOLINE,1-(morpholin-4-yl)undec-10-en-1-one,4204-68-6,4204-68-6,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",253.38400000000001,3.7942,-2.525,3,0,29.54,9,0,13,,,amide,,,,,,,Morpholine,C1COCCN1
1-Morpholinooctadecane-1-one (Azone_analog-147),CCCCCCCCCCCCCCCCCC(=O)N1CCOCC1,9924707,MORPHOLINE,1-(morpholin-4-yl)octadecan-1-one,5299-54-7,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",353.588,7.1605,-4.476,3,0,29.54,16,0,22,,,amide,,,,,,,Morpholine,C1COCCN1
N-Decanoylmorpholine (Azone_analog-140),CCCCCCCCCC(=O)N1CCOCC1,94801,MORPHOLINE,1-(morpholin-4-yl)decan-1-one,5299-65-0,5299-65-0,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",241.373,3.5253,-2.316,3,0,29.54,8,0,14,,,amide,,,,,,,Morpholine,C1COCCN1
4-Lauroylmorpholine (Azone_analog-133),CCCCCCCCCCCC(=O)N1CCOCC1,94793,MORPHOLINE,1-(morpholin-4-yl)dodecan-1-one,5299-67-2,5299-67-2,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",269.427,4.4341,-2.8560000000000003,3,0,29.54,10,0,16,,,amide,,,,,,,Morpholine,C1COCCN1
1-(Morpholin-4-yl)hexadecan-1-one (Azone_analog-145),CCCCCCCCCCCCCCCC(=O)N1CCOCC1,220414,MORPHOLINE,1-(morpholin-4-yl)hexadecan-1-one,5299-68-3,5299-68-3,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",325.535,6.2517,-3.9360000000000004,3,0,29.54,14,0,20,,,amide,,,,,,,Morpholine,C1COCCN1
4-Myristoylmorpholine (Azone_analog-143),CCCCCCCCCCCCCC(=O)N1CCOCC1,94792,MORPHOLINE,1-(morpholin-4-yl)tetradecan-1-one,5338-53-4,5338-53-4,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",297.481,5.3429,-3.3960000000000004,3,0,29.54,12,0,18,,,amide,,,,,,,Morpholine,C1COCCN1
Delmopinol,CCCC(CCC)CCCC1COCCN1CCO,57337,MORPHOLINE,2-[3-(4-propylheptyl)morpholin-4-yl]ethan-1-ol,79874-76-3,"98092-92-3,79874-76-3",,"Jampilek, J., & Brychtova, K. (2012). Azone analogues: classification, design, and transdermal penetration principles. Medicinal research reviews, 32(5), 907-947.",271.443,3.4912,-2.365,3,1,32.7,10,0,19,,,,amine,alkyl-amine,,,basic nitrogen,,Morpholine,C1COCCN1
1-Decanoyl-4-methylpiperazine (Azone_analog-191),CCCCCCCCCC(=O)N1CCN(C)CC1,3416567,PIPERAZINE,1-(4-methylpiperazin-1-yl)decan-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",254.416,3.6347,-1.818,3,0,23.55,8,0,15,,,amide,amine,alkyl-amine,,,basic nitrogen,,Piperazine,C1CNCCN1
1-Piperazin-1-yldodecan-1-one (Azone_analog-183),CCCCCCCCCCCC(=O)N1CCNCC1,9993189,PIPERAZINE,1-(piperazin-1-yl)dodecan-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",268.443,4.2906,-2.72,3,1,32.34,10,0,16,,,amide,amine,alkyl-amine,,,basic nitrogen,,Piperazine,C1CNCCN1
1-(4-Methylpiperazin-1-yl)dodecan-1-one (Azone_analog-192),CCCCCCCCCCCC(=O)N1CCN(C)CC1,4560447,PIPERAZINE,1-(4-methylpiperazin-1-yl)dodecan-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",282.47,4.5435,-2.358,3,0,23.55,10,0,17,,,amide,amine,alkyl-amine,,,basic nitrogen,,Piperazine,C1CNCCN1
4-Methyl-1-(1-oxotetradecyl)piperazine (Azone_analog-193),CCCCCCCCCCCCCC(=O)N1CCN(C)CC1,9972710,PIPERAZINE,1-(4-methylpiperazin-1-yl)tetradecan-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",310.524,5.4523,-2.898,3,0,23.55,12,0,19,,,amide,amine,alkyl-amine,,,basic nitrogen,,Piperazine,C1CNCCN1
1-Piperazin-1-ylhexadecan-1-one (Azone_analog-184),CCCCCCCCCCCCCCCC(=O)N1CCNCC1,10314205,PIPERAZINE,1-(piperazin-1-yl)hexadecan-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",324.551,6.1082,-3.8,3,1,32.34,14,0,20,,,amide,amine,alkyl-amine,,,basic nitrogen,,Piperazine,C1CNCCN1
1-(4-Methylpiperazin-1-yl)hexadecan-1-one (Azone_analog-194),CCCCCCCCCCCCCCCC(=O)N1CCN(C)CC1,422716,PIPERAZINE,1-(4-methylpiperazin-1-yl)hexadecan-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",338.577,6.3611,-3.438,3,0,23.55,14,0,21,,,amide,amine,alkyl-amine,,,basic nitrogen,,Piperazine,C1CNCCN1
1-Piperazin-1-ylheptadecan-1-one (Azone_analog-185),CCCCCCCCCCCCCCCCC(=O)N1CCNCC1,19981253,PIPERAZINE,1-(piperazin-1-yl)heptadecan-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",338.577,6.5626,-4.07,3,1,32.34,15,0,21,,,amide,amine,alkyl-amine,,,basic nitrogen,,Piperazine,C1CNCCN1
"1,4-Dioctanoylpiperazine (Azone_analog-199)",CCCCCCCC(=O)N1CCN(CC1)C(=O)CCCCCCC,3094208,PIPERAZINE,1-(4-octanoylpiperazin-1-yl)octan-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",338.534,5.5089999999999995,-3.18,4,0,40.62,12,0,18,,,amide,,,,,,,Piperazine,C1CNCCN1
"1,4-Didecanoylpiperazine (Azone_analog-200)",CCCCCCCCCC(=O)N1CCN(CC1)C(=O)CCCCCCCCC,4623369,PIPERAZINE,1-(4-decanoylpiperazin-1-yl)decan-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",394.64099999999996,7.3266,-4.26,4,0,40.62,16,0,22,,,amide,,,,,,,Piperazine,C1CNCCN1
1-(4-Hexadecanoylpiperazin-1-yl)hexadecan-1-one (Azone_analog-202),CCCCCCCCCCCCCCCC(=O)N1CCN(CC1)C(=O)CCCCCCCCCCCCCCC,19981246,PIPERAZINE,1-(4-hexadecanoylpiperazin-1-yl)hexadecan-1-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",562.964,12.779000000000002,-7.5,4,0,40.62,28,0,34,,,amide,,,,,,,Piperazine,C1CNCCN1
"1,6-Bis(4-methylpiperazin-1-yl)hexane-1,6-dione (Azone_analog-323)",CN1CCN(CC1)C(=O)CCCCC(=O)N1CCN(C)CC1,3455784,PIPERAZINE,"1,6-bis(4-methylpiperazin-1-yl)hexane-1,6-dione",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",310.44,0.8394,0.588,6,0,47.1,5,0,16,,,amide,amine,alkyl-amine,,,basic nitrogen,,,O=C(CCCCC(=O)N1CCNCC1)N1CCNCC1
"1,7-Bis(4-methylpiperazin-1-yl)heptane-1,7-dione (Azone_analog-324)",CN1CCN(CC1)C(=O)CCCCCC(=O)N1CCN(C)CC1,19981256,PIPERAZINE,"1,7-bis(4-methylpiperazin-1-yl)heptane-1,7-dione",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",324.467,1.2938,0.318,6,0,47.1,6,0,17,,,amide,amine,alkyl-amine,,,basic nitrogen,,,O=C(CCCCCC(=O)N1CCNCC1)N1CCNCC1
"1,9-Di(piperazin-1-yl)nonane-1,9-dione (Azone_analog-321)",O=C(CCCCCCCC(=O)N1CCNCC1)N1CCNCC1,19981240,PIPERAZINE,"1,9-bis(piperazin-1-yl)nonane-1,9-dione",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",324.467,1.6968,-0.946,6,2,64.68,8,0,17,,,amide,amine,alkyl-amine,,,basic nitrogen,,,O=C(CCCCCCCC(=O)N1CCNCC1)N1CCNCC1
"1,10-Di(piperazin-1-yl)decane-1,10-dione (Azone_analog-322)",O=C(CCCCCCCCC(=O)N1CCNCC1)N1CCNCC1,19981244,PIPERAZINE,"1,10-bis(piperazin-1-yl)decane-1,10-dione",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",338.494,2.1512,-1.216,6,2,64.68,9,0,18,,,amide,amine,alkyl-amine,,,basic nitrogen,,,O=C(CCCCCCCCC(=O)N1CCNCC1)N1CCNCC1
1-hexanoyl-4-methylpiperazine (Azone_analog-187),CCCCCC(=O)N1CCN(C)CC1,3470875,PIPERAZINE,1-(4-methylpiperazin-1-yl)hexan-1-one,10001-08-8,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",198.30900000000003,1.8171,-0.738,3,0,23.55,4,0,11,,,amide,amine,alkyl-amine,,,basic nitrogen,,Piperazine,C1CNCCN1
"1,10-Bis(4-methylpiperazin-1-yl)decane-1,10-dione (Azone_analog-325)",CN1CCN(CC1)C(=O)CCCCCCCCC(=O)N1CCN(C)CC1,58174,PIPERAZINE,"1,10-bis(4-methylpiperazin-1-yl)decane-1,10-dione",101077-11-6,101077-11-6,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",366.548,2.657,-0.49200000000000005,6,0,47.1,9,0,20,,,amide,amine,alkyl-amine,,,basic nitrogen,,,O=C(CCCCCCCCC(=O)N1CCNCC1)N1CCNCC1
1-(Piperazin-1-yl)pentan-1-one (Azone_analog-182),CCCCC(=O)N1CCNCC1,10535172,PIPERAZINE,1-(piperazin-1-yl)pentan-1-one,117905-47-2,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",170.255,1.1098,-0.83,3,1,32.34,3,0,9,,,amide,amine,alkyl-amine,,,basic nitrogen,,Piperazine,C1CNCCN1
"1,4-Dihexanoylpiperazine (Azone_analog-197)",CCCCCC(=O)N1CCN(CC1)C(=O)CCCCC,205871,PIPERAZINE,1-(4-hexanoylpiperazin-1-yl)hexan-1-one,18903-09-8,18903-09-8,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",282.426,3.6914,-2.1,4,0,40.62,8,0,14,,,amide,,,,,,,Piperazine,C1CNCCN1
"1,4-Diheptanoylpiperazine (Azone_analog-198)",CCCCCCC(=O)N1CCN(CC1)C(=O)CCCCCC,205872,PIPERAZINE,1-(4-heptanoylpiperazin-1-yl)heptan-1-one,18903-10-1,18903-10-1,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",310.48,4.6002,-2.64,4,0,40.62,10,0,16,,,amide,,,,,,,Piperazine,C1CNCCN1
"1,4-Distearoylpiperazine (Azone_analog-203)",CCCCCCCCCCCCCCCCCC(=O)N1CCN(CC1)C(=O)CCCCCCCCCCCCCCCCC,550164,PIPERAZINE,1-(4-octadecanoylpiperazin-1-yl)octadecan-1-one,53575-22-7,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",619.071,14.597000000000001,-8.58,4,0,40.62,32,0,38,,,amide,,,,,,,Piperazine,C1CNCCN1
1-Methyl-4-stearoylpiperazine (Azone_analog-195),CCCCCCCCCCCCCCCCCC(=O)N1CCN(C)CC1,550877,PIPERAZINE,1-(4-methylpiperazin-1-yl)octadecan-1-one,56252-83-6,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",366.631,7.2699,-3.978,3,0,23.55,16,0,23,,,amide,amine,alkyl-amine,,,basic nitrogen,,Piperazine,C1CNCCN1
1-Heptanoyl-4-methylpiperazine (Azone_analog-188),CCCCCCC(=O)N1CCN(C)CC1,3044363,PIPERAZINE,1-(4-methylpiperazin-1-yl)heptan-1-one,57150-47-7,57150-47-7,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",212.33599999999998,2.2715,-1.008,3,0,23.55,5,0,12,,,amide,amine,alkyl-amine,,,basic nitrogen,,Piperazine,C1CNCCN1
1-Octanoyl-4-methylpiperazine (Azone_analog-189),CCCCCCCC(=O)N1CCN(C)CC1,3044364,PIPERAZINE,1-(4-methylpiperazin-1-yl)octan-1-one,57150-48-8,57150-48-8,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",226.362,2.7259,-1.278,3,0,23.55,6,0,13,,,amide,amine,alkyl-amine,,,basic nitrogen,,Piperazine,C1CNCCN1
1-(4-Methylpiperazin-1-yl)nonan-1-one (Azone_analog-190),CCCCCCCCC(=O)N1CCN(C)CC1,303111,PIPERAZINE,1-(4-methylpiperazin-1-yl)nonan-1-one,57150-49-9,57150-49-9,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",240.389,3.1803,-1.548,3,0,23.55,7,0,14,,,amide,amine,alkyl-amine,,,basic nitrogen,,Piperazine,C1CNCCN1
"1,4-Dilauroylpiperazine (Azone_analog-201)",CCCCCCCCCCCC(=O)N1CCN(CC1)C(=O)CCCCCCCCCCC,81108,PIPERAZINE,1-(4-dodecanoylpiperazin-1-yl)dodecan-1-one,6626-83-1,6626-83-1,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",450.749,9.1442,-5.34,4,0,40.62,20,0,26,,,amide,,,,,,,Piperazine,C1CNCCN1
1-(2-Butylsulfanylethyl)piperidine-3-carboxylic acid (Azone_analog-121),CCCCSCCN1CCCC(C1)C(O)=O,19002611,PIPERIDINE,1-[2-(butylsulfanyl)ethyl]piperidine-3-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",245.386,1.0252,-1.845,3,1,65.84,7,0,14,,,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,Piperidine,C1CCNCC1
1-(2-Pentylsulfanylethyl)piperidine-3-carboxylic acid (Azone_analog-122),CCCCCSCCN1CCCC(C1)C(O)=O,19002614,PIPERIDINE,1-[2-(pentylsulfanyl)ethyl]piperidine-3-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",259.413,1.4796,-2.115,3,1,65.84,8,0,15,,,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,Piperidine,C1CCNCC1
1-(2-Hexylsulfanylethyl)piperidine-3-carboxylic acid (Azone_analog-123),CCCCCCSCCN1CCCC(C1)C(O)=O,19002574,PIPERIDINE,1-[2-(hexylsulfanyl)ethyl]piperidine-3-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",273.439,1.9340000000000002,-2.385,3,1,65.84,9,0,16,,,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,Piperidine,C1CCNCC1
1-(2-Heptylsulfanylethyl)piperidine-3-carboxylic acid (Azone_analog-124),CCCCCCCSCCN1CCCC(C1)C(O)=O,19002588,PIPERIDINE,1-[2-(heptylsulfanyl)ethyl]piperidine-3-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",287.466,2.3884,-2.655,3,1,65.84,10,0,17,,,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,Piperidine,C1CCNCC1
1-(2-Octylsulfanylethyl)piperidine-3-carboxylic acid (Azone_analog-125),CCCCCCCCSCCN1CCCC(C1)C(O)=O,19002617,PIPERIDINE,1-[2-(octylsulfanyl)ethyl]piperidine-3-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",301.493,2.8428,-2.925,3,1,65.84,11,0,18,,,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,Piperidine,C1CCNCC1
1-(2-Nonylsulfanylethyl)piperidine-3-carboxylic acid (Azone_analog-126),CCCCCCCCCSCCN1CCCC(C1)C(O)=O,19002581,PIPERIDINE,1-[2-(nonylsulfanyl)ethyl]piperidine-3-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",315.52,3.2972,-3.195,3,1,65.84,12,0,19,,,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,Piperidine,C1CCNCC1
1-(2-Decylsulfanylethyl)piperidine-3-carboxylic acid (Azone_analog-127),CCCCCCCCCCSCCN1CCCC(C1)C(O)=O,19002594,PIPERIDINE,1-[2-(decylsulfanyl)ethyl]piperidine-3-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",329.54699999999997,3.7516,-3.465,3,1,65.84,13,0,20,,,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,Piperidine,C1CCNCC1
1-(2-Dodecylsulfanylethyl)piperidine-3-carboxylic acid (Azone_analog-128),CCCCCCCCCCCCSCCN1CCCC(C1)C(O)=O,19002607,PIPERIDINE,1-[2-(dodecylsulfanyl)ethyl]piperidine-3-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",357.601,4.6604,-4.005,3,1,65.84,15,0,22,,,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,Piperidine,C1CCNCC1
1-(2-Tetradecylsulfanylethyl)piperidine-3-carboxylic acid (Azone_analog-129),CCCCCCCCCCCCCCSCCN1CCCC(C1)C(O)=O,19002605,PIPERIDINE,1-[2-(tetradecylsulfanyl)ethyl]piperidine-3-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",385.654,5.5692,-4.545,3,1,65.84,17,0,24,,,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,Piperidine,C1CCNCC1
1-(2-Hexadecylsulfanylethyl)piperidine-3-carboxylic acid (Azone_analog-130),CCCCCCCCCCCCCCCCSCCN1CCCC(C1)C(O)=O,19002606,PIPERIDINE,1-[2-(hexadecylsulfanyl)ethyl]piperidine-3-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",413.708,6.478,-5.085,3,1,65.84,19,0,26,,,,amine,alkyl-amine,,,basic nitrogen,acidic oxygen,Piperidine,C1CCNCC1
1-(Piperidin-1-yl)dodecan-1-one (Azone_analog-99),CCCCCCCCCCCC(=O)N1CCCCC1,246811,PIPERIDINE,1-(piperidin-1-yl)dodecan-1-one,22342-28-5,22342-28-5,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",267.455,5.5981,-3.745,2,0,20.31,10,0,16,,,amide,,,,,,,Piperidine,C1CCNCC1
1-Dodecylpiperidine (Azone_analog-102),CCCCCCCCCCCCN1CCCCC1,80014,PIPERIDINE,1-dodecylpiperidine,5917-47-5,5917-47-5,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",253.472,5.9477,-3.763,1,0,3.24,11,0,18,,,,amine,alkyl-amine,,,basic nitrogen,,Piperidine,C1CCNCC1
1-Butyl-6-oxopiperidine-2-carboxylic acid (Azone_analog-111),CCCCN1C(CCCC1=O)C(O)=O,19002586,PIPERIDONE,1-butyl-6-oxopiperidine-2-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",199.24900000000002,0.7947,-1.4380000000000002,4,1,57.61,4,0,9,,,amide,,,,,,acidic oxygen,Piperidone,O=C1CCCCN1
6-Oxo-1-pentylpiperidine-2-carboxylic acid (Azone_analog-112),CCCCCN1C(CCCC1=O)C(O)=O,19002580,PIPERIDONE,6-oxo-1-pentylpiperidine-2-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",213.27599999999998,1.2491,-1.7080000000000002,4,1,57.61,5,0,10,,,amide,,,,,,acidic oxygen,Piperidone,O=C1CCCCN1
1-Hexyl-6-oxopiperidine-2-carboxylic acid (Azone_analog-113),CCCCCCN1C(CCCC1=O)C(O)=O,19002568,PIPERIDONE,1-hexyl-6-oxopiperidine-2-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",227.303,1.7035,-1.9780000000000002,4,1,57.61,6,0,11,,,amide,,,,,,acidic oxygen,Piperidone,O=C1CCCCN1
1-Heptyl-6-oxopiperidine-2-carboxylic acid (Azone_analog-114),CCCCCCCN1C(CCCC1=O)C(O)=O,19002567,PIPERIDONE,1-heptyl-6-oxopiperidine-2-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",241.33,2.1579,-2.248,4,1,57.61,7,0,12,,,amide,,,,,,acidic oxygen,Piperidone,O=C1CCCCN1
1-Octyl-6-oxopiperidine-2-carboxylic acid (Azone_analog-115),CCCCCCCCN1C(CCCC1=O)C(O)=O,19002570,PIPERIDONE,1-octyl-6-oxopiperidine-2-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",255.356,2.6123,-2.5180000000000002,4,1,57.61,8,0,13,,,amide,,,,,,acidic oxygen,Piperidone,O=C1CCCCN1
1-Nonyl-6-oxopiperidine-2-carboxylic acid (Azone_analog-116),CCCCCCCCCN1C(CCCC1=O)C(O)=O,19002583,PIPERIDONE,1-nonyl-6-oxopiperidine-2-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",269.383,3.0667,-2.7880000000000003,4,1,57.61,9,0,14,,,amide,,,,,,acidic oxygen,Piperidone,O=C1CCCCN1
Octyl 2-(2-oxopiperidin-1-yl)acetate (Azone_analog-104),CCCCCCCCOC(=O)CN1CCCCC1=O,10707104,PIPERIDONE,octyl 2-(2-oxopiperidin-1-yl)acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",269.383,3.1218,-2.568,4,0,46.61,10,0,14,,,amide,,,,,,,Piperidone,O=C1CCCCN1
1-(1-Oxododecyl)piperidin-2-one (Azone_analog-103),CCCCCCCCCCCC(=O)N1CCCCC1=O,85940558,PIPERIDONE,1-dodecanoylpiperidin-2-one,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",281.438,5.0319,-3.727,3,0,37.38,10,0,15,,,amide,,,,,,,Piperidone,O=C1CCCCN1
1-Decyl-6-oxopiperidine-2-carboxylic acid (Azone_analog-117),CCCCCCCCCCN1C(CCCC1=O)C(O)=O,19002584,PIPERIDONE,1-decyl-6-oxopiperidine-2-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",283.41,3.5211,-3.0580000000000003,4,1,57.61,10,0,15,,,amide,,,,,,acidic oxygen,Piperidone,O=C1CCCCN1
Nonyl 2-(2-oxopiperidin-1-yl)acetate (Azone_analog-105),CCCCCCCCCOC(=O)CN1CCCCC1=O,10731713,PIPERIDONE,nonyl 2-(2-oxopiperidin-1-yl)acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",283.41,3.5762,-2.838,4,0,46.61,11,0,15,,,amide,,,,,,,Piperidone,O=C1CCCCN1
Decyl 2-(2-oxopiperidin-1-yl)acetate (Azone_analog-106),CCCCCCCCCCOC(=O)CN1CCCCC1=O,10086007,PIPERIDONE,decyl 2-(2-oxopiperidin-1-yl)acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",297.437,4.0306,-3.108,4,0,46.61,12,0,16,,,amide,,,,,,,Piperidone,O=C1CCCCN1
1-Dodecyl-6-oxopiperidine-2-carboxylic acid (Azone_analog-118),CCCCCCCCCCCCN1C(CCCC1=O)C(O)=O,19002571,PIPERIDONE,1-dodecyl-6-oxopiperidine-2-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",311.464,4.4299,-3.5980000000000003,4,1,57.61,12,0,17,,,amide,,,,,,acidic oxygen,Piperidone,O=C1CCCCN1
Undecyl 2-(2-oxopiperidin-1-yl)acetate (Azone_analog-107),CCCCCCCCCCCOC(=O)CN1CCCCC1=O,10662849,PIPERIDONE,undecyl 2-(2-oxopiperidin-1-yl)acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",311.464,4.485,-3.378,4,0,46.61,13,0,17,,,amide,,,,,,,Piperidone,O=C1CCCCN1
Dodecyl 2-(2-oxopiperidin-1-yl)acetate (Azone_analog-108),CCCCCCCCCCCCOC(=O)CN1CCCCC1=O,9996443,PIPERIDONE,dodecyl 2-(2-oxopiperidin-1-yl)acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",325.491,4.9394,-3.648,4,0,46.61,14,0,18,,,amide,,,,,,,Piperidone,O=C1CCCCN1
6-Oxo-1-tetradecylpiperidine-2-carboxylic acid (Azone_analog-119),CCCCCCCCCCCCCCN1C(CCCC1=O)C(O)=O,19002589,PIPERIDONE,6-oxo-1-tetradecylpiperidine-2-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",339.51800000000003,5.3387,-4.138,4,1,57.61,14,0,19,,,amide,,,,,,acidic oxygen,Piperidone,O=C1CCCCN1
Tridecyl 2-(2-oxopiperidin-1-yl)acetate (Azone_analog-109),CCCCCCCCCCCCCOC(=O)CN1CCCCC1=O,10337275,PIPERIDONE,tridecyl 2-(2-oxopiperidin-1-yl)acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",339.51800000000003,5.3938,-3.918,4,0,46.61,15,0,19,,,amide,,,,,,,Piperidone,O=C1CCCCN1
Tetradecyl 2-(2-oxopiperidin-1-yl)acetate (Azone_analog-110),CCCCCCCCCCCCCCOC(=O)CN1CCCCC1=O,10428172,PIPERIDONE,tetradecyl 2-(2-oxopiperidin-1-yl)acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",353.545,5.8482,-4.188,4,0,46.61,16,0,20,,,amide,,,,,,,Piperidone,O=C1CCCCN1
1-Hexadecyl-6-oxopiperidine-2-carboxylic acid (Azone_analog-120),CCCCCCCCCCCCCCCCN1C(CCCC1=O)C(O)=O,19002579,PIPERIDONE,1-hexadecyl-6-oxopiperidine-2-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",367.57199999999995,6.2475,-4.678,4,1,57.61,16,0,21,,,amide,,,,,,acidic oxygen,Piperidone,O=C1CCCCN1
1-Butyl-2-piperidinone,CCCCN1CCCCC1=O,10374661,PIPERIDONE,1-butylpiperidin-2-one,4789-08-6,NA,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",155.24,1.7463,-1.585,2,0,20.31,3,0,8,,,amide,,,,,,,Piperidone,O=C1CCCCN1
"1,2,3-Nonanetriol",CCCCCCC(C(CO)O)O,14283774,POLYOL,"nonane-1,2,3-triol",102439-69-0,NA,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",176.255,1.1877,-1.569,3,3,60.69,7,0,12,,,,,,,,,,,
Polypropylene Glycol,CC(CO)OCC(C)O,32881,POLYOL,2-(2-hydroxypropoxy)propan-1-ol,106-62-7,"106-62-7,25322-69-4",,"Narishetty, S. T., Garcia-Tapia, D., & Bonnema, K. J. (2015). Toxicological Aspects of Chemical Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 387-405). Springer, Berlin, Heidelberg.",134.174,-0.2501,-0.647,3,2,49.69,4,0,9,,,,,,,,,,,
ethylene glycol,C(CO)O,174,POLYOL,"ethane-1,2-diol",107-21-1,"37221-95-7,71767-64-1,107-21-1,37225-26-6,2219-51-4,25322-68-3",-2.2,"Sloan, K. B., Koch, S. A., Siver, K. G., & Flowers, F. P. (1986). Use of solubility parameters of drug and vehicle to predict flux through skin. Journal of investigative dermatology, 87(2), 244-252.",62.0676,-0.8762,0.03,2,2,40.46,1,0,4,,,,,,,,,,,
"1,2-Octanediol",CCCCCCC(CO)O,14231,POLYOL,"octane-1,2-diol",1117-86-8,"87720-89-6,1117-86-8",,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",146.22899999999998,1.7551,-1.6980000000000002,2,2,40.46,6,0,10,experimental,DB14589,,,,,,,,,
Sucrose palmitate (P-1670),CCCCCCCCCCCCCCCC(=O)OCC1C(C(C(C(O1)OC2(C(C(C(O2)CO)O)O)CO)O)O)O,11238581,POLYOL,"(6-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl hexadecanoate",13039-41-3,NA,,"Nava-Arzaluz, M. G., Piñón-Segundo, E., & Ganem-Rondero, A. (2015). Sucrose esters as transdermal permeation enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 273-290). Springer, Berlin, Heidelberg.",580.7090000000001,2.2359999999999998,-3.508,12,7,195.6,21,0,38,,,,,,,,,,Tetrahydrofuran,C1CCC(OC2CCCO2)OC1
Sucrose-6-oleate,CCCCCCCCC=CCCCCCCCC(=O)OCC1C(C(C(C(O1)OC2(C(C(C(O2)CO)O)O)CO)O)O)O,9830275,POLYOL,"(6-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl octadec-9-enoate",13102-49-3,NA,,"Nava-Arzaluz, M. G., Piñón-Segundo, E., & Ganem-Rondero, A. (2015). Sucrose esters as transdermal permeation enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 273-290). Springer, Berlin, Heidelberg.",606.747,2.8926,-3.82,12,7,195.6,22,0,38,,,,,,,,,,Tetrahydrofuran,C1CCC(OC2CCCO2)OC1
Sucrose myristate (M-1695),CCCCCCCCCCCCCC(=O)OCC1(C(C(C(O1)CO)O)O)OC2C(C(C(C(O2)CO)O)O)O,9937484,POLYOL,"[3,4-dihydroxy-5-(hydroxymethyl)-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-2-yl]methyl tetradecanoate",200615-17-4,NA,,"Nava-Arzaluz, M. G., Piñón-Segundo, E., & Ganem-Rondero, A. (2015). Sucrose esters as transdermal permeation enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 273-290). Springer, Berlin, Heidelberg.",552.655,1.3272,-2.968,12,7,195.6,19,0,36,,,,,,,,,,Tetrahydrofuran,C1CCC(OC2CCCO2)OC1
"Sucrose-6,6-dilaurate",CCCCCCCCCCCC(=O)OCC1C(C(C(C(O1)OC2(C(C(C(O2)COC(=O)CCCCCCCCCCC)O)O)CO)O)O)O,21630296,POLYOL,"[5-({6-[(dodecanoyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl}oxy)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl dodecanoate",20881-06-05,NA,,"Nava-Arzaluz, M. G., Piñón-Segundo, E., & Ganem-Rondero, A. (2015). Sucrose esters as transdermal permeation enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 273-290). Springer, Berlin, Heidelberg.",706.9069999999999,5.447,-5.537999999999999,13,6,201.67,29,0,45,,,,,,,,,,Tetrahydrofuran,C1CCC(OC2CCCO2)OC1
Sucrose laurate,CCCCCCCCCCCC(=O)OC1(C(C(C(C(O1)CO)O)O)O)C2(C(C(C(O2)CO)O)O)CO,5360776,POLYOL,"2-[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl dodecanoate",25339-99-5,NA,,"Babu, R. J., Chen, L., & Kanikkannan, N. (2015). Fatty alcohols, fatty acids, and fatty acid esters as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 133-150). Springer, Berlin, Heidelberg.",524.601,-0.3693,-2.166,12,8,206.6,16,0,34,,,,,,,,,,,C1CCC(C2CCCO2)OC1
Sucrose-6'-oleate,CCCCCCCCC=CCCCCCCCC(=O)OCC1C(C(C(O1)(CO)OC2C(C(C(C(O2)CO)O)O)O)O)O,6438037,POLYOL,"[3,4-dihydroxy-5-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-2-yl]methyl octadec-9-enoate",25496-92-8,NA,,"Nava-Arzaluz, M. G., Piñón-Segundo, E., & Ganem-Rondero, A. (2015). Sucrose esters as transdermal permeation enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 273-290). Springer, Berlin, Heidelberg.",606.747,2.8926,-3.82,12,7,195.6,22,0,38,,,,,,,,,,Tetrahydrofuran,C1CCC(OC2CCCO2)OC1
Octyl-beta-D-glucoside,CCCCCCCCOC1C(C(C(C(O1)CO)O)O)O,62852,POLYOL,"2-(hydroxymethyl)-6-(octyloxy)oxane-3,4,5-triol",29836-26-8,4742-80-7,,"Li, S. K., & Chantasart, D. (2019). Skin Permeation Enhancement in Aqueous Solution: Correlation with Equilibrium Enhancer Concentration and Octanol/water Partition Coefficient. Journal of pharmaceutical sciences, 108(1), 350-357.",292.37,0.9398,-1.797,6,4,99.38,9,0,20,experimental,DB02451,,,,,,,,Oxane,C1CCOCC1
"Sucrose-1,6-dilaurate",CCCCCCCCCCCC(=O)OCC1C(C(C(O1)(COC(=O)CCCCCCCCCCC)OC2C(C(C(C(O2)CO)O)O)O)O)O,21630295,POLYOL,"{5-[(dodecanoyloxy)methyl]-3,4-dihydroxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-2-yl}methyl dodecanoate",335281-15-7,NA,,"Nava-Arzaluz, M. G., Piñón-Segundo, E., & Ganem-Rondero, A. (2015). Sucrose esters as transdermal permeation enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 273-290). Springer, Berlin, Heidelberg.",706.9069999999999,5.447,-5.537999999999999,13,6,201.67,29,0,45,,,,,,,,,,Tetrahydrofuran,C1CCC(OC2CCCO2)OC1
raffinose,C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3(C(C(C(O3)CO)O)O)CO)O)O)O)O)O)O)O,439242,POLYOL,"2-[(6-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol",512-69-6,NA,-4.81,"K.D. Peck, A.H. Ghanem, W.I. Higuchi, Hindered diffusion of polar molecules through and effective pore radii estimates of intact and ethanol treated human epidermal membrane, Pharm. Res. 11 (1994) 1306‐1314",504.436,-6.4473,0.982,16,11,268.68,8,0,34,,,,,,,,,,,C1CCC(OCC2CCCC(OC3CCCO3)O2)OC1
"2,3‐Butanediol",CC(C(C)O)O,262,POLYOL,"butane-2,3-diol",513-85-9,"6982-25-8,24347-58-8,35007-63-7,98923-25-2",-4.21,"I. H. Blank, R. J. Scheuplein, and D. J. MacFarlane, ""Mechanism of Percutaneous Absorption. 111. The Effect of Temperature on the Transport of Non‐Electrolytes Across the Skin,"" J. Invest. Dermatol. 49,582‐589 (1967)",90.1214,-0.1576,-0.726,2,2,40.46,1,0,6,experimental,DB02418,,,,,,,,,
sucrose,C(C1C(C(C(C(O1)OC2(C(C(C(O2)CO)O)O)CO)O)O)O)O,5988,POLYOL,"2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol",57-50-1,NA,-4.92,"Anderson, B.D., Higuchi, W.I. and Raykar, P.V. (1988): Heterogeneity effects on permeability‐partition coefficient relationships in human stratum corneum. Pharm. Res., 5, 566‐573",342.296,-4.6102,0.682,11,8,189.53,5,0,23,approved; experimental; investigational,DB02772,,,,,,,,Tetrahydrofuran,C1CCC(OC2CCCO2)OC1
Propylene glycol,CC(CO)O,1030,POLYOL,"propane-1,2-diol",57-55-6,"57-55-6,190913-75-8,4254-16-4,63625-56-9,4254-15-3",-2.13,"Narishetty, S. T., Garcia-Tapia, D., & Bonnema, K. J. (2015). Toxicological Aspects of Chemical Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 387-405). Springer, Berlin, Heidelberg.
Sloan, K. B., & Koch, S. A. (1986). M.; Siver, KG; Flowers, F. P. J. Invest.",76.0945,-0.5169,-0.348,2,2,40.46,1,0,5,approved; investigational,DB01839,,,,,,,,,
1-Decyl-β-D-glucopyranoside,CCCCCCCCCCOC1C(C(C(C(O1)CO)O)O)O,62142,POLYOL,"2-(decyloxy)-6-(hydroxymethyl)oxane-3,4,5-triol",58846-77-8,NA,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",320.42400000000004,1.8486,-2.3369999999999997,6,4,99.38,11,0,22,experimental,DB02451,,,,,,,,Oxane,C1CCOCC1
Dodecyl glucoside,CCCCCCCCCCCCOC1C(C(C(C(O1)CO)O)O)O,93321,POLYOL,"2-(dodecyloxy)-6-(hydroxymethyl)oxane-3,4,5-triol",59122-55-3,NA,,"Ghafourian, T., Nokhodchi, A., & Kaialy, W. (2015). Surfactants as penetration enhancers for dermal and transdermal drug delivery. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 207-230). Springer, Berlin, Heidelberg.",348.478,2.7574,-2.877,6,4,99.38,13,0,24,experimental,DB02451,,,,,,,,Oxane,C1CCOCC1
Cremophor EL,C1CO1.C(C(CO)O)O,104840,POLYOL,"oxirane; propane-1,2,3-triol",63393-92-0,63393-92-0,,"Fox, L. T., Gerber, M., Plessis, J. D., & Hamman, J. H. (2011). Transdermal drug delivery enhancement by compounds of natural origin. Molecules, 16(12), 10507-10540.",136.14600000000002,-1.4436,0.159,3,3,60.69,2,0,6,approved; investigational,DB09462,,,,,,,,,C1CO1
mannitol,C(C(C(C(C(CO)O)O)O)O)O,6251,POLYOL,"hexane-1,2,3,4,5,6-hexol",69-65-8,"87-78-5,6706-59-8,50-70-4,25878-23-3,45007-61-2,608-66-2,69-65-8,488-45-9",-4.32,"H.M. Clowes, Skin absorption: flow‐through or statistic diffusion cells, Toxicol. In Vitro 8 (1994) 827‐830.",182.171,-3.1458,0.546,6,6,121.38,5,0,12,approved; investigational,DB00742,,,,,,,,,
"1,2-Hexanediol",CCCCC(CO)O,94335,POLYOL,"hexane-1,2-diol",6920-22-5,87760-48-3,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",118.175,0.8463,-1.158,2,2,40.46,4,0,8,experimental,DB14108,,,,,,,,,
N-Octyl-beta-D-thioglucopyranoside,CCCCCCCCSC1C(C(C(C(O1)CO)O)O)O,656909,POLYOL,"2-(hydroxymethyl)-6-(octylsulfanyl)oxane-3,4,5-triol",85618-21-9,85618-21-9,,"Li, S. K., & Chantasart, D. (2019). Skin Permeation Enhancement in Aqueous Solution: Correlation with Equilibrium Enhancer Concentration and Octanol/water Partition Coefficient. Journal of pharmaceutical sciences, 108(1), 350-357.",308.437,1.9498,-2.3,5,4,115.45,9,0,20,experimental,DB04450,,,,,,,,Oxane,C1CCOCC1
Hyaluronic acid,CC(=O)NC1CC(C(OC1OC2C(C(C(OC2C(=O)[O-])O)O)O)CO)O.[Na+],23663392,POLYOL,"sodium 3-{[3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,5,6-trihydroxyoxane-2-carboxylate",9004-61-9,NA,,"Witting, M., Boreham, A., Brodwolf, R., Vavrova, K., Alexiev, U., Friess, W., & Hedtrich, S. (2015). Interactions of hyaluronic acid with the skin and implications for the dermal delivery of biomacromolecules. Molecular pharmaceutics, 12(5), 1391-1401.",403.315,-6.021,-0.10400000000000001,12,6,198.07,5,0,21,,,amide,,,,,,acidic oxygen,,C1CCC(OC2CCCOC2)OC1
Polyoxyethylene (20) sorbitant monostearate (Tween 60),CCCCCCCCCCCC(=O)OCC(C1C(C(CO1)OCCO)OCCO)O,22833389,POLYOL,"2-[3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-hydroxyethyl dodecanoate",9005-67-8,NA,,"Yutani, R., Teraoka, R., & Kitagawa, S. (2015). Microemulsion using polyoxyethylene sorbitan trioleate and its usage for skin delivery of resveratrol to protect skin against UV-induced damage. Chemical and Pharmaceutical Bulletin, 63(9), 741-745.",434.56699999999995,2.516,-2.887,8,3,114.68,20,0,28,,,,,,,,,,Tetrahydrofuran,C1CCOC1
Glycols,CCCCCCCCCCCC(CO)O,3086307,POLYOL,"tridecane-1,2-diol",90091-76-2,NA,,"Narishetty, S. T., Garcia-Tapia, D., & Bonnema, K. J. (2015). Toxicological Aspects of Chemical Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 387-405). Springer, Berlin, Heidelberg.",216.363,4.0271,-3.048,2,2,40.46,11,0,15,experimental,DB14589,,,,,,,,,
1-Acetylpyrrolidine-2-carboxylic acid octyl ester (Azone_analog-273),CCCCCCCCOC(=O)C1CCCN1C(C)=O,66695155,PYRROLIDINE,octyl 1-acetylpyrrolidine-2-carboxylate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",269.383,3.3211,-2.676,4,0,46.61,9,0,14,,,amide,,,,,,,Pyrrolidine,C1CCNC1
1-Acetylpyrrolidine-2-carboxylic acid decyl ester (Azone_analog-274),CCCCCCCCCCOC(=O)C1CCCN1C(C)=O,85768884,PYRROLIDINE,decyl 1-acetylpyrrolidine-2-carboxylate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",297.437,4.2299,-3.216,4,0,46.61,11,0,16,,,amide,,,,,,,Pyrrolidine,C1CCNC1
1-Acetylpyrrolidine-2-carboxylic acid undecyl ester (Azone_analog-275),CCCCCCCCCCCOC(=O)C1CCCN1C(C)=O,85101195,PYRROLIDINE,undecyl 1-acetylpyrrolidine-2-carboxylate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",311.464,4.6843,-3.486,4,0,46.61,12,0,17,,,amide,,,,,,,Pyrrolidine,C1CCNC1
1-Acetylpyrrolidine-2-carboxylic acid dodecyl ester (Azone_analog-276),CCCCCCCCCCCCOC(=O)C1CCCN1C(C)=O,85152441,PYRROLIDINE,dodecyl 1-acetylpyrrolidine-2-carboxylate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",325.491,5.1387,-3.7560000000000002,4,0,46.61,13,0,18,,,amide,,,,,,,Pyrrolidine,C1CCNC1
1-Dodecylpyrrolidine (Azone_analog-235),CCCCCCCCCCCCN1CCCC1,3732021,PYRROLIDINE,1-dodecylpyrrolidine,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",239.445,5.6057,-3.4930000000000003,1,0,3.24,11,0,17,,,,amine,alkyl-amine,,,basic nitrogen,,Pyrrolidine,C1CCNC1
1-(Pyrrolidin-1-yl)dodecan-1-one (Azone_analog-233),CCCCCCCCCCCC(=O)N1CCCC1,246839,PYRROLIDINE,1-(pyrrolidin-1-yl)dodecan-1-one,70974-45-7,70974-45-7,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",253.428,5.2561,-3.475,2,0,20.31,10,0,15,,,amide,,,,,,,Pyrrolidine,C1CCNC1
1-Acetylpyrrolidine-2-carboxylic acid pentyl ester (Azone_analog-272),CCCCCOC(=O)C1CCCN1C(C)=O,10242845,PYRROLIDINE,pentyl 1-acetylpyrrolidine-2-carboxylate,,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",227.303,1.9579,-1.8659999999999999,4,0,46.61,6,0,11,,,,,,,,,,Pyrrolidine,C1CCNC1
"1-(2,3-Dihydroxypropyl)pyrrolidin-2-one (Azone_analog-215)",OCC(O)CN1CCCC1=O,3388642,PYRROLIDONE,"1-(2,3-dihydroxypropyl)pyrrolidin-2-one",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",159.184,-0.9986,-0.139,4,2,60.77,3,0,8,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
1-Butyl-5-oxopyrrolidine-2-carboxylic acid (Azone_analog-241),CCCCN1C(CCC1=O)C(O)=O,19002595,PYRROLIDONE,1-butyl-5-oxopyrrolidine-2-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",185.222,0.4527,-1.168,4,1,57.61,4,0,8,,,amide,,,,,,acidic oxygen,Pyrrolidone,O=C1CCCN1
5-Oxo-1-pentylpyrrolidine-2-carboxylic acid (Azone_analog-242),CCCCCN1C(CCC1=O)C(O)=O,19002575,PYRROLIDONE,5-oxo-1-pentylpyrrolidine-2-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",199.24900000000002,0.9071,-1.4380000000000002,4,1,57.61,5,0,9,,,amide,,,,,,acidic oxygen,Pyrrolidone,O=C1CCCN1
1-Hexyl-5-oxopyrrolidine-2-carboxylic acid (Azone_analog-243),CCCCCCN1C(CCC1=O)C(O)=O,19002564,PYRROLIDONE,1-hexyl-5-oxopyrrolidine-2-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",213.27599999999998,1.3615,-1.7080000000000002,4,1,57.61,6,0,10,,,amide,,,,,,acidic oxygen,Pyrrolidone,O=C1CCCN1
1-Heptyl-5-oxopyrrolidine-2-carboxylic acid (Azone_analog-244),CCCCCCCN1C(CCC1=O)C(O)=O,19002593,PYRROLIDONE,1-heptyl-5-oxopyrrolidine-2-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",227.303,1.8159,-1.9780000000000002,4,1,57.61,7,0,11,,,amide,,,,,,acidic oxygen,Pyrrolidone,O=C1CCCN1
1-Octyl-5-oxopyrrolidine-2-carboxylic acid (Azone_analog-245),CCCCCCCCN1C(CCC1=O)C(O)=O,19002559,PYRROLIDONE,1-octyl-5-oxopyrrolidine-2-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",241.33,2.2703,-2.248,4,1,57.61,8,0,12,,,amide,,,,,,acidic oxygen,Pyrrolidone,O=C1CCCN1
1-Nonyl-5-oxopyrrolidine-2-carboxylic acid (Azone_analog-246),CCCCCCCCCN1C(CCC1=O)C(O)=O,19002602,PYRROLIDONE,1-nonyl-5-oxopyrrolidine-2-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",255.356,2.7247,-2.5180000000000002,4,1,57.61,9,0,13,,,amide,,,,,,acidic oxygen,Pyrrolidone,O=C1CCCN1
Octyl 2-(2-oxopyrrolidin-1-yl)acetate (Azone_analog-221),CCCCCCCCOC(=O)CN1CCCC1=O,10706193,PYRROLIDONE,octyl 2-(2-oxopyrrolidin-1-yl)acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",255.356,2.7798,-2.298,4,0,46.61,10,0,13,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
1-Decyl-5-oxopyrrolidine-2-carboxylic acid (Azone_analog-247),CCCCCCCCCCN1C(CCC1=O)C(O)=O,19002598,PYRROLIDONE,1-decyl-5-oxopyrrolidine-2-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",269.383,3.1791,-2.7880000000000003,4,1,57.61,10,0,14,,,amide,,,,,,acidic oxygen,Pyrrolidone,O=C1CCCN1
Decyl 5-oxopyrrolidine-2-carboxylate (Azone_analog-251),CCCCCCCCCCOC(=O)C1CCC(=O)N1,14233357,PYRROLIDONE,decyl 5-oxopyrrolidine-2-carboxylate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",269.383,3.3541,-3.278,4,1,55.4,11,0,14,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
Nonyl 2-(2-oxopyrrolidin-1-yl)acetate (Azone_analog-222),CCCCCCCCCOC(=O)CN1CCCC1=O,10778404,PYRROLIDONE,nonyl 2-(2-oxopyrrolidin-1-yl)acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",269.383,3.2342,-2.568,4,0,46.61,11,0,14,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
2-(2-oxopyrrolidin-1-yl)ethyl decanoate (Azone_analog-228),CCCCCCCCCC(=O)OCCN1CCCC1=O,42634625,PYRROLIDONE,2-(2-oxopyrrolidin-1-yl)ethyl decanoate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",283.41,3.6886,-2.838,4,0,46.61,12,0,15,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
Decyl 2-(2-oxopyrrolidin-1-yl)acetate (Azone_analog-223),CCCCCCCCCCOC(=O)CN1CCCC1=O,10265861,PYRROLIDONE,decyl 2-(2-oxopyrrolidin-1-yl)acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",283.41,3.6886,-2.838,4,0,46.61,12,0,15,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
1-Dodecyl-5-oxopyrrolidine-2-carboxylic acid (Azone_analog-248),CCCCCCCCCCCCN1C(CCC1=O)C(O)=O,19969114,PYRROLIDONE,1-dodecyl-5-oxopyrrolidine-2-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",297.437,4.0879,-3.3280000000000003,4,1,57.61,12,0,16,,,amide,,,,,,acidic oxygen,Pyrrolidone,O=C1CCCN1
Undecyl 2-(2-oxopyrrolidin-1-yl)acetate (Azone_analog-224),CCCCCCCCCCCOC(=O)CN1CCCC1=O,10565942,PYRROLIDONE,undecyl 2-(2-oxopyrrolidin-1-yl)acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",297.437,4.143,-3.108,4,0,46.61,13,0,16,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
2-Oxopyrrolidine-1-acetic acid dodecyl ester (Azone_analog-225),CCCCCCCCCCCCOC(=O)CN1CCCC1=O,10267479,PYRROLIDONE,dodecyl 2-(2-oxopyrrolidin-1-yl)acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",311.464,4.5974,-3.378,4,0,46.61,14,0,17,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
5-Oxo-1-tetradecylpyrrolidine-2-carboxylic acid (Azone_analog-249),CCCCCCCCCCCCCCN1C(CCC1=O)C(O)=O,19002615,PYRROLIDONE,5-oxo-1-tetradecylpyrrolidine-2-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",325.491,4.9967,-3.8680000000000003,4,1,57.61,14,0,18,,,amide,,,,,,acidic oxygen,Pyrrolidone,O=C1CCCN1
Tridecyl 2-(2-oxopyrrolidin-1-yl)acetate (Azone_analog-226),CCCCCCCCCCCCCOC(=O)CN1CCCC1=O,10782329,PYRROLIDONE,tridecyl 2-(2-oxopyrrolidin-1-yl)acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",325.491,5.0518,-3.648,4,0,46.61,15,0,18,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
Tetradecyl 2-(2-oxopyrrolidin-1-yl)acetate (Azone_analog-227),CCCCCCCCCCCCCCOC(=O)CN1CCCC1=O,10569106,PYRROLIDONE,tetradecyl 2-(2-oxopyrrolidin-1-yl)acetate,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",339.51800000000003,5.5062,-3.918,4,0,46.61,16,0,19,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
1-Hexadecyl-5-oxopyrrolidine-2-carboxylic acid (Azone_analog-250),CCCCCCCCCCCCCCCCN1C(CCC1=O)C(O)=O,19002592,PYRROLIDONE,1-hexadecyl-5-oxopyrrolidine-2-carboxylic acid,-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",353.545,5.9055,-4.408,4,1,57.61,16,0,20,,,amide,,,,,,acidic oxygen,Pyrrolidone,O=C1CCCN1
1-Dodecyl-5-oxopyrrolidine-3-carboxylic acid (Azone_analog-256),CCCCCCCCCCCCN1CC(CC1=O)C(O)=O,111996,PYRROLIDONE,1-dodecyl-5-oxopyrrolidine-3-carboxylic acid,10054-21-4,10054-21-4,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",297.437,4.0325,-3.11,4,1,57.61,12,0,16,,,amide,,,,,,acidic oxygen,Pyrrolidone,O=C1CCCN1
1-Lauryl-4-methoxycarbonyl-2-pyrrolidone (Azone_analog-259),CCCCCCCCCCCCN1CC(CC1=O)C(=O)OC,5745164,PYRROLIDONE,methyl 1-dodecyl-5-oxopyrrolidine-3-carboxylate,101881-19-0,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",311.464,4.4604,-3.238,4,0,46.61,13,0,17,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
5-Methyl-2-pyrrolidone,CC1CCC(=O)N1,66055,PYRROLIDONE,5-methylpyrrolidin-2-one,108-27-0,108-27-0,,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",99.1325,0.161,-1.215,2,1,29.1,0,0,4,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
Pirotiodecane (Azone_analog-216),CCCCCCCCCCSCCN1CCCC1=O,124240,PYRROLIDONE,1-[2-(decylsulfanyl)ethyl]pyrrolidin-2-one,113855-10-0,113855-10-0,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",285.494,4.7769,-3.542,2,0,45.61,12,0,16,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
2-pyrrolidone-5-carboxylic acid (2PC),C1CC(=O)NC1C(=O)O,499,PYRROLIDONE,5-oxopyrrolidine-2-carboxylic acid,149-87-1,"4042-36-8,149-87-1,98-79-3",,"Babu, R. J., & Chen, L. (2015). Pyrrolidones as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 291-299). Springer, Berlin, Heidelberg.",129.115,-1.1153,-0.69,4,2,66.4,1,0,4,approved; investigational,DB03088,amide,,,,,,acidic oxygen,Pyrrolidone,O=C1CCCN1
Dodecyl 5-oxopyrrolidine-2-carboxylate (Azone_analog-252),CCCCCCCCCCCCOC(=O)C1CCC(=O)N1,90841,PYRROLIDONE,dodecyl 5-oxopyrrolidine-2-carboxylate,22794-26-9,22794-26-9,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",297.437,4.2629,-3.818,4,1,55.4,13,0,16,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
1-Ethyl-2-pyrrolidone,CCN1CCCC1=O,17595,PYRROLIDONE,1-ethylpyrrolidin-2-one,2687-91-4,2687-91-4,,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",113.15899999999999,0.4955,-0.775,2,0,20.31,1,0,5,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
1‐octyl‐2‐pyrrolidone,CCCCCCCCN1CCCC1=O,3033871,PYRROLIDONE,1-octylpyrrolidin-2-one,2687-94-7,2687-94-7,-1.27,"Chantasart D, Li SK. Relationship between the enhancement effects of chemical permeation enhancers on the lipoidal transport pathway across human skin under the symmetric and asymmetric conditions in vitro. Pharm Res. 2010;27(9):1825‐1836.",197.321,3.2219,-2.395,2,0,20.31,7,0,11,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
N-Lauryl-2-pyrrolidone,CCCCCCCCCCCCN1CCCC1=O,62459,PYRROLIDONE,1-dodecylpyrrolidin-2-one,2687-96-9,2687-96-9,,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",253.428,5.0395,-3.475,2,0,20.31,11,0,15,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
1-(2-Hydroxyethyl)pyrrolidin-2-one (Azone_analog-213),OCCN1CCCC1=O,76980,PYRROLIDONE,1-(2-hydroxyethyl)pyrrolidin-2-one,3445-11-2,3445-11-2,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",129.158,-0.4312,-0.268,3,1,40.54,2,0,6,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
1-Butyl-2-pyrrolidone,CCCCN1CCCC1=O,18984,PYRROLIDONE,1-butylpyrrolidin-2-one,3470-98-2,3470-98-2,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",141.213,1.4043,-1.315,2,0,20.31,3,0,7,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
1-Propylpyrrolidin-2-one (Azone_analog-207),CCCN1CCCC1=O,566544,PYRROLIDONE,1-propylpyrrolidin-2-one,3470-99-3,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",127.186,0.9499,-1.045,2,0,20.31,2,0,6,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
1-(1-Adamantyl)pyrrolidin-2-one (Azone_analog-217),O=C1CCCN1C12CC3CC(CC(C3)C1)C2,3010156,PYRROLIDONE,1-(adamantan-1-yl)pyrrolidin-2-one,3716-62-9,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",219.327,2.1644,-2.81,2,0,20.31,1,0,13,,,amide,,,,,,,1-(1-Adamantyl)pyrrolidin-2-one,O=C1CCCN1C12CC3CC(CC(C3)C1)C2
5-Oxo-1-phenylpyrrolidine-3-carboxylic acid (Azone_analog-255),OC(=O)C1CN(C(=O)C1)C1=CC=CC=C1,2737107,PYRROLIDONE,5-oxo-1-phenylpyrrolidine-3-carboxylic acid,39629-86-2,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",205.21200000000002,0.5774,-1.955,4,1,57.61,2,1,4,,,amide,,,,,,acidic oxygen,N-Phenyl-2-Pyrrolidonee,O=C1CCCN1c1ccccc1
1-[3-(2-Oxopyrrolidin-1-yl)butyl]pyrrolidin-2-one (Azone_analog-327),CC(CCN1CCCC1=O)N1CCCC1=O,10220147,PYRROLIDONE,1-[3-(2-oxopyrrolidin-1-yl)butyl]pyrrolidin-2-one,41033-13-0,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",224.303,0.8275,-1.214,4,0,40.62,4,0,10,,,amide,,,,,,,,O=C1CCCN1CCCN1CCCC1=O
1-Methyl-5-oxopyrrolidine-3-carboxylic acid (Azone_analog-254),CN1CC(CC1=O)C(O)=O,122766,PYRROLIDONE,1-methyl-5-oxopyrrolidine-3-carboxylic acid,42346-68-9,42346-68-9,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",143.141,-0.9178,-0.11,4,1,57.61,1,0,5,,,amide,,,,,,acidic oxygen,Pyrrolidone,O=C1CCCN1
"1,1'-(Propane-1,3-diyl)di(pyrrolidin-2-one) (Azone_analog-311)",O=C1CCCN1CCCN1CCCC1=O,12485480,PYRROLIDONE,1-[3-(2-oxopyrrolidin-1-yl)propyl]pyrrolidin-2-one,48149-56-0,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",210.27599999999998,0.4682,-0.836,4,0,40.62,4,0,9,,,amide,,,,,,,,O=C1CCCN1CCCN1CCCC1=O
1‐hexyl‐2‐pyrrolidone,CCCCCCN1CCCC1=O,78555,PYRROLIDONE,1-hexylpyrrolidin-2-one,4838-65-7,4838-65-7,-1.65,"Chantasart D, Li SK. Relationship between the enhancement effects of chemical permeation enhancers on the lipoidal transport pathway across human skin under the symmetric and asymmetric conditions in vitro. Pharm Res. 2010;27(9):1825‐1836.",169.267,2.3131,-1.855,2,0,20.31,5,0,9,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
"1,5-Dimethyl-2-pyrrolidone",CC1CCC(=O)N1C,101194,PYRROLIDONE,"1,5-dimethylpyrrolidin-2-one",5075-92-3,5075-92-3,,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",113.15899999999999,0.4139,-0.853,2,0,20.31,0,0,5,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
1-Decylpyrrolidin-2-one (Azone_analog-211),CCCCCCCCCCN1CCCC1=O,171427,PYRROLIDONE,1-decylpyrrolidin-2-one,55257-88-0,55257-88-0,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",225.37400000000002,4.1307,-2.935,2,0,20.31,9,0,13,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
Methyl 1-methyl-5-oxopyrrolidine-3-carboxylate (Azone_analog-257),COC(=O)C1CN(C)C(=O)C1,108402,PYRROLIDONE,methyl 1-methyl-5-oxopyrrolidine-3-carboxylate,59857-86-2,59857-86-2,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",157.168,-0.4899,-0.23800000000000002,4,0,46.61,2,0,6,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
2-Pyrrolidinone (Azone_analog-204),[H]N1CCCC1=O,12025,PYRROLIDONE,pyrrolidin-2-one,616-45-5,"22580-55-8,616-45-5",,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",85.1056,-0.1637,-0.8370000000000001,2,1,29.1,0,0,3,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
1-(3-Hydroxypropyl)pyrrolidin-2-one (Azone_analog-214),OCCCN1CCCC1=O,566744,PYRROLIDONE,1-(3-hydroxypropyl)pyrrolidin-2-one,62012-15-1,62012-15-1,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",143.185,0.0232,-0.5379999999999999,3,1,40.54,3,0,7,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
Methyl 5-oxo-1-phenylpyrrolidine-3-carboxylate (Azone_analog-258),COC(=O)C1CN(C(=O)C1)C1=CC=CC=C1,2883829,PYRROLIDONE,methyl 5-oxo-1-phenylpyrrolidine-3-carboxylate,64320-92-9,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",219.239,1.1953,-2.083,4,0,46.61,3,1,5,,,amide,,,,,,,N-Phenyl-2-Pyrrolidonee,O=C1CCCN1c1ccccc1
N-Hexyl-2-pyrrolidone,CCCCCN1CCCC1=O,11989722,PYRROLIDONE,1-pentylpyrrolidin-2-one,65032-11-3,NA,,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",155.24,1.8587,-1.585,2,0,20.31,4,0,8,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
Ethyl 5-oxo-DL-prolinate (Azone_analog-240),CCOC(=O)C1CCC(=O)N1,98047,PYRROLIDONE,ethyl 5-oxopyrrolidine-2-carboxylate,66183-71-9,"66183-71-9,7149-65-7",,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",157.168,-0.2811,-1.1179999999999999,4,1,55.4,3,0,6,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
1-Dodecanoyl-2-pyrrolidinone (Azone_analog-236),CCCCCCCCCCCC(=O)N1CCCC1=O,95148,PYRROLIDONE,1-dodecanoylpyrrolidin-2-one,66283-26-9,66283-26-9,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",267.411,4.6899,-3.457,3,0,37.38,10,0,14,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
N-Methyl-2-pyrrolidone,CN1CCCC1=O,13387,PYRROLIDONE,1-methylpyrrolidin-2-one,872-50-4,"26138-58-9,53774-35-9,57762-46-6,30207-69-3,51013-18-4,872-50-4",,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",99.1325,0.0892,-0.475,2,0,20.31,0,0,4,investigational,DB12521,amide,,,,,,,Pyrrolidone,O=C1CCCN1
1-Methyl-3-dodecyl2-pyrrolidone,CCCCCCCCCCCCC1CCN(C1=O)C,67554224,PYRROLIDONE,3-dodecyl-1-methylpyrrolidin-2-one,,NA,,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",267.455,5.3569,-3.605,2,0,20.31,11,0,16,,,amide,,,,,,,Pyrrolidone,O=C1CCCN1
Glycohyocholate,CC(CCC(=O)NCC(=O)[O-])C1CCC2C1(CCC3C2C(C(C4C3(CCC(C4)O)C)O)O)C,121596236,STEROID,"2-(4-{4,5,7-trihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl}pentanamido)acetate",-,NA,,"Moghimipour, Eskandar, Abdulghani Ameri, and Somayeh Handali. ""Absorption-enhancing effects of bile salts."" Molecules 20.8 (2015): 14451-14473.",464.62,0.1871,-4.247,7,4,129.92,6,0,28,,,amides,,,,,,acidic oxygens,,C1CCC2C(C1)CCC1C3CCCC3CCC21
Taurolithocholate,CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,439763,STEROID,"2-(4-{7-hydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl}pentanamido)ethane-1-sulfonic acid",-,NA,,"Moghimipour, Eskandar, Abdulghani Ameri, and Somayeh Handali. ""Absorption-enhancing effects of bile salts."" Molecules 20.8 (2015): 14451-14473.",483.711,01.02,-4.794,6,3,112.08,7,0,28,,,amides,,,,,,acidic oxygens,,C1CCC2C(C1)CCC1C3CCCC3CCC21
Taurohyocholate,CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C1(CCC3C2C(C(C4C3(CCC(C4)O)C)O)O)C,11954195,STEROID,"2-(4-{4,5,7-trihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl}pentanamido)ethane-1-sulfonic acid",32747-07-2,NA,,"Moghimipour, Eskandar, Abdulghani Ameri, and Somayeh Handali. ""Absorption-enhancing effects of bile salts."" Molecules 20.8 (2015): 14451-14473.",515.7090000000001,1.2391,-3.9960000000000004,8,5,152.54,7,0,30,,,amides,,,,,,acidic oxygens,,C1CCC2C(C1)CCC1C3CCCC3CCC21
Glycodeoxycholic acid,CC(CCC(=O)NCC(=O)O)C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C,3035026,STEROID,"2-(4-{7,11-dihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl}pentanamido)acetic acid",360-65-6,NA,,"Pavlović, N., Goločorbin-Kon, S., Ðanić, M., Stanimirov, B., Al-Salami, H., Stankov, K., & Mikov, M. (2018). Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles. Frontiers in pharmacology, 9, 1283.",449.629,3.1152,-4.646,6,4,106.86,6,0,27,,,amide,,,,,,acidic oxygen,Gonane,C1CCC2C(C1)CCC1C3CCCC3CCC21
Lithocholic acid,CC(CCC(=O)O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,9903,STEROID,"4-{7-hydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl}pentanoic acid",434-13-9,NA,,"Pavlović, N., Goločorbin-Kon, S., Ðanić, M., Stanimirov, B., Al-Salami, H., Stankov, K., & Mikov, M. (2018). Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles. Frontiers in pharmacology, 9, 1283.",376.579,4.8836,-5.278,3,2,57.53,4,0,25,,,,,,,,,acidic oxygen,Gonane,C1CCC2C(C1)CCC1C3CCCC3CCC21
Glycolithocholate,CC(CCC(=O)NCC(=O)O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,115245,STEROID,"2-(4-{7-hydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl}pentanamido)acetic acid",474-74-8,NA,,"Moghimipour, Eskandar, Abdulghani Ameri, and Somayeh Handali. ""Absorption-enhancing effects of bile salts."" Molecules 20.8 (2015): 14451-14473.",433.63,3.9673,-5.045,5,3,86.63,6,0,26,,,amides,,,,,,acidic oxygens,,C1CCC2C(C1)CCC1C3CCCC3CCC21
Glycocholate,CC(CCC(=O)NCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C,10140,STEROID,"2-(4-{4,7,11-trihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl}pentanamido)acetic acid",475-31-0,NA,,"Moghimipour, Eskandar, Abdulghani Ameri, and Somayeh Handali. ""Absorption-enhancing effects of bile salts."" Molecules 20.8 (2015): 14451-14473.",465.62800000000004,01.02,-4.247,7,5,127.09,6,0,28,,,amides,,,,,,acidic oxygens,,C1CCC2C(C1)CCC1C3CCCC3CCC21
Taurochenodeoxycholic acid,CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,387316,STEROID,"2-(4-{4,7-dihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl}pentanamido)ethane-1-sulfonic acid",516-35-8,NA,,"Pavlović, N., Goločorbin-Kon, S., Ðanić, M., Stanimirov, B., Al-Salami, H., Stankov, K., & Mikov, M. (2018). Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles. Frontiers in pharmacology, 9, 1283.",499.71,2.0912,-4.395,7,4,132.31,7,0,29,experimental,DB08833,amide,,,,,,acidic oxygen,Gonane,C1CCC2C(C1)CCC1C3CCCC3CCC21
Taurochenodeoxycholate,CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C1(CCC3C2CC(C4C3(CCC(C4)O)C)O)C,387316,STEROID,"2-(4-{4,7-dihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl}pentanamido)ethane-1-sulfonic acid",516-35-8,NA,,"Moghimipour, Eskandar, Abdulghani Ameri, and Somayeh Handali. ""Absorption-enhancing effects of bile salts."" Molecules 20.8 (2015): 14451-14473.",499.71,01.02,-4.395,7,4,132.31,7,0,29,,,amides,,,,,,acidic oxygens,,C1CCC2C(C1)CCC1C3CCCC3CCC21
Taurodeoxycholate,CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C,2733768,STEROID,"2-(4-{7,11-dihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl}pentanamido)ethane-1-sulfonic acid",516-50-7,NA,,"Moghimipour, Eskandar, Abdulghani Ameri, and Somayeh Handali. ""Absorption-enhancing effects of bile salts."" Molecules 20.8 (2015): 14451-14473.",499.71,01.02,-4.395,7,4,132.31,7,0,29,,,amides,,,,,,acidic oxygens,,C1CCC2C(C1)CCC1C3CCCC3CCC21
Glycochenodeoxycholic acid,CC(CCC(=O)NCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,12544,STEROID,"2-(4-{4,7-dihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl}pentanamido)acetic acid",640-79-9,NA,,"Pavlović, N., Goločorbin-Kon, S., Ðanić, M., Stanimirov, B., Al-Salami, H., Stankov, K., & Mikov, M. (2018). Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles. Frontiers in pharmacology, 9, 1283.",449.629,3.1152,-4.646,6,4,106.86,6,0,27,experimental,DB02123,amide,,,,,,acidic oxygen,Gonane,C1CCC2C(C1)CCC1C3CCCC3CCC21
CHAPS,CC(CCC(=O)NCCC[N+](C)(C)CCCS(=O)(=O)[O-])C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C,107670,STEROID,"3-{dimethyl[3-(4-{4,7,11-trihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl}pentanamido)propyl]azaniumyl}propane-1-sulfonate",75621-03-3,NA,,"Pandey A, Mittal A, Chauhan N, Alam S (2014) Role of Surfactants as Penetration Enhancer in Transdermal Drug Delivery System. J Mol
Pharm Org Process Res 2: 113. doi: 10.4172/2329-9053.1000113",614.886,-2.3377,-3.694,9,4,155.37,12,0,37,,,amide,amine,alkyl-amine,,,,acidic oxygen,Gonane,C1CCC2C(C1)CCC1C3CCCC3CCC21
Triamcinolone acetonide,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C,6436,STEROID,"12-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosa-14,17-dien-16-one",76-25-5,NA,-4.69,"Siddiqui O, Roberts MS, Polack AE. Pexcutaneous absorption of steroids: relative contributions of epidermal penetration and dermal clearance. J.Pharmacokinet.Biopharm. 1989; 17(4): 405‐424",434.50199999999995,1.3319999999999999,-3.661,6,2,93.06,2,0,22,,,,,,,,,,,O=C1C=CC2C(=C1)CCC1C2CCC2C1CC1OCOC12
Taurocholate,CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C,6675,STEROID,"2-(4-{4,7,11-trihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl}pentanamido)ethane-1-sulfonic acid",81-24-3,NA,,"Moghimipour, Eskandar, Abdulghani Ameri, and Somayeh Handali. ""Absorption-enhancing effects of bile salts."" Molecules 20.8 (2015): 14451-14473.",515.7090000000001,1.2391,-3.9960000000000004,8,5,152.54,7,0,30,approved; experimental,DB04348,amides,,,,,,acidic oxygens,,C1CCC2C(C1)CCC1C3CCCC3CCC21
"1-(3,7-Dimethylocta-2,6-dienyl)pyrrolidine-2,5-dione (Azone_analog-270)",CC(C)=CCCC(C)=CCN1C(=O)CCC1=O,190630,SUCCINIMIDE,"1-(3,7-dimethylocta-2,6-dien-1-yl)pyrrolidine-2,5-dione",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",235.326,3.3641,-2.169,3,0,37.38,5,0,8,,,amide,,,,,,,"2,5-Pyrrolidinedione",O=C1CCC(=O)N1
"1-Dodecylpyrrolidine-2,5-dione (Azone_analog-269)",CCCCCCCCCCCCN1C(=O)CCC1=O,21472966,SUCCINIMIDE,"1-dodecylpyrrolidine-2,5-dione",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",267.411,4.4733,-3.457,3,0,37.38,11,0,14,,,amide,,,,,,,"2,5-Pyrrolidinedione",O=C1CCC(=O)N1
"Hexyl 6-(2,5-dioxopyrrolidin-1-yl)hexanoate (Azone_analog-340)",CCCCCCOC(=O)CCCCCN1C(=O)CCC1=O,70686386,SUCCINIMIDE,"hexyl 6-(2,5-dioxopyrrolidin-1-yl)hexanoate",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",297.393,3.1224,-2.82,5,0,63.68,12,0,14,,,amide,,,,,,,"2,5-Pyrrolidinedione",O=C1CCC(=O)N1
"Heptyl 6-(2,5-dioxopyrrolidin-1-yl)hexanoate (Azone_analog-341)",CCCCCCCOC(=O)CCCCCN1C(=O)CCC1=O,70696783,SUCCINIMIDE,"heptyl 6-(2,5-dioxopyrrolidin-1-yl)hexanoate",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",311.42,3.5768,-3.09,5,0,63.68,13,0,15,,,amide,,,,,,,"2,5-Pyrrolidinedione",O=C1CCC(=O)N1
"Octyl 6-(2,5-dioxopyrrolidin-1-yl)hexanoate (Azone_analog-342)",CCCCCCCCOC(=O)CCCCCN1C(=O)CCC1=O,70686387,SUCCINIMIDE,"octyl 6-(2,5-dioxopyrrolidin-1-yl)hexanoate",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",325.447,4.0312,-3.36,5,0,63.68,14,0,16,,,amide,,,,,,,"2,5-Pyrrolidinedione",O=C1CCC(=O)N1
"Nonyl 6-(2,5-dioxopyrrolidin-1-yl)hexanoate (Azone_analog-343)",CCCCCCCCCOC(=O)CCCCCN1C(=O)CCC1=O,70682128,SUCCINIMIDE,"nonyl 6-(2,5-dioxopyrrolidin-1-yl)hexanoate",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",339.474,4.4856,-3.63,5,0,63.68,15,0,17,,,amide,,,,,,,"2,5-Pyrrolidinedione",O=C1CCC(=O)N1
"Decyl 6-(2,5-dioxopyrrolidin-1-yl)hexanoate (Azone_analog-344)",CCCCCCCCCCOC(=O)CCCCCN1C(=O)CCC1=O,56837637,SUCCINIMIDE,"decyl 6-(2,5-dioxopyrrolidin-1-yl)hexanoate",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",353.501,4.94,-3.9,5,0,63.68,16,0,18,,,amide,,,,,,,"2,5-Pyrrolidinedione",O=C1CCC(=O)N1
"Undecyl 6-(2,5-dioxopyrrolidin-1-yl)hexanoate (Azone_analog-345)",CCCCCCCCCCCOC(=O)CCCCCN1C(=O)CCC1=O,56837638,SUCCINIMIDE,"undecyl 6-(2,5-dioxopyrrolidin-1-yl)hexanoate",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",367.528,5.3944,-4.17,5,0,63.68,17,0,19,,,amide,,,,,,,"2,5-Pyrrolidinedione",O=C1CCC(=O)N1
"Dodecyl 6-(2,5-dioxopyrrolidin-1-yl)hexanoate (Azone_analog-346)",CCCCCCCCCCCCOC(=O)CCCCCN1C(=O)CCC1=O,70684243,SUCCINIMIDE,"dodecyl 6-(2,5-dioxopyrrolidin-1-yl)hexanoate",-,NA,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",381.555,5.8488,-4.44,5,0,63.68,18,0,20,,,amide,,,,,,,"2,5-Pyrrolidinedione",O=C1CCC(=O)N1
N-Methylsuccinimide (Azone_analog-268),CN1C(=O)CCC1=O,70717,SUCCINIMIDE,"1-methylpyrrolidine-2,5-dione",1121-07-9,1121-07-9,,"Jampílek, J. (2015). Azone® and Its Analogues as Penetration Enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 69-105). Springer, Berlin, Heidelberg.",113.116,-0.47700000000000004,-0.457,3,0,37.38,0,0,3,,,amide,,,,,,,"2,5-Pyrrolidinedione",O=C1CCC(=O)N1
Tyloxapol,CC(C)(C)CC(C)(C)C1=CC=C(C=C1)O.C=O.C(CO)O,16219992,SURF,"4-(2,4,4-trimethylpentan-2-yl)phenol; ethane-1,2-diol; formaldehyde",-,NA,,"Schäfer-Korting, M., Mehnert, W., & Korting, H. C. (2007). Lipid nanoparticles for improved topical application of drugs for skin diseases. Advanced drug delivery reviews, 59(6), 427-443.",298.421,4.5887,-3.3569999999999998,1,1,20.23,3,1,9,,,,,,,,,,Benzene,c1ccccc1
Polysorbate 80,CCCCCCCCC=CCCCCCCCC(=O)OCCOCC(C1C(CC(O1)OCCO)OCCO)OCCO,5284448,SURF,"2-{2-[3,5-bis(2-hydroxyethoxy)oxolan-2-yl]-2-(2-hydroxyethoxy)ethoxy}ethyl octadec-9-enoate",-,NA,,"Pandey, A., Mittal, A., Chauhan, N., & Alam, S. (2014). Role of surfactants as penetration enhancer in transdermal drug delivery system. J Mol Pharm Org Process Res, 2(113), 2-7.",604.818,5.3068,-4.334,10,3,133.14,31,0,38,,,,,,,,,,Tetrahydrofuran,C1CCOC1
Sucrose monostearate,CCCCCCCCCCCCCCCCCC(=O)OC1C(O)C(CO)OC1(CO)OC2OC(CO)C(O)C(O)C2O,14515659,SURF,"4-hydroxy-2,5-bis(hydroxymethyl)-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-3-yl octadecanoate",-,NA,,"Ghafourian, T., Nokhodchi, A., & Kaialy, W. (2015). Surfactants as penetration enhancers for dermal and transdermal drug delivery. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 207-230). Springer, Berlin, Heidelberg.",608.763,3.1448,-4.048,12,7,195.6,23,0,40,,,,,,,,,,Tetrahydrofuran,C1CCC(OC2CCCO2)OC1
Docusate,CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)O,11339,SURF,"1,4-bis[(2-ethylhexyl)oxy]-1,4-dioxobutane-2-sulfonic acid",10041-19-7,"147-89-7,21954-86-9,123344-03-6",,"Vejnovic, I., Simmler, L., & Betz, G. (2010). Investigation of different formulations for drug delivery through the nail plate. International journal of pharmaceutics, 386(1-2), 185-194.",422.58099999999996,3.6341,-3.5,7,1,115.35,18,0,22,approved,DB11089,,,,,,,acidic oxygen,,
Dodecyltrimethylammonium,CCCCCCCCCCCC[N+](C)(C)C,8153,SURF,dodecyltrimethylazanium,10182-91-9,NA,,"Som, I., Bhatia, K., & Yasir, M. (2012). Status of surfactants as penetration enhancers in transdermal drug delivery. Journal of pharmacy & bioallied sciences, 4(1), 2.",228.442,1.8769,-2.542,1,0,0.0,11,0,16,approved,DB01718,,amine,alkyl-amine,,,,,,
Tetradecyltrimethylammonium,CCCCCCCCCCCCCC[N+](C)(C)C,14251,SURF,trimethyl(tetradecyl)azanium,10182-92-0,NA,,"Som, I., Bhatia, K., & Yasir, M. (2012). Status of surfactants as penetration enhancers in transdermal drug delivery. Journal of pharmacy & bioallied sciences, 4(1), 2.",256.496,2.7857,-3.082,1,0,0.0,13,0,18,approved,DB01718,,amine,alkyl-amine,,,,,,
Tetrabutylammonium,CCCC[N+](CCCC)(CCCC)CCCC,16028,SURF,tetrabutylazanium,10549-76-5,"122544-96-1,70623-38-0,63314-37-4",,"Wong, O., Huntington, J., Konishi, R., Rytting, J. H., & Higuchi, T. (1988). Unsaturated cyclic ureas as new nontoxic biodegradable transdermal penetration enhancers I: Synthesis. Journal of pharmaceutical sciences, 77(11), 967-971.",242.46900000000002,2.187,-2.9019999999999997,1,0,0.0,12,0,17,experimental,DB01851,,amine,alkyl-amine,,,,,,
Dodecyl betaine,CCCCCCCCCCCC[N+](C)(C)CC(=O)[O-].[Na+].[Cl-],12686,SURF,sodium 2-(dodecyldimethylazaniumyl)acetate chloride,11140-78-6,"103171-41-1,128885-05-2,131131-70-9,25251-14-3,39033-74-4,683-10-3,89045-97-6",,"Som, I., Bhatia, K., & Yasir, M. (2012). Status of surfactants as penetration enhancers in transdermal drug delivery. Journal of pharmacy & bioallied sciences, 4(1), 2.",329.88599999999997,-1.0691,-2.3169999999999997,3,0,40.13,13,0,17,experimental,DB07631,,amine,alkyl-amine,,,,acidic oxygen,,
"N,N-Dimethylheptanamide",CCCCCCC(=O)N(C)C,14221,SURF,"N,N-dimethylheptanamide",1115-96-4,1115-96-4,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",157.256,2.1931,-1.439,2,0,20.31,5,0,8,,,amide,,,,,,,,
"N,N-Dimethyloctanamide",CCCCCCCC(=O)N(C)C,14240,SURF,"N,N-dimethyloctanamide",1118-92-9,1118-92-9,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",171.283,2.6475,-1.709,2,0,20.31,6,0,9,,,amide,,,,,,,,
Sodium Tetradecyl Sulfate,CCCCCCCCCCCCCCOS(=O)(=O)[O-].[Na+],23665770,SURF,sodium tetradecyl sulfate,1191-50-0,"1191-50-0,22088-37-5",,"Pandey, A., Mittal, A., Chauhan, N., & Alam, S. (2014). Role of surfactants as penetration enhancer in transdermal drug delivery system. J Mol Pharm Org Process Res, 2(113), 2-7.",316.436,2.6409,-2.571,4,0,74.81,14,0,17,experimental,DB00815,,,,,,,acidic oxygen,,
Benzalkonium chloride,CC(C)(C)CC(C)(C)C1=CC=C(C=C1)OCCOCC[N+](C)(C)CC2=CC=CC=C2.[Cl-],8478,SURF,"benzyldimethyl(2-{2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy}ethyl)azanium chloride",121-54-0,"121-54-0,39362-38-4,5929-09-9",,"Moghadam, S. H., Saliaj, E., Wettig, S. D., Dong, C., Ivanova, M. V., Huzil, J. T., & Foldvari, M. (2013). Effect of chemical permeation enhancers on stratum corneum barrier lipid organizational structure and interferon alpha permeability. Molecular pharmaceutics, 10(6), 2248-2260.",448.088,2.952,-4.073,3,0,18.46,12,2,18,approved,DB11125,,amine,alkyl-amine,,,,,,c1ccc(C[NH2+]CCOCCOc2ccccc2)cc1
Cetalkonium chloride,CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1.[Cl-],31202,SURF,benzyl(hexadecyl)dimethylazanium chloride,122-18-9,"10328-34-4,122-18-9,60484-28-8,89004-36-4",,"Ibrahim, S. S. (2019). The role of surface active agents in ophthalmic drug delivery: a comprehensive review. Journal of Pharmaceutical Sciences, 108(6), 1923-1933.",396.1,5.1126,-4.945,1,0,0.0,17,1,20,approved,DB11583,,amine,alkyl-amine,,,,,Benzene,c1ccccc1
Dodecylamine,CCCCCCCCCCCCN,13583,SURF,dodecan-1-amine,124-22-1,"68155-27-1,124-22-1,126162-08-1,27177-40-8",,"Alsaqr, A., Rasoully, M., & Musteata, F. M. (2015). Investigating Transdermal Delivery of Vitamin D 3. Aaps Pharmscitech, 16(4), 963-972.",185.35299999999998,4.1967,-3.253,1,1,26.02,10,0,13,,,,amine,alkyl-amine,,,basic nitrogen,,,
Docusate calcium,CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)[O-].CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)[O-].[Ca+2],31407,SURF,"calcium bis(1,4-bis[(2-ethylhexyl)oxy]-1,4-dioxobutane-2-sulfonate)",128-49-4,128-49-4,,"Miwa, Y., Hamamoto, H., & Ishida, T. (2016). Lidocaine self-sacrificially improves the skin permeation of the acidic and poorly water-soluble drug etodolac via its transformation into an ionic liquid. European Journal of Pharmaceutics and Biopharmaceutics, 102, 92-100.",883.2239999999999,2.3865,-3.5,7,0,118.18,18,0,22,,,,,,,,,acidic oxygen,,
Sodium lauroylsarcosinate,CCCCCCCCCCCC(=O)N(C)CC(=O)[O-].[Na+],23668817,SURF,sodium 2-(N-methyldodecanamido)acetate,137-16-6,"1322-85-6,137-16-6,75195-12-9",,"Som, I., Bhatia, K., & Yasir, M. (2012). Status of surfactants as penetration enhancers in transdermal drug delivery. Journal of pharmacy & bioallied sciences, 4(1), 2.",293.381,1.5191,-2.5639999999999996,4,0,60.44,12,0,14,,,amide,,,,,,acidic oxygen,,
Dimethyldioctadecylammonium,CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC,7880,SURF,dimethyldioctadecylazanium,14357-21-2,116466-64-9,,"Kulkarni, V. S., & Shaw, C. (2015). Essential chemistry for formulators of semisolid and liquid dosages. Academic Press.",551.06,12.28,-8.782,1,0,0.0,34,0,39,approved; experimental,DB04221,,amine,alkyl-amine,,,,,,
3-(Dodecyldimethylammonio)propanesulfonate,CCCCCCCCCCCC[N+](C)(C)CCCS(=O)(=O)[O-],84703,SURF,3-(dodecyldimethylazaniumyl)propane-1-sulfonate,14933-08-5,"134280-89-0,14933-08-5,74812-18-3,76975-15-0,107934-23-6",,"Ullah, I., Baloch, M. K., & Durrani, G. F. (2012). Solubility of lidocaine in ionic, nonionic and zwitterionic surfactants. Journal of solution chemistry, 41(2), 215-222.",335.551,-0.8103,-2.336,4,0,65.58,15,0,20,,,,amine,alkyl-amine,,,,acidic oxygen,,
Decyltrimethylammonium,CCCCCCCCCC[N+](C)(C)C,16389,SURF,decyltrimethylazanium,15053-09-05,NA,,"Som, I., Bhatia, K., & Yasir, M. (2012). Status of surfactants as penetration enhancers in transdermal drug delivery. Journal of pharmacy & bioallied sciences, 4(1), 2.",200.388,0.9681,-2.002,1,0,0.0,9,0,14,approved,DB01718,,amine,alkyl-amine,,,,,,
Sodium lauryl sulphate,CCCCCCCCCCCCOS(=O)(=O)[O-].[Na+],3423265,SURF,sodium dodecyl sulfate,151-21-3,"8012-56-4,111726-87-5,121481-64-9,12738-53-3,12765-21-8,129203-37-8,1334-67-4,1335-72-4,152155-52-7,51222-39-0,151-21-3,58640-35-0,61711-39-5,64441-33-4,74433-77-5,57176-54-2",-2.54,"Effendy, I., Weltfriend, S., Kwangsukstith, C., Singh, P. and Maibach, H.I. (1996): Effects of all‐trans reitinoic acid and sodium lauryl sulphate on the permeability of human skin in vitro. Br. J. Dermatol, 135, 428‐432",288.383,1.7321,-2.031,4,0,74.81,12,0,15,experimental,DB00815,,,,,,,acidic oxygen,,
1-dodecylurea,CCCCCCCCCCCCNC(=O)N,75091,SURF,dodecylurea,2158-09-0,2158-09-0,,"Williams, A. C. (2015). Urea and derivatives as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 301-308). Springer, Berlin, Heidelberg.",228.378,3.9824,-3.714,3,2,55.12,11,0,12,,,amide,,,,,,,,
Alkylbenzyl sulfonic acid,CCCCCCCCCCC(C)C1=CC=C(C=C1)S(=O)(=O)[O-].[Na+],23691965,SURF,sodium 4-(dodecan-2-yl)benzene-1-sulfonate,2211-99-6,"2211-99-6,42615-29-2",,"Som, I., Bhatia, K., & Yasir, M. (2012). Status of surfactants as penetration enhancers in transdermal drug delivery. Journal of pharmacy & bioallied sciences, 4(1), 2.",348.481,3.4593,-3.523,3,0,65.58,11,1,14,,,,,,,,,acidic oxygen,Benzene,c1ccccc1
L-beta-Oleoyl-gamma-palmitoyl-alpha-lecithin,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC,5497103,SURF,(2-{[3-(hexadecanoyloxy)-2-(octadec-9-enoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium,26853-31-6,NA,,"Ghafourian, T., Nokhodchi, A., & Kaialy, W. (2015). Surfactants as penetration enhancers for dermal and transdermal drug delivery. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 207-230). Springer, Berlin, Heidelberg.",760.086,6.6157,-6.666,9,0,121.0,41,0,45,investigational,DB05456,,amine,alkyl-amine,,,,acidic oxygen,,
Viscosin,CCCCCCCC(CC(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC1C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)CC(C)C)CO)CC(C)C)CO)C(C)CC)C)O,72937,SURF,"4-{[3-(butan-2-yl)-6,12-bis(hydroxymethyl)-22-methyl-9,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-18-(propan-2-yl)-1-oxa-4,7,10,13,16,19-hexaazacyclodocosan-21-yl]carbamoyl}-4-[2-(3-hydroxydecanamido)-4-methylpentanamido]butanoic acid",27127-62-4,NA,,"Banat, I. M., Makkar, R. S., & Cameotra, S. S. (2000). Potential commercial applications of microbial surfactants. Applied microbiology and biotechnology, 53(5), 495-508.",1126.4,0.4778,-6.108,25,13,386.19,27,0,48,,,amide,,,,,,acidic oxygen,,O=C1CCOC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)CN1
"1,3-didodecylurea",CCCCCCCCCCCCNC(=O)NCCCCCCCCCCCC,533921,SURF,"1,3-didodecylurea",3542-20-9,NA,,"Williams, A. C. (2015). Urea and derivatives as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 301-308). Springer, Berlin, Heidelberg.",396.70099999999996,9.2842,-6.63,3,2,41.13,22,0,24,,,amide,,,,,,,,
Cocamidopropyl betaine,CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(=O)[O-],20280,SURF,2-[(3-dodecanamidopropyl)dimethylazaniumyl]acetate,4292-10-8,"4292-10-8,5437-10-5,65277-51-2",,"Pandey, A., Mittal, A., Chauhan, N., & Alam, S. (2014). Role of surfactants as penetration enhancer in transdermal drug delivery system. J Mol Pharm Org Process Res, 2(113), 2-7.",342.522,-1.531,-2.354,5,1,69.23,16,0,19,,,amide,amine,alkyl-amine,,,,acidic oxygen,,
Dodecyl benzene sulfonic acid,CCCCCCCCCCCCC1=CC=CC=C1S(=O)(=O)O,25457,SURF,2-dodecylbenzene-1-sulfonic acid,47221-31-8,47221-31-8,,"Imura, T., Morita, T., Fukuoka, T., Ryu, M., Igarashi, K., Hirata, Y., & Kitamoto, D. (2014). Spontaneous vesicle formation from sodium salt of acidic sophorolipid and its application as a skin penetration enhancer. Journal of Oleo Science, ess13117.",326.499,4.7338,-3.425,3,1,62.75,12,1,14,,,,,,,,,acidic oxygen,Benzene,c1ccccc1
"N,N-Dimethylhexanamide",CCCCCC(=O)N(C)C,22084,SURF,"N,N-dimethylhexanamide",5830-30-8,5830-30-8,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",143.22899999999998,1.7387,-1.169,2,0,20.31,4,0,7,,,amide,,,,,,,,
"N,N-Dimethylnonanamide",CCCCCCCCC(=O)N(C)C,138694,SURF,"N,N-dimethylnonanamide",6225-08-7,07.08.6225,,"Li, S. K., & Higuchi, W. I. (2015). Quantitative structure–enhancement relationship and the microenvironment of the enhancer site of action. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 55-67). Springer, Berlin, Heidelberg.",185.31,3.1019,-1.979,2,0,20.31,7,0,10,,,amide,,,,,,,,
1-dodecyl-3- phenylthiourea,CCCCCCCCCCCCNC(=S)NC1=CC=CC=C1,2758732,SURF,3-dodecyl-1-phenylthiourea,63980-78-9,NA,,"Williams, A. C. (2015). Urea and derivatives as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 301-308). Springer, Berlin, Heidelberg.",320.543,6.4393,-5.221,2,2,56.15,12,1,13,,,,,,,,,,Benzene,c1ccccc1
1-dodecyl-3-methylthiourea,CCCCCCCCCCCCNC(=S)NC,5151745,SURF,1-dodecyl-3-methylthiourea,6430-76-8,6430-76-8,,"Williams, A. C. (2015). Urea and derivatives as penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 301-308). Springer, Berlin, Heidelberg.",258.472,4.7306,-3.714,2,2,56.15,11,0,14,,,,,,,,,,,
Cetrimonium,CCCCCCCCCCCCCCCC[N+](C)(C)C,2681,SURF,hexadecyltrimethylazanium,6899-10-1,NA,,"Monti, D., Chetoni, P., Burgalassi, S., Najarro, M., & Saettone, M. F. (2002). Increased corneal hydration induced by potential ocular penetration enhancers: assessment by differential scanning calorimetry (DSC) and by desiccation. International journal of pharmaceutics, 232(1-2), 139-147.",284.54900000000004,3.6945,-3.622,1,0,0.0,15,0,20,approved,DB01718,,amine,alkyl-amine,,,,,,
Dodecyl maltoside,CCCCCCCCCCCCOC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)CO)O)O)O)O)O,114880,SURF,"2-{[6-(dodecyloxy)-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol",69227-93-6,NA,,"Kim, E., Lee, J., Lee, S. R., Jung, H. J., Kim, H. S., Jung, K., ... & Suh, A. J. The Permeability Enhancement Capability of Sodium Lauryl Sulfate and Dodecyl Maltoside Across The Dermal Tissue of L. Terrestris.",510.61800000000005,0.9203,-2.577,11,7,178.53,16,0,35,experimental,DB02686,,,,,,,,,C1CCC(OC2CCCOC2)OC1
Diarachidoyl phosphatidylcholine,CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC,10169785,SURF,"(2-{[2,3-bis(icosanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium",71259-34-2,NA,,"Dragicevic, N., Atkinson, J. P., & Maibach, H. I. (2015). Chemical penetration enhancers: classification and mode of action. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 11-27). Springer, Berlin, Heidelberg.",846.263,9.5943,-8.514,9,0,121.0,48,0,53,approved; investigational; withdrawn,DB09114,,amine,alkyl-amine,,,,acidic oxygen,,
4-decyloxazolidin-2-one,CCCCCCCCCCC1COC(=O)N1,10220190,SURF,"4-decyl-1,3-oxazolidin-2-one",7693-82-5,NA,,"Dragicevic, N., Atkinson, J. P., & Maibach, H. I. (2015). Chemical penetration enhancers: classification and mode of action. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 11-27). Springer, Berlin, Heidelberg.",227.347,4.1983,-3.72,3,1,38.33,9,0,13,,,,,,,,,,2-Oxazolidinone,O=C1NCCO1
Cetylpyridinium chloride,CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1,2683,SURF,1-hexadecylpyridin-1-ium,7773-52-6,7773-52-6,,"Monti, D., Egiziano, E., Burgalassi, S., Tampucci, S., Terreni, E., Tivegna, S., & Chetoni, P. (2018). Influence of a combination of chemical enhancers and iontophoresis on in vitro transungual permeation of nystatin. AAPS PharmSciTech, 19(4), 1574-1581.",304.54,3.3527,-4.269,1,0,3.88,15,1,16,approved,DB11073,,,,,aromatic nitrogen,,,,c1cc[nH+]cc1
Cetomacrogol,CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,2724259,SURF,"3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60-icosaoxahexaheptacontan-1-ol",9004-95-9,NA,,"Patel, A., Bell, M., O’Connor, C., Inchley, A., Wibawa, J., & Lane, M. E. (2013). Delivery of ibuprofen to the skin. International journal of pharmaceutics, 457(1), 9-13.",1123.5,4.5621,-2.677,21,1,204.83,74,0,77,experimental,DB04233,,,,,,,,,
Polysorbate 40 [USAN:INN:BAN:NF],CCCCCCCCCCCC(=O)OCCOCC(C1C(C(CO1)OCCO)OCCO)OCCO,92329579,SURF,"2-{2-[3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-(2-hydroxyethoxy)ethoxy}ethyl dodecanoate",9005-66-7,"9005-67-8,9005-64-5,9005-66-7",,"Pandey, A., Mittal, A., Chauhan, N., & Alam, S. (2014). Role of surfactants as penetration enhancer in transdermal drug delivery system. J Mol Pharm Org Process Res, 2(113), 2-7.",522.673,2.331,-2.7289999999999996,10,3,133.14,26,0,34,,,,,,,,,,Tetrahydrofuran,C1CCOC1
Benzyldimethyloctylammonium Chloride,CCCCCCCC[N+](C)(C)CC1=CC=CC=C1.[Cl-],13740,SURF,benzyldimethyloctylazanium chloride,959-55-7,959-55-7,,"Dragicevic, N., Atkinson, J. P., & Maibach, H. I. (2015). Chemical penetration enhancers: classification and mode of action. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 11-27). Springer, Berlin, Heidelberg.",283.885,1.4774,-2.785,1,0,0.0,9,1,12,approved,DB11583,,amine,alkyl-amine,,,,,Benzene,c1ccccc1
cyclohexanemethanol,OCC1CCCCC1,7507,TERP,cyclohexylmethanol,100-49-2,100-49-2,-3.48,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",114.18700000000001,1.3946,-1.8030000000000002,1,1,20.23,1,0,8,,,,,,,,,,Cyclohexane,C1CCCCC1
menthone,CC(C)C1CCC(C)CC1=O,6986,TERP,5-methyl-2-(propan-2-yl)cyclohexan-1-one,10458-14-7,"17627-49-5,7786-64-3,89-80-5,36977-92-1,491-07-6,10458-14-7,39307-52-3,1074-95-9",-3.83,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",154.252,2.5549,-2.552,1,0,17.07,1,0,9,,,,,,,,,,Cyclohexanon,O=C1CCCCC1
β-citronellol,C[C@@H](CCO)CCC=C(C)C,101977,TERP,"(3R)-3,7-dimethyloct-6-en-1-ol",106-22-9,"106-22-9,1117-61-9",-2.97,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",156.268,3.3494,-2.153,1,1,20.23,5,0,9,,,,,,,,,,,
geraniol,CC(C)=CCC\C(C)=C\CO,637566,TERP,"(2E)-3,7-dimethylocta-2,6-dien-1-ol",106-24-1,"624-15-7,106-24-1,8007-13-4,68311-14-8",-3.22,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",154.252,3.4853,-1.889,1,1,20.23,4,0,7,experimental,DB02509,,,,,,,,,
nerol,CC(C)=CCC\C(C)=C/CO,643820,TERP,"(2Z)-3,7-dimethylocta-2,6-dien-1-ol",106-25-2,106-25-2,-3.39,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",154.252,3.4853,-1.889,1,1,20.23,4,0,7,experimental,DB02509,,,,,,,,,
squalene,CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CCC=C(C)C,638072,TERP,"(6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene",111-02-4,"111-02-4,94016-35-0,7683-64-9",-3.65,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",410.727,13.099,-6.3,0,0,0.0,15,0,18,vet_approved,DB11460,,,,,,,,,
(-)-isolongifolol,C[C@@]12CCCC([C@@H]3[C@H]1CC[C@@H]3[C@@H]2CO)(C)C,16217350,TERP,"[(1R,2S,7R,8S,9S)-3,3,7-trimethyltricyclo[5.4.0.0²,⁹]undecan-8-yl]methanol",1139-17-9,NA,-3.62,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",222.37,3.1597,-3.3989999999999996,1,1,20.23,1,0,16,,,,,,,,,,,C1CC[C@@H]2[C@H]3CC[C@@H]2CC3C1
(-)-caryophyllene oxide,C[C@@]12CC[C@@H]3[C@H](CC3(C)C)C(=C)CC[C@H]1O2,1742210,TERP,"(1R,4R,6R,10S)-4,12,12-trimethyl-9-methylidene-5-oxatricyclo[8.2.0.0⁴,⁶]dodecane",1139-30-6,NA,-2.65,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",220.355,4.0553,-3.5580000000000003,1,0,12.53,0,0,14,,,,,,,,,,,C=C1CC[C@H]2OC2CC[C@H]2CC[C@H]12
octisalate,CCCCC(CC)COC(=O)C1=CC=CC=C1O,8364,TERP,2-ethylhexyl 2-hydroxybenzoate,118-60-5,"118-60-5,8014-40-2",-2.25,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",250.33700000000002,4.1235,-3.2710000000000004,3,1,46.53,8,1,10,approved; investigational,DB11062,,,,,,,,Benzene,c1ccccc1
Fenchone,CC1(C2CCC(C2)(C1=O)C)C,14525,TERP,"1,3,3-trimethylbicyclo[2.2.1]heptan-2-one",1195-79-5,"18492-37-0,126-21-6,1195-79-5",,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",152.236,2.1793,-2.452,1,0,17.07,0,0,9,,,,,,,,,,,O=C1CC2CCC1C2
Limonene oxide,CC(=C)C1CCC2(C(C1)O2)C,91496,TERP,1-methyl-4-(prop-1-en-2-yl)-7-oxabicyclo[4.1.0]heptane,1195-92-2,"10008-60-3,31326-91-7,98240-20-1",,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",152.236,2.3448,-2.435,1,0,12.53,1,0,9,experimental,DB02924,,,,,,,,,C1CCC2OC2C1
myrcene,CC(C)=CCCC(=C)C=C,31253,TERP,"7-methyl-3-methylideneocta-1,6-diene",123-35-3,"123-35-3,2153-31-3",-2.19,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",136.237,4.2932,-2.502,0,0,0.0,4,0,4,,,,,,,,,,,
Pulegone,CC1CCC(=C(C)C)C(=O)C1,6988,TERP,5-methyl-2-(propan-2-ylidene)cyclohexan-1-one,15932-80-6,"90449-51-7,15932-80-6,3285-04-9",,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",152.236,2.8501,-2.252,1,0,17.07,0,0,7,,,,,,,,,,,C=C1CCCCC1=O
Pinene oxide,CC1(C2CC1C3(C(C2)O3)C)C,91508,TERP,"2,7,7-trimethyl-3-oxatricyclo[4.1.1.0²,⁴]octane",1686-14-2,"25488-94-2,32162-27-9,1686-14-2,74525-43-2",,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",152.236,1.7044,-2.415,1,0,12.53,0,0,11,,,,,,,,,,,C1C2CC1C1OC1C2
(S)-(-)-perillaldehyde,CC(=C)[C@H]1CCC(=CC1)C=O,2724159,TERP,(4S)-4-(prop-1-en-2-yl)cyclohex-1-ene-1-carbaldehyde,18031-40-8,NA,-2.86,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",150.22,2.2224,-2.247,1,0,17.07,2,0,5,,,,,,,,,,,C1=CCCCC1
(-)-dihydrocarveol,C[C@@H]1CC[C@H](C[C@H]1O)C(C)=C,443163,TERP,"(1R,2R,5R)-2-methyl-5-(prop-1-en-2-yl)cyclohexan-1-ol",20549-47-7,NA,-3.89,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",154.252,2.6138,-2.404,1,1,20.23,1,0,9,,,,,,,,,,Cyclohexane,C1CCCCC1
(+)-dihydrocarveol,C[C@H]1CC[C@@H](C[C@@H]1O)C(C)=C,89755,TERP,"(1S,2S,5S)-2-methyl-5-(prop-1-en-2-yl)cyclohexan-1-ol",22567-21-1,22567-21-1,-3.77,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",154.252,2.6138,-2.404,1,1,20.23,1,0,9,,,,,,,,,,Cyclohexane,C1CCCCC1
alpha Pinene,CC1=CCC2CC1C2(C)C,6654,TERP,"2,6,6-trimethylbicyclo[3.1.1]hept-2-ene",25766-18-1,"53569-35-0,56833-58-0,67762-73-6,68411-25-6,102640-64-2,103657-08-5,25766-18-1,39388-04-0,39423-40-0,50815-61-7,2437-95-8,80-56-8,57762-87-5,72510-05-5",,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",136.237,2.721,-2.519,0,0,0.0,0,0,8,experimental,DB15573,,,,,,,,,C1=CC2CC(C1)C2
7-Oxabicylo- (2-2-1)heptane,C1CC2CCC1O2,9234,TERP,7-oxabicyclo[2.2.1]heptane,279-49-2,279-49-2,,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",98.1444,0.9022,-1.8330000000000002,1,0,9.23,0,0,7,,,,,,,,,,,C1CC2CCC1O2
Cyclopentene oxide,C1CC2C(C1)O2,9244,TERP,6-oxabicyclo[3.1.0]hexane,285-67-6,"117193-12-1,149827-17-8,285-67-6",,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",84.1175,0.5602,-1.5630000000000002,1,0,12.53,0,0,6,,,,,,,,,,,C1CC2OC2C1
retinoic acid,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,444795,TERP,"(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid",302-79-4,"5300-03-8,302-79-4,56573-65-0,7005-78-9",-4.7,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",300.44,5.8207,-3.478,2,1,37.3,5,0,10,approved; investigational,DB00523,,,,,,,acidic oxygen,,C1=CCCCC1
farnesol,CC(C)=CCCC(C)=CCCC(C)=CCO,3327,TERP,"3,7,11-trimethyldodeca-2,6,10-trien-1-ol",4602-84-0,NA,-2.79,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",222.37,5.6571,-2.865,1,1,20.23,7,0,10,experimental,DB02509,,,,,,,,,
(-)-α-cedrene,C[C@@H]1CC[C@H]2C(C)(C)[C@H]3C[C@@]12CC=C3C,6431015,TERP,"(1S,2R,5S,7S)-2,6,6,8-tetramethyltricyclo[5.3.1.0¹,⁵]undec-8-ene",469-61-4,NA,-2.92,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",204.356,3.9819,-3.642,0,0,0.0,0,0,13,,,,,,,,,,,C1=C[C@H]2C[C@@H]3CCC[C@]3(C1)C2
EUCALYPTOL,CC1(C2CCC(O1)(CC2)C)C,2758,TERP,"1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane",470-82-6,"470-82-6,10458-11-4,8024-52-0,8024-53-1",,"Dragicevic, N., Atkinson, J. P., & Maibach, H. I. (2015). Chemical penetration enhancers: classification and mode of action. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 11-27). Springer, Berlin, Heidelberg.",154.252,2.1095,-2.481,1,0,9.23,0,0,11,experimental; nutraceutical,DB03852,,,,,,,,,C1CC2CCC1CO2
(+)-longifolene,C[C@]12CCCC(C)(C)[C@H]3[C@H](CC[C@@H]13)C2=C,1796220,TERP,"(1R,2S,7S,9S)-3,3,7-trimethyl-8-methylidenetricyclo[5.4.0.0²,⁹]undecane",475-20-7,NA,-3.25,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",204.356,4.0602,-3.8089999999999997,0,0,0.0,0,0,13,,,,,,,,,,,C=C1C2CCCC[C@H]3[C@@H]1CC[C@@H]23
(-)-α-santonin,C[C@H]1[C@@H]2CC[C@@]3(C)C=CC(=O)C(C)=C3[C@H]2OC1=O,221071,TERP,"(3S,3aS,5aS,9bS)-3,5a,9-trimethyl-2H,3H,3aH,4H,5H,5aH,8H,9bH-naphtho[1,2-b]furan-2,8-dione",481-06-1,481-06-1,-3.44,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",246.305,1.8467,-2.7039999999999997,3,0,43.37,0,0,10,,,,,,,,,,,O=C1C=CC2CC[C@H]3CC(=O)O[C@@H]3C2=C1
(+)-aromadendrene,C[C@@H]1CC[C@@H]2[C@@H]1[C@H]3[C@H](C3(C)C)CCC2=C,11095734,TERP,"(1aR,4aR,7R,7aR,7bS)-1,1,7-trimethyl-4-methylidene-decahydro-1H-cyclopropa[e]azulene",489-39-4,NA,-3.17,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",204.356,3.998,-3.792,0,0,0.0,0,0,13,,,,,,,,,,,C=C1CC[C@H]2C[C@H]2[C@@H]2CCC[C@@H]12
(-)-guaiol,C[C@H]1CC[C@H](CC2=C1CC[C@@H]2C)C(C)(C)O,227829,TERP,"2-[(3S,5R,8S)-3,8-dimethyl-1,2,3,4,5,6,7,8-octahydroazulen-5-yl]propan-2-ol",489-86-1,489-86-1,-3.54,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",222.37,3.6689,-3.2560000000000002,1,1,20.23,1,0,14,,,,,,,,,,,C1CCC2=C(CC1)CCC2
carvacrol,CC(C)C1=CC=C(C)C(O)=C1,10364,TERP,2-methyl-5-(propan-2-yl)phenol,499-75-2,499-75-2,-3.77,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",150.22,2.8448,-2.535,1,1,20.23,1,1,5,,,,,,,,,,Benzene,c1ccccc1
ocimene,CC(=C)CC\C=C(/C)C=C,5320249,TERP,"(3E)-3,7-dimethylocta-1,3,7-triene",502-99-8,502-99-8,-2.36,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",136.237,4.2932,-2.502,0,0,0.0,4,0,4,,,,,,,,,,,
eucarvone,CC1=CC=CC(C)(C)CC1=O,136330,TERP,"2,6,6-trimethylcyclohepta-2,4-dien-1-one",503-93-5,503-93-5,-3.33,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",150.22,2.1758,-2.077,1,0,17.07,0,0,5,,,,,,,,,,,O=C1C=CC=CCC1
Ascaridole,CC(C)C12CCC(C=C1)(OO2)C,10545,TERP,"1-methyl-4-(propan-2-yl)-2,3-dioxabicyclo[2.2.2]oct-5-ene",512-85-6,512-85-6,,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",168.235,2.3961,-2.454,2,0,18.46,1,0,10,,,,,,,,,,,C1=CC2CCC1OO2
(1R)-(-)-myrtenol,CC1(C)C2CC1C(CO)=CC2,10582,TERP,"{6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl}methanol",515-00-4,"19250-18-1,6712-78-3,111957-74-5,515-00-4",-2.63,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",152.236,1.7943,-2.012,1,1,20.23,1,0,9,,,,,,,,,,,C1=CC2CC(C1)C2
(±)-α-bisabolol,CC1=CCC(CC1)C(C)(CCC=C(C)C)O,10586,TERP,6-methyl-2-(4-methylcyclohex-3-en-1-yl)hept-5-en-2-ol,515-69-5,"21090-60-8,25428-43-7,63601-23-0,67375-41-1",-2.18,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",222.37,4.4711,-3.162,1,1,20.23,4,0,12,approved; experimental,DB13153,,,,,,,,,C1=CCCCC1
citral,CC(C)=CCC\C(C)=C\C=O,638011,TERP,"(2E)-3,7-dimethylocta-2,6-dienal",5392-40-5,"37350-34-8,8022-94-4,96680-15-8,141-27-5,5392-40-5",-2.22,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",152.236,3.273,-2.104,1,0,17.07,4,0,5,,,,,,,,,,,
(+)-β-cedrene,C[C@@H]1CC[C@H]2C(C)(C)[C@H]3C[C@@]12CCC3=C,11106485,TERP,"(1S,2R,5S,7S)-2,6,6-trimethyl-8-methylidenetricyclo[5.3.1.0¹,⁵]undecane",546-28-1,NA,-2.9,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",204.356,4.0602,-3.8089999999999997,0,0,0.0,0,0,13,,,,,,,,,,,C=C1CC[C@]23CCC[C@H]2C[C@H]1C3
(-)-α-thujone,CC(C)[C@@]12C[C@@H]1[C@@H](C)C(=O)C2,261491,TERP,"(1S,4R,5R)-4-methyl-1-(propan-2-yl)bicyclo[3.1.0]hexan-3-one",546-80-5,"546-80-5,59573-80-7",-3.75,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",152.236,2.1785,-2.435,1,0,17.07,1,0,9,,,,,,,,,,,O=C1CC2C[C@@H]2C1
(+)-dihydrocarvone,C[C@@H]1CC[C@H](CC1=O)C(C)=C,22227,TERP,"(2R,5R)-2-methyl-5-(prop-1-en-2-yl)cyclohexan-1-one",5524-05-0,"5524-05-0,5948-04-9",-3.15,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",152.236,2.7575,-2.455,1,0,17.07,1,0,7,,,,,,,,,,Cyclohexanon,O=C1CCCCC1
Terpinen-4-ol,CC1=CCC(CC1)(C(C)C)O,11230,TERP,4-methyl-1-(propan-2-yl)cyclohex-3-en-1-ol,562-74-3,"1336-05-6,28219-82-1,562-74-3",,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",154.252,2.3354,-2.186,1,1,20.23,1,0,9,investigational,DB12816,,,,,,,,,C1=CCCCC1
(1R)-(-)-myrtenal,CC1(C2CC=C(C1C2)C=O)C,61130,TERP,"6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-carbaldehyde",564-94-3,"23727-16-4,564-94-3,57526-63-3",-2.39,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",150.22,1.5819999999999999,-2.227,1,0,17.07,1,0,7,,,,,,,,,,,C1=CC2CC(C1)C2
terpinolene,CC(C)=C1CCC(C)=CC1,11463,TERP,1-methyl-4-(propan-2-ylidene)cyclohex-1-ene,586-62-9,"69073-38-7,586-62-9",-3.06,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",136.237,3.4539999999999997,-2.336,0,0,0.0,0,0,6,,,,,,,,,,,C=C1CC=CCC1
(S)-(-)-citronellal,C[C@@H](CCC=C(C)C)CC=O,443157,TERP,"(3S)-3,7-dimethyloct-6-enal",5949-05-3,03.05.5949,-2.22,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",154.252,3.1371,-2.3680000000000003,1,0,17.07,5,0,7,,,,,,,,,,,
d-Limonene,CC1=CCC(CC1)C(=C)C,440917,TERP,1-methyl-4-(prop-1-en-2-yl)cyclohex-1-ene,5989-27-5,"6876-12-6,555-08-8,7705-14-8,8050-32-6,138-86-3,7705-13-7,8022-90-0,95327-98-3,68246-90-2,26123-39-7,7721-11-1,9003-73-0,65996-98-7",,"Dragicevic, N., Atkinson, J. P., & Maibach, H. I. (2015). Chemical penetration enhancers: classification and mode of action. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 11-27). Springer, Berlin, Heidelberg.",136.237,3.3614,-2.539,0,0,0.0,1,0,6,investigational,DB08921,,,,,,,,,C1=CCCCC1
(R)-(-)-carvone,CC(=C)[C@@H]1CC=C(C)C(=O)C1,439570,TERP,(5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one,6485-40-1,6485-40-1,-3.32,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",150.22,2.653,-2.191,1,0,17.07,1,0,5,,,,,,,,,,,O=C1C=CCCC1
α-humulene,CC1=CCC(C)(C)C=CCC(C)=CCC1,23204,TERP,"2,6,6,9-tetramethylcycloundeca-1,4,8-triene",6753-98-6,NA,-2.71,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",204.356,6.2387,-3.4010000000000002,0,0,0.0,0,0,9,,,,,,,,,,,C1=CCCC=CCCC=CC1
retinol,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C,445354,TERP,"(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol",68-26-8,"1341-18-0,1406-67-3,53637-36-8,13123-33-6,17104-91-5,5979-23-7,11103-57-4,68-26-8",-2.86,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",286.457,6.1703,-3.4960000000000004,1,1,20.23,5,0,11,approved; nutraceutical; vet_approved,DB00162,,,,,,,,,C1=CCCCC1
Nerolidol,CC(=CCCC(=CCCC(C)(C=C)O)C)C,5284507,TERP,"3,7,11-trimethyldodeca-1,6,10-trien-3-ol",7212-44-4,NA,,"Pandit, J., Aqil, M., & Sultana, Y. (2015). Terpenes and essential oils as skin penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 173-193). Springer, Berlin, Heidelberg.",222.37,5.4029,-3.125,1,1,20.23,7,0,10,,,,,,,,,,,
(±)-nerolidol,CC(=CCC/C(=C/CCC(C)(C=C)O)/C)C,5284507,TERP,"(6E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol",7212-44-4,"40716-66-3,11055-57-5,14528-94-0,35944-21-9,7212-44-4",-2.08,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",222.37,5.4029,-3.125,1,1,20.23,7,0,10,,,,,,,,,,,
β-carotene,C\C(\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)CCCC1(C)C,5280489,TERP,"1,3,3-trimethyl-2-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-1-ene",7235-40-7,"7235-40-7,116-32-5,31797-85-0",-4.62,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",536.885,13.873,-7.334,0,0,0.0,10,0,18,approved; nutraceutical,DB06755,,,,,,,,,C1=C(/C=C/C=C/C=C/C=C/C=C/C=C/C=C/C=C/C=C/C2=CCCCC2)CCCC1
3-Carene,CC1=CCC2C(C1)C2(C)C,26049,TERP,"3,7,7-trimethylbicyclo[4.1.0]hept-3-ene",74806-04-5,"74806-04-5,116783-27-8,13466-78-9",,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",136.237,2.721,-2.519,0,0,0.0,0,0,8,,,,,,,,,,,C1=CCC2CC2C1
phytol,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO,5280435,TERP,"(2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol",7541-49-3,"5016-81-9,150-86-7,7541-49-3",-2.21,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",296.53700000000003,7.4212,-4.633,1,1,20.23,13,0,19,,,,,,,,,,,
(+)-cedrol,C[C@@H]1CC[C@H]2C(C)(C)[C@H]3C[C@@]12CC[C@@]3(C)O,65575,TERP,"(1S,2R,5S,7R,8R)-2,6,6,8-tetramethyltricyclo[5.3.1.0¹,⁵]undecan-8-ol",77-53-2,"13567-37-8,77-53-2",-3.42,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",222.37,3.263,-3.4560000000000004,1,1,20.23,0,0,16,,,,,,,,,,,C1C[C@H]2C[C@@H]3CCC[C@]3(C1)C2
(+)-cedryl acetate,C[C@@H]1CC[C@@H]2[C@]13CC[C@@]([C@H](C3)C2(C)C)(C)OC(=O)C,13918856,TERP,"(1S,2R,5S,7R,8R)-2,6,6,8-tetramethyltricyclo[5.3.1.0¹,⁵]undecan-8-yl acetate",77-54-3,NA,-2.38,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",264.407,3.7476,-3.866,2,0,26.3,2,0,17,,,,,,,,,,,C1C[C@H]2C[C@@H]3CCC[C@]3(C1)C2
(±)-linalool,CC(C)=CCCC(C)(O)C=C,6549,TERP,"3,7-dimethylocta-1,6-dien-3-ol",78-70-6,"11024-20-7,78-70-6,22564-99-4",-4.0,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",154.252,3.2311,-2.149,1,1,20.23,4,0,7,,,,,,,,,,,
Fennel oil,CC=CC1=CC=C(C=C1)OC.CC1(C2CCC(C2)(C1=O)C)C.COC1=CC=C(C=C1)CC=C,6850740,TERP,"1,3,3-trimethylbicyclo[2.2.1]heptan-2-one; 1-methoxy-4-(prop-1-en-1-yl)benzene; 1-methoxy-4-(prop-2-en-1-yl)benzene",8006-84-6,NA,,"Pandit, J., Aqil, M., & Sultana, Y. (2015). Terpenes and essential oils as skin penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 173-193). Springer, Berlin, Heidelberg.",448.645,2.1793,-2.452,1,0,17.07,0,0,9,,,,,,,,,,Benzene,c1ccccc1
Peppermint oil,CC1CCC2(CC1)C(CO2)C.CC1CCC(C(C1)O)C(C)C.CC1CCC(C(C1)OC(=O)C)C(C)C.CC1CCC(C(=O)C1)C(C)C.CC1CCC2=C(C1)OC=C2C.CC1CCC(=C(C)C)C(=O)C1,6850741,TERP,"3,6-dimethyl-4,5,6,7-tetrahydro-1-benzofuran; 3,7-dimethyl-1-oxaspiro[3.5]nonane; 5-methyl-2-(propan-2-yl)cyclohexan-1-ol; 5-methyl-2-(propan-2-yl)cyclohexan-1-one; 5-methyl-2-(propan-2-yl)cyclohexyl acetate; 5-methyl-2-(propan-2-ylidene)cyclohexan-1-one",8006-90-4,NA,,"Pandit, J., Aqil, M., & Sultana, Y. (2015). Terpenes and essential oils as skin penetration enhancers. In Percutaneous penetration enhancers chemical methods in penetration enhancement (pp. 173-193). Springer, Berlin, Heidelberg.",965.533,2.8958,-2.911,2,0,26.3,3,0,12,,,,,,,,,,Cyclohexane,C1CCCCC1
(-)-trans-caryophyllene,C/C/1=C\CCC(=C)[C@H]2CC([C@@H]2CC1)(C)C,5281515,TERP,"(1R,4E,9S)-4,11,11-trimethyl-8-methylidenebicyclo[7.2.0]undec-4-ene",87-44-5,"8007-38-3,1407-53-0,87-44-5",-3.15,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",204.356,5.4861,-3.662,0,0,0.0,0,0,11,,,,,,,,,,,C=C1CC/C=C/CC[C@H]2CC[C@H]12
(-)-epiglobulol,C[C@@H]1CC[C@@H]2[C@@H]1[C@H]3[C@H](C3(C)C)CC[C@]2(C)O,11858788,TERP,"(1aR,4S,4aR,7R,7aS,7bS)-1,1,4,7-tetramethyl-decahydro-1H-cyclopropa[e]azulen-4-ol",88728-58-9,NA,-1.96,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",222.37,3.2008,-3.4389999999999996,1,1,20.23,0,0,16,,,,,,,,,,,C1C[C@H]2C[C@H]2[C@@H]2CCC[C@H]2C1
L-(-)-menthol,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O,16666,TERP,"(1R,2S,5R)-5-methyl-2-(propan-2-yl)cyclohexan-1-ol",89-78-1,"98167-53-4,2216-51-5,89-78-1",-3.21,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",156.268,2.4112,-2.501,1,1,20.23,1,0,11,approved,DB00825,,,,,,,,Cyclohexane,C1CCCCC1
(-)-isopulegol,C[C@@H]1CC[C@H]([C@@H](C1)O)C(=C)C,170833,TERP,"(1R,2S,5R)-5-methyl-2-(prop-1-en-2-yl)cyclohexan-1-ol",89-79-2,"50373-36-9,59905-53-2",-3.72,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",154.252,2.6138,-2.404,1,1,20.23,1,0,9,,,,,,,,,,Cyclohexane,C1CCCCC1
piperitone,CC1=CC(=O)C(CC1)C(C)C,6987,TERP,3-methyl-6-(propan-2-yl)cyclohex-2-en-1-one,89-81-6,6091-52-7,,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",152.236,2.4504,-2.2880000000000003,1,0,17.07,1,0,7,,,,,,,,,,,O=C1C=CCCC1
(R)-(+)-pulegone,C[C@@H]1CCC(=C(C)C)C(=O)C1,442495,TERP,(5R)-5-methyl-2-(propan-2-ylidene)cyclohexan-1-one,89-82-7,89-82-7,-2.87,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",152.236,2.8501,-2.252,1,0,17.07,0,0,7,,,,,,,,,,,C=C1CCCCC1=O
thymol,CC(C)C1=CC=C(C)C=C1O,6989,TERP,5-methyl-2-(propan-2-yl)phenol,89-83-8,89-83-8,-3.74,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",150.22,2.8448,-2.535,1,1,20.23,1,1,5,approved,DB02513,,,,,,,,Benzene,c1ccccc1
alpha Terpineol,CC1=CCC(CC1)C(C)(C)O,17100,TERP,2-(4-methylcyclohex-3-en-1-yl)propan-2-ol,98-55-5,"11103-96-1,37195-01-0,8000-41-7,8031-32-1,2438-12-2,8006-39-1,22347-88-2",,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",154.252,2.2993,-2.186,1,1,20.23,1,0,9,,,,,,,,,,,C1=CCCCC1
(-)-carveol,CC1=CCC(CC1O)C(=C)C,7438,TERP,2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-ol,99-48-9,"20307-86-2,22567-18-6,2102-59-2,99-48-9",-2.91,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",152.236,2.5093,-2.14,1,1,20.23,1,0,7,,,,,,,,,,,C1=CCCCC1
Carvone,CC1=CCC(CC1=O)C(=C)C,7439,TERP,2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one,99-49-0,"22327-39-5,99-49-0",,"Kanikkannan, N., & Babu, R. J. (2015). Structure-activity relationship of chemical penetration enhancers. In Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement (pp. 39-54). Springer, Berlin, Heidelberg.",150.22,2.653,-2.191,1,0,17.07,1,0,5,,,,,,,,,,,O=C1C=CCCC1
α-phellandrene,CC(C)C1CC=C(C)C=C1,7460,TERP,"2-methyl-5-(propan-2-yl)cyclohexa-1,3-diene",99-83-2,"34448-33-4,1330-17-2,13811-01-3,1329-99-3,25377-78-0",-2.23,"LIFENG, K. (2006). Skin permeation enhancement by terpenes for transdermal drug delivery (Doctoral dissertation).",136.237,2.8834,-2.408,0,0,0.0,1,0,6,,,,,,,,,,,C1=CCCC=C1